
<html lang="en"     class="pb-page"  data-request-id="7eb5a4d9-8ecf-4022-8263-fae26f7f372c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.9b00644;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2019.62.issue-19;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Natural Product Albiziabioside A Conjugated with Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate To Induce Apoptosis-Ferroptosis-M2-TAMs Polarization for Combined Cancer Therapy" /></meta><meta name="dc.Creator" content="Gaofei  Wei" /></meta><meta name="dc.Creator" content="Jiahong  Sun" /></meta><meta name="dc.Creator" content="Weijing  Luan" /></meta><meta name="dc.Creator" content="Zhuang  Hou" /></meta><meta name="dc.Creator" content="Shuai  Wang" /></meta><meta name="dc.Creator" content="Shanshan  Cui" /></meta><meta name="dc.Creator" content="Maosheng  Cheng" /></meta><meta name="dc.Creator" content="Yang  Liu" /></meta><meta name="dc.Description" content="The reprogramming of energy metabolism is considered to be one of the main characteristics of cancer. The development of therapeutic agents targeting glycolysis to alter aberrant glucose metabolism..." /></meta><meta name="Description" content="The reprogramming of energy metabolism is considered to be one of the main characteristics of cancer. The development of therapeutic agents targeting glycolysis to alter aberrant glucose metabolism..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 11, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00644" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00644" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00644" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00644" /></link>
        
    
    

<title>Natural Product Albiziabioside A Conjugated with Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate To Induce Apoptosis-Ferroptosis-M2-TAMs Polarization for Combined Cancer Therapy | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00644" /></meta><meta property="og:title" content="Natural Product Albiziabioside A Conjugated with Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate To Induce Apoptosis-Ferroptosis-M2-TAMs Polarization for Combined Cancer Therapy" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0011.jpeg" /></meta><meta property="og:description" content="The reprogramming of energy metabolism is considered to be one of the main characteristics of cancer. The development of therapeutic agents targeting glycolysis to alter aberrant glucose metabolism and restore oxidative phosphorylation has emerged as an effective approach for cancer therapy. In this way, we have developed a conjugate AlbA-DCA, which can induce a marked increase in intracellular ROS and alleviate the accumulation of lactic acid in TME. Meanwhile, AlbA-DCA selectively kills cancer cells and exhibits an excellent synergistic effect. Mechanism studies confirm that AlbA-DCA can induce apoptosis and ferroptosis. We also confirm that AlbA-DCA can remold the tumor immunosuppression microenvironment via eliminating M2-TAMs to inhibit both primary and distal tumor progression in a dual-4T1 tumor model in female BALB/c mice. As a result, rational design of natural saponin and PDK inhibitor to induce apoptosis-ferroptosis-M2-TAMs polarization for enhanced cancer therapy is a promising strategy, thus providing a new idea for cancer therapy." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00644"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00644">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00644&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00644&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00644&amp;href=/doi/10.1021/acs.jmedchem.9b00644" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 8760-8772</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00638" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00882" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Natural Product Albiziabioside A Conjugated with Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate To Induce Apoptosis-Ferroptosis-M2-TAMs Polarization for Combined Cancer Therapy</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Gaofei Wei</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gaofei Wei</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China</div><div class="loa-info-affiliations-info">Institute of Medical Research, Northwestern Polytechnical University, Xi’an 710072, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#4b3c2e222c2d7b7d7b7e0b7a7d7865282426"><span class="__cf_email__" data-cfemail="6512000c020355535550255453564b060a08">[email protected]</span></a> (G.W.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gaofei++Wei">Gaofei Wei</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jiahong Sun</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jiahong Sun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biopharmaceutical Science, School of Pharmacy and Health Sciences, Keck Graduate Institute, Claremont, California 91711, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jiahong++Sun">Jiahong Sun</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Weijing Luan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Weijing Luan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China</div><div class="loa-info-affiliations-info">Yantai Branch, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), Yantai 264000, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Weijing++Luan">Weijing Luan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhuang Hou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhuang Hou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhuang++Hou">Zhuang Hou</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shuai Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shuai Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shuai++Wang">Shuai Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shanshan Cui</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shanshan Cui</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shanshan++Cui">Shanshan Cui</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Maosheng Cheng</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maosheng Cheng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#3f524c5c575a51587f4c464f574a115a5b4a115c51"><span class="__cf_email__" data-cfemail="78150b1b101d161f380b0108100d561d1c0d561b16">[email protected]</span></a> (M.C.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maosheng++Cheng">Maosheng Cheng</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Yang Liu</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yang Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#0f762163667a4f7c767f677a216a6b7a216c61"><span class="__cf_email__" data-cfemail="a1d88fcdc8d4e1d2d8d1c9d48fc4c5d48fc2cf">[email protected]</span></a> (Y.L.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yang++Liu">Yang Liu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9284-1944" title="Orcid link">http://orcid.org/0000-0002-9284-1944</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00644&amp;href=/doi/10.1021%2Facs.jmedchem.9b00644" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 8760–8772</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 11, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>16 April 2019</li><li><span class="item_label"><b>Published</b> online</span>11 September 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 October 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00644" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00644</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8760%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGaofei%2BWei%252C%2BJiahong%2BSun%252C%2BWeijing%2BLuan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D19%26contentID%3Dacs.jmedchem.9b00644%26title%3DNatural%2BProduct%2BAlbiziabioside%2BA%2BConjugated%2Bwith%2BPyruvate%2BDehydrogenase%2BKinase%2BInhibitor%2BDichloroacetate%2BTo%2BInduce%2BApoptosis-Ferroptosis-M2-TAMs%2BPolarization%2Bfor%2BCombined%2BCancer%2BTherapy%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8772%26publicationDate%3DOctober%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00644"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2160</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">7</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00644" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Natural Product Albiziabioside A Conjugated with Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate To Induce Apoptosis-Ferroptosis-M2-TAMs Polarization for Combined Cancer Therapy&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Gaofei&quot;,&quot;last_name&quot;:&quot;Wei&quot;},{&quot;first_name&quot;:&quot;Jiahong&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Weijing&quot;,&quot;last_name&quot;:&quot;Luan&quot;},{&quot;first_name&quot;:&quot;Zhuang&quot;,&quot;last_name&quot;:&quot;Hou&quot;},{&quot;first_name&quot;:&quot;Shuai&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Shanshan&quot;,&quot;last_name&quot;:&quot;Cui&quot;},{&quot;first_name&quot;:&quot;Maosheng&quot;,&quot;last_name&quot;:&quot;Cheng&quot;},{&quot;first_name&quot;:&quot;Yang&quot;,&quot;last_name&quot;:&quot;Liu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;8760-8772&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00644&quot;},&quot;abstract&quot;:&quot;The reprogramming of energy metabolism is considered to be one of the main characteristics of cancer. The development of therapeutic agents targeting glycolysis to alter aberrant glucose metabolism and restore oxidative phosphorylation has emerged as an effective approach for cancer therapy. In this way, we have developed a conjugate AlbA-DCA, which can induce a marked increase in intracellular ROS and alleviate the accumulation of lactic acid in TME. Meanwhile, AlbA-DCA selectively kills cancer cells and exhibits an excellent synergistic effect. Mechanism studies confirm that AlbA-DCA can induce apoptosis and ferroptosis. We also confirm that AlbA-DCA can remold the tumor immunosuppression microenvironment via eliminating M2-TAMs to inhibit both primary and distal tumor progression in a dual-4T1 tumor model in female BALB/c mice. As a result, rational design of natural saponin and PDK inhibitor to induce apoptosis-ferroptosis-M2-TAMs polarization for enhanced cancer therapy is a promising strategy, thus prov&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00644&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00644" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00644&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00644" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00644&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00644" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00644&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00644&amp;href=/doi/10.1021/acs.jmedchem.9b00644" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00644" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00644" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (10 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00644%26sid%3Dliteratum%253Aachs%26pmid%3D31509699%26genre%3Darticle%26aulast%3DWei%26date%3D2019%26atitle%3DNatural%2BProduct%2BAlbiziabioside%2BA%2BConjugated%2Bwith%2BPyruvate%2BDehydrogenase%2BKinase%2BInhibitor%2BDichloroacetate%2BTo%2BInduce%2BApoptosis-Ferroptosis-M2-TAMs%2BPolarization%2Bfor%2BCombined%2BCancer%2BTherapy%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D19%26spage%3D8760%26epage%3D8772%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/jmcmar.2019.62.issue-19/20191010/jmcmar.2019.62.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/medium/jm9b00644_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00644&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The reprogramming of energy metabolism is considered to be one of the main characteristics of cancer. The development of therapeutic agents targeting glycolysis to alter aberrant glucose metabolism and restore oxidative phosphorylation has emerged as an effective approach for cancer therapy. In this way, we have developed a conjugate AlbA-DCA, which can induce a marked increase in intracellular ROS and alleviate the accumulation of lactic acid in TME. Meanwhile, AlbA-DCA selectively kills cancer cells and exhibits an excellent synergistic effect. Mechanism studies confirm that AlbA-DCA can induce apoptosis and ferroptosis. We also confirm that AlbA-DCA can remold the tumor immunosuppression microenvironment via eliminating M2-TAMs to inhibit both primary and distal tumor progression in a dual-4T1 tumor model in female BALB/c mice. As a result, rational design of natural saponin and PDK inhibitor to induce apoptosis-ferroptosis-M2-TAMs polarization for enhanced cancer therapy is a promising strategy, thus providing a new idea for cancer therapy.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12468" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12468" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The reprogramming of energy metabolism is considered to be one of the main characteristics of cancer.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Glucose is transported into the cytoplasm via glucose transporters and metabolized to pyruvate. Normal cells typically convert pyruvate to acetyl-CoA catalyzed by pyruvate dehydrogenase (PDH) during mitochondria oxidative phosphorylation (OXPHOS) as the main source of energy. However, due to the up-regulation of the glucose transporter and glycolytic enzymes, such as lactate dehydrogenase A (LDHA) and pyruvate dehydrogenase kinase (PDK), cancer cells avidly consume glucose and convert pyruvate to lactate for energy to survive, resulting in a phenomenon known as the “Warburg effect” or aerobic glycolysis.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> The enhanced aerobic glycolysis continuously transports lactate out of cells, leading to the accumulation of lactic acid in the tumor microenvironment (TME) and causing local acidification.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Increasing evidence demonstrates that high levels of aerobic glycolysis-derived lactic acid promote tumor progression through reduced apoptosis, enhanced cell mobility, augmented metastatic potential, and limited immune response.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5−8)</a> Given these correlations, the development of therapeutic agents targeting glycolysis to alter aberrant glucose metabolism and restore OXPHOS has emerged as an effective approach for cancer therapy.</div><div class="NLM_p">Dichloroacetate acid (DCA) is used for the treatment of lactic acidosis in humans as an inhibitor of PDK, which is a kinase that regulates the flux of pyruvate into mitochondria by inhibiting the mitochondrial enzyme PDH.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> By inhibiting PDK and thereby stimulating PDH, DCA can shift cellular metabolism away from aerobic glycolysis to OXPHOS and eventually alleviate the accumulation of lactic acid in TME.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> This metabolic switch facilitates the up-regulation of pro-apoptotic mediators such as cytochrome <i>c</i> (cyt <i>c</i>) and the Bcl-2 family of proteins, both of which can induce apoptosis.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Moreover, DCA can also improve the immunosuppressive status modulated by glycolysis-derived lactic acid and promote tumor immunotherapy.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Unlike many anticancer drugs, DCA reverses only the mitochondrial status of tumor cells, resulting in a higher sensitivity to malignant cells more vulnerable than normal cells.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> However, therapeutically high doses of DCA (∼100 mM) are required for anticancer proliferation due to the poor mitochondrial targeting of DCA.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">Construction of mitochondria-targeted molecular scaffold triphenylphosphonium (TPP) cation and DCA load via an esterase-triggered ester bond has been proven to be an effective method for enhancing mitochondrial targeting and antitumor potency.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> Although this design would suggest the effective delivery of DCA to mitochondria, the biodegradable linker may break before reaching the target site, resulting in the actual DCA concentration in mitochondria to be significantly reduced. The fusion of metallodrugs with DCA has also been developed as a DCA delivery strategy for synergistic therapy, including platinum(IV)<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17−19)</a> and rhenium(I).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> However, the toxicity of metallodrugs is also a problem that cannot be ignored. Therefore, the construction of an efficient and safe multifunctional DCA delivery conjugate still needs unremitting effort and development.</div><div class="NLM_p">Recent studies have revealed that the antitumor activity of the natural product triterpenoid is associated with mitochondria by ΔΨ<sub>m</sub> depolarization and the release of cytochrome <i>c</i>. This results in activation of the caspase protein family, ultimately leading to apoptosis.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In our previous study, we focused on the synthesis and structural modification of a natural oleanane triterpenoid saponin Albiziabioside A (AlbA), originally isolated from the aerial parts of <i>Albizia inundata</i>.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> For example, we found that AlbA could induce A375 cell apoptosis by regulating mitochondrial function involving a caspase cascade with an IC<sub>50</sub> value of 5.47 μM.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The AlbA coupled cinnamoyl substituent derivative could also affect mitochondrial pathways and then reverse the apoptotic silence of HCT116 cells with IC<sub>50</sub> value 7.6 μM.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Furthermore, AlbA and its derivative showed excellent selective killing of cancer cells without affecting normal human cell growth.<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23−25)</a> However, like other oleanane triterpenoid saponins, AlbA derivatives reached their limit in regulating the normalization of mitochondrial respiration and inhibiting tumor proliferation.</div><div class="NLM_p">In this study, we designed a conjugate AlbA-DCA, AlbA connected to a DCA subunit, using the regulatory capacity of AlbA-disrupting mitochondria and the inhibitory effect of DCA on PDK. We hypothesized that, through the intramolecular synergistic effects of AlbA and DCA, conjugate AlbA-DCA can affect energy metabolism reprogramming of tumor cells, shift cellular metabolism away from aerobic glycolysis to OXPHOS, and thereby alleviate the accumulation of lactic acid in TME, ultimately to induce mitochondrial-dependent apoptosis and improve the tumor immunosuppressive environment to combined cancer therapy. Here, we described the synthesis, characterization, and investigation of antitumor modes of conjugateAlbA-DCA (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/medium/jm9b00644_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Schematic Illustration of Mechanism for Combined Cancer Therapy by AlbA-DCA</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00644&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65087" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65087" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Design and Synthesis of AlbA-DCA</h3><div class="NLM_p">Major challenges in designing multifunctional therapeutic agents that couple two different functional drug molecules include the compatibility, stability, and activity of drugs, and the number of suitable attachment sites. With those issues in mind, we designed conjugate AlbA-DCA and control compounds AlbA-CA. We designed this agent to test whether metabolic reprogramming, followed by drug activation, could be achieved in the context of a single multifunctional chemical entity. AlbA-DCA contains a mitochondria-disrupting AlbA moiety reversibly connected to a DCA subunit via a comparatively stable amide linkage, which was expected to be susceptible to carboxylesterase-induced release. Conjugate AlbA-DCA was obtained by coupling DCA-anhydride with intermediate 1, which was synthesized according to our previously reported method,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> followed by debenzoylation and deacetylation in a catalytic amount of sodium methoxide (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Conjugate AlbA-DCA was purified by silica gel column chromatography and characterized by <sup>1</sup>H NMR, <sup>13</sup>C NMR, and HRMS analyses. All of the characteristic signals can correspond to the structure one by one in the NMR, such as in the <sup>13</sup>C NMR δ 180.0 for -CO- of -COOH, 164.7 for -CO in -Cl<sub>2</sub>Ac,, 144.5 and 122.4 for -C═C in oleanolic acid, 105.2 and 104.0 for two terminal carbons in Glu and Ara, and 88.8 for -3′C of oleanolic acid. In addition, the molecular formula obtained by high-resolution mass spectrometry test was consistent with the theoretical calculation value, which is C<sub>44</sub>H<sub>69</sub>Cl<sub>2</sub>NO<sub>12</sub>. Next, we investigated the stability of conjugates. Upon incubation of Alb-DCA in phosphate-buffered saline (PBS [pH 7.4]) and plasma at 37 °C for 2 h, no decomposition was observed. The results provided a certain stability basis for tail vein injection in the follow-up in vivo experiments. On the other hand, exposure of conjugate Alb-DCA to carboxylesterase (1 U/mL) resulted in the scission of the aniline–amide bond (<a class="ref internalNav" href="#notes1" aria-label="Supporting Information">Supporting Information</a> Figure S1).</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/medium/jm9b00644_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of AlbA-DCA and Control (AlbA-CA)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00644&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: Anhydride, DCM, rt, 2 h; then MeONa, MeOH, DCM, rt, overnight.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Inhibition of PDK Activity</h3><div class="NLM_p">First, we measured the expression of PDK on several cancer cell lines by Western blot assay, including human melanoma A375 cells, human breast cancer MCF-7 cells, human colon cancer HCT116 cells, and mouse breast cancer 4T1 cells. The results showed that the PDK protein is highly expressed in breast cancer cells, especially MCF-7 (<a class="ref internalNav" href="#notes1" aria-label="Figure S2">Figure S2</a>). The inhibition effect of conjugate AlbA-DCA, AlbA, Na-DCA, and AlbA-CA on the PDK activity was investigated in vitro using ADP-Glo Luminescent Kinase Assay. Encouragingly, covalently coupled DCA had little effect on its PDK inhibition activity in the MCF-7 cell culture fluid. As shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A, both AlbA-DCA and Na-DCA displayed the same level of inhibition activity. AlbA and AlbA-CA had no effect on its PDK inhibition activity. However, AlbA-DCA displayed no PDK inhibition activity in the PBS and plasma (<a class="ref internalNav" href="#notes1" aria-label="Figure S3">Figure S3</a>). This finding leads us to suggest that AlbA-DCA is an effective substrate for carboxylesterase and that it may be activated in the tumor microenvironment (compared with plasma, a high concentration of carboxyesterase was found in the tumor microenvironment.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a>). Furthermore, the inhibition effect of conjugate AlbA-DCA, AlbA, and Na-DCA on the PDK activity was investigated in MCF-7 cells using Western blot assay. However, Na-DCA could not effectively down-regulate the expression of PDK, which may be caused by low permeability and the mitochondria-targeted capacity of DCA in the cell (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B,C). Additionally, AlbA-DCA could effectively down-regulate the PDK expression in a concentration-dependent manner, which was consistent with the kinase experiments.</div><figure id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/medium/jm9b00644_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. AlbA-DCA altered energy metabolism from aerobic glycolysis back to OXPHOS in MCF-7 cells by inhibiting PDK. (A) PDK kinase activity assay in the presence of various inhibitors; (B, C) Expression of PDK in MCF-7 cells. GAPDH was used as internal control. (D) Effects of AlbA-DCA, AlbA, and Na-DCA on MCF-7 cell glycolysis. MCF-7 cells were treated with AlbA-DCA (2 μM), AlbA (10 μM), and Na-DCA (30 μM) for 4 h and subsequently treated with glucose, oligomycin, and 2-DG. ECAR traces were measured by a Seahorse XF24 Extracellular Flux Analyzer (D1). Calculations of glycolysis (D2), glycolytic capacity (D3), and glycolytic reserve (D4). (E) Effects of AlbA-DCA, AlbA, and Na-DCA on MCF-7 cells’ mitochondrial OXPHOS. MCF-7 cells were treated with AlbA-DCA (2 μM), AlbA (10 μM), and Na-DCA (30 μM) for 4 h and AlbA-DCA (2 μM) for 2 h. Determination of OCR traces using a Seahorse XF24 Extracellular Flux Analyzer (E1). Calculations of basal respiration (E2), ATP produvtion (E3), and spare respiration capacity (E4). Data are represented as mean ± SD of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00644&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Effects of AlbA-DCA on Cancer Cell Metabolic Reversal</h3><div class="NLM_p">According to the consensus that DCA can alter the energy metabolism reprogramming of tumor cells from aerobic glycolysis back to OXPHOS, a mitochondrial bioenergetic curve of AlbA-DCA in MCF-7 cells metabolic profiling was obtained using Seahorse XF24 extracellular flux analyzer. MCF-7 cells were pretreated with AlbA-DCA (2 μM), AlbA (10 μM), and Na-DCA (30 μM) for 4 h. Then the extracellular acidification rate (ECAR) was measured in response to the sequential injection of glucose (10 mM), oligomycin A (1 μM), and 2-deoxy-<span class="smallcaps smallerCapital">d</span>-glucose (2-DG, 100 mM) which are indirect measures of glycolysis, maximal glycolysis capacity, and glycolysis reserve, respectively (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D1). In a glucose-free medium, injecting glucose into MCF-7 cells caused increases in the ECAR of the control, AlbA and Na-DCA (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D1,D2). Then, an inhibitor of mitochondrial ATP synthase, oligomycin, was added, which triggered further change in the control, AlbA, and Na-DCA (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D1,D3). Finally, the hexokinase inhibitor 2-DG was injected and induced a rapid decline in the ECAR (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D1,D4). However, AlbA-DCA-treated cells did not show any significant changes in the ECAR (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D). These data confirmed that AlbA-DCA significantly inhibited glycolysis in MCF-7 cells.</div><div class="NLM_p last">We next investigated the changes in the oxygen consumption rate (OCR) as a method of assessing mitochondrial OXPHOS. Oligomycin, FCCP, and a mix of antimycin/rotenone were serially injected to measure ATP production, maximal respiration, and spare respiration capacity, respectively. The control MCF-7 cells exhibited an OCR curve change as follows (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>E1): an initial basal respiration level that indicated that the cells were using glucose to oxidize to produce oxygen; an attenuated, ATP-linked respiration with the subsequent addition of oligomycin (an ATP synthase inhibitor, 1 μM); a rebound of the OCR peak that represented maximum respiratory capacity after the injection of FCCP (a mitochondrial uncoupling agent, 2 μM); and a substantial decrease after the addition of antimycin/rotenone (1 μM) that completely inhibited mitochondrial respiration. As shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>E, the OCR level of AlbA-DCA was less than those of cells treated with AlbA and Na-DCA (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>E1), indicating that AlbA-DCA (6 h) could effectively inhibit mitochondrial respiration and non-mitochondrial respiration. In the shortened treatment time of AlbA-DCA (3 h), the treated MCF-7 cells showed a higher OCR curve with increased basal respiration (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>E2), enhanced ATP production (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>E3), and elevated spare respiration capacity (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>E4) compared to the control cells. These data documented that AlbA-DCA altered the energy metabolism from aerobic glycolysis back to OXPHOS in MCF-7 cells in the early stage.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Effects of AlbA-DCA on Mitochondria Dysfunction</h3><div class="NLM_p">On the basis of the targeting of mitochondrial capacity and remodeling of mitochondrial respiration, the effect of AlbA-DCA on mitochondrial membrane potential (MMP, ΔΨ<sub>m</sub>) was examined, and AlbA and Na-DCA were compared using JC-1 staining by flow cytometry. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A, after treatment with AlbA (10 μM), a moderate loss of ΔΨ<sub>m</sub> (25.86%) was observed, which also proved that AlbA could target the mitochondria and further disrupt the function. In addition, the AlbA-DCA (2 μM) treatment of MCF-7 cells resulted in a significant decrease in ΔΨ<sub>m</sub>(46.39%), which was consistent with its altered energy metabolism capacity.</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/medium/jm9b00644_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Effect of AlbA-DCA (2 μM), AlbA (10 μM), and Na-DCA (30 μM) on the mitochondria membrane potential of MCF-7 cells by flow cytometry using JC-1 staining. (B) Effect of AlbA-DCA (2 μM), AlbA (10 μM), and Na-DCA (30 μM) on the generation of intracellular ROS by flow cytometry using DCF-DA staining. (C, D) Intracellular lactate levels and in the media lactate levels in MCF-7 cells and MCF-7 cells after treatment with AlbA-DCA (2 μM), AlbA (10 μM), and Na-DCA (30 μM) at indicated concentrations for 6 h. Data are represented as mean ± SD of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00644&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">It is well-known that mitochondria are the major source of reactive oxygen species (ROS), which are important mediators and players in cell death. Therefore, we examined the intracellular ROS-inducing capability of AlbA-DCA by flow cytometry using 2′,7′-dichlorodihydrofluorescein diacetate fluorescence (DCF-DA). The results showed that AlbA-DCA induced a marked increase in intracellular ROS, compared to the control, AlbA, and Na-DCA; the rates of increase were 6.7-fold, 2.9-fold, and 1.7-fold, respectively (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Effects of AlbA-DCA on the Tumor Acidic Microenvironment</h3><div class="NLM_p last">According to the general knowledge that cancer cells avidly convert pyruvate to lactate, which is then transported out of cells and results in the accumulation of lactic acid and local acidification of TME,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and combined with the above experimental results that AlbA-DCA could alter energy metabolism by effectively inhibiting PDK activity, we tested the ability of AlbA-DCA to reduce lactate production. Intracellular lactate levels and the media lactate levels in MCF-7 cells were measured and compared to PDK-medium-expressed 4T1 cells. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C,D, treatment with AlbA-DCA at 2 μM for 6 h markedly decreased intracellular lactate levels and the media lactate levels of 4T1 cells. Upon treating the 4T1 cells with AlbA-DCA, both intracellular lactate levels and the media lactate levels were reduced, but the magnitude of decrease was less than that in the MCF-7 cells (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>E,F), which further proved that AlbA-DCA can effectively reverse the glycolysis by inhibiting PDK. However, AlbA and DCA did not reduce both intra- and extracellular lactate in the MCF-7 and 4T1 cells. These observations suggested that AlbA-DCA was efficient in alleviating the accumulation of lactic acid in TME by inhibiting glycolysis.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> AlbA-DCA-Induced Apoptosis via a Caspase-Dependent Pathway</h3><div class="NLM_p">Reprogramming of energy metabolism in tumor cells results in altered mitochondrial respiration and reduced lactic acid generation, both of which induce cancer cells resistance to mitochondrial apoptosis and ensure cancer progression.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> As such, the ability of AlbA-DCA to induce apoptosis was analyzed by DAPI staining and annexin V-FITC/PI double staining (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A,B). Na-DCA and AlbA induced increases in the mean percentage of apoptotic cells, mainly in the early apoptotic cells (12.5 and 18.50). In addition, the ability of AlbA-DCA to induce apoptosis was the strongest, with the percentages of early apoptotic cells increasing from 3.53 to 25.16 and late apoptotic cells increasing from 2.97 to 22.92. Taken together, these results suggested that AlbA-DCA induces apoptotic cell death in MCF-7 cells.</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/medium/jm9b00644_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. AlbA-DCA-induced apoptosis of MCF-7 cells. (A, B) Effect of AlbA-DCA, AlbA, and Na-DCA on apoptosis in MCF-7 cells. MCF-7 cells were incubated with AlbA-DCA (2 μM), AlbA (10 μM), and Na-DCA (30 μM). After 24 h of incubation, cells were collected and stained with Annexin V/PI, followed by flow cytometric analysis. (C, D) Expression of apoptosis-related protein. GAPDH was used as internal control. (E) Cell cytotoxicity of AlbA-DCA (2 μM), AlbA (10 μM), and Na-DCA (30 μM) in MCF-7 cells pretreated with z-VAD-fmk. Data are represented as mean ± SD of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00644&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">After obtaining the above results, to investigate of the mechanism of AlbA-DCA-induced MCF-7 cell apoptosis, we examined the change in expression of cytochrome <i>c</i>, Bcl-2, and caspase 9 protein. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C,D, AlbA-DCA could significantly up-regulate the expression of cytochrome <i>c</i> (4.4-fold) and down-regulate the expression of antiapoptotic protein Bcl-2 (0.5-fold). Furthermore, the expression of caspase-9, the essential initiator caspase via the mitochondrial pathway, was significantly enhanced in AlbA-DCA-treated groups (6.0-fold). Moreover, we also found that Z-VAD-fmk (a wide-spectrum inhibitor of caspases) partially reversed the death of MCF-7 cells (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>E). These results indicated that AlbA-DCA- nduced apoptosis in MCF-7 cells via a caspase-dependent pathway.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> AlbA-DCA-Induced Ferroptosis</h3><div class="NLM_p">On the basis of the effective AlbA-DCA mediation of energy metabolism reprogramming and ROS accumulation, combined with the result that ROS accumulation induced by mitochondrial dysfunction is involved in the induction of ferroptosis,<a onclick="showRef(event, 'ref25 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref25 ref28 ref29">(25,28,29)</a> we hypothesized that AlbA-DCA can cause the inactivation of GPX4 for ferroptosis-mediated cancer cell death. To verify the occurrence of ferroptosis of AlbA-DCA-induced MCF-7 cells death, various well-known ferroptosis inhibitors and promoters were used. The cytotoxicity induced by AlbA-DCA was significantly alleviated by ferrostatin-1 (Fer-1, an inhibitor of ferroptosis, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). Deferoxamine (DFO), an iron chelating agent, also significantly reduced the toxicity induced by AlbA-DCA (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). In contrast, the addition of exogenous iron, Fe(II), slightly exacerbated AlbA-DCA-induced mortality (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C), whereas vitamin E (VE, an antioxidant) obviously relieved the toxicity of AlbA-DCA (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D). These data revealed that iron-dependent ferroptosis was induced by AlbA-DCA.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/medium/jm9b00644_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. AlbA-DCA-induced MCF-7 cells ferroptosis. Cell cytotoxicity of AlbA-DCA (2 μM), AlbA (10 μM), and Na-DCA (30 μM) in MCF-7 cells pretreated with 200 nM Fer-1 (A), 100 mM DFO (B), 25 mM Fe<sup>2+</sup> (C), and 20 mM VE (D). GSH/GSSG level (E) and MDA level (H). Expression of GPX4 (F, G) and lipid peroxides of MCF-7 cells stained with BODIPY-C11 (I) in MCF-7 cells treated with AlbA-DCA (2 μM), AlbA (10 μM), and Na-DCA (30 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00644&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Glutathione peroxidase IV (GPX4) plays a key role in preventing lipid peroxidation, inactivated by glutathione (GSH) depletion, and therefore induces the ferroptosis.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30−32)</a> Accordingly, we further measured GSH depletion in MCF-7 cells. As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>E, the GSH level in MCF-7 cells treated with AlbA-DCA was significantly alleviated, possibly due to the oxidation of GSH into glutathione disulfide (GSSG). We also examined the effect of AlbA-DCA on the expression of GPX4. As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>F,G, the level of GPX4 expression was decreased substantially by AlbA-DCA. In addition, the inhibition of GPX4 activity led to the accumulation of lipid peroxidation in cells, which is considered to be a significant hallmark and indicator of ferroptosis.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> Thus, the effect of AlbA-DCA on lipid peroxidation was evaluated by measuring MDA levels. A more than 2.5-fold increase in the MDA level was induced by AlbA-DCA (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>H). Furthermore, the lipid peroxidation probe BODIPY-C11 was applied to monitor the lipid peroxide level. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>I, MCF-7 cells in AlbA-DCA groups showed the strongest red fluorescence in confocal images compared to those of cells in the other group. Above all, these results provided evidence that AlbA-DCA suppressed the GPX4 pathway and induced the accumulation of lipid peroxidation, thereby leading to ferroptosis.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/medium/jm9b00644_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. AlbA-DCA inhibits MCF-7 cells xenograft growth in vivo. MCF-7 cells were subcutaneously inoculated into the right flank of nude mice. Mice were treated intravenously with saline, AlbA-DCA (2 mg/kg), AlbA (10 mg/kg), Na-DCA (30 mg/kg), and 5-Fu (10 mg/kg) every 2 days for 2 weeks. (A) Image of a tumor-bearing mouse after initiation of treatment. (B) Body weight, (C) tumor volume, and (E) tumor weight changes of nude mice in the experimental process. (D) Photograph of tumors removed from nude mice after treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00644&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> In Vitro Cytotoxicy on Cancer Cells and Normal Human Cells</h3><div class="NLM_p">The cytotoxicity of AlbA, Na-DCA, and AlbA-DCA against cancer and normal cell lines was tested by MTT assay, and IC<sub>50</sub> values were summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. It was found that Na-DCA was nontoxic to all tested cells, whereas AlbA and AlbA-DCA displayed stronger cytotoxicity compared with positive control drug 5-Fu against all cancer cell lines. More importantly, AlbA-DCA possessed significantly improved cytotoxicity against PDK-medium-expressed cancer cells HCT116 (3.87 μM, 5.6-fold), A375 (3.78 μM, 1.5-fold), and 4T1 (1.31 μM, 12.5-fold) compared to AlbA. Moreover, the conjugate AlbA-DCA exhibited the best cytotoxicity against the PDK-high-expressed cancer MCF-7 cells with IC<sub>50</sub> value 0.43 μM, which is enhanced 47.5-fold, and can be attributed to the more-efficient PDK inhibition capacity of AlbA-DCA. Interestingly, the IC<sub>50</sub> values of AlbA and AlbA-DCA against two normal human cells were much higher than those against tumor cells. These results indicated that AlbA-DCA could selectively kill cancer cells, especially PDK-high-expressing cancer cells.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. IC<sub>50</sub> Values (μM) of Tested Compounds against Different Cell Lines<a class="ref internalNav" href="#t1fn4" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">IC<sub>50</sub> for given compd (μM, 72 h)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">selectivity factor</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cell</th><th class="colsep0 rowsep0" align="center" char=".">5-Fu</th><th class="colsep0 rowsep0" align="center" char=".">AlbA</th><th class="colsep0 rowsep0" align="center">Na-DCA</th><th class="colsep0 rowsep0" align="center" char=".">AlbA-DCA</th><th class="colsep0 rowsep0" align="center" char="."><a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center" char="."><a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center" char=".">CI</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MCF-7<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">31.04 ± 1.12</td><td class="colsep0 rowsep0" align="char" char=".">20.43 ± 0.93</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="char" char=".">0.43 ± 0.12</td><td class="colsep0 rowsep0" align="char" char=".">88.83</td><td class="colsep0 rowsep0" align="char" char=".">123.58</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HCT116<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">26.14 ± 1.14</td><td class="colsep0 rowsep0" align="char" char=".">21.56 ± 0.91</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="char" char=".">3.87 ± 0.37</td><td class="colsep0 rowsep0" align="char" char=".">9.87</td><td class="colsep0 rowsep0" align="char" char=".">12.73</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">A375<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">21.09 ± 1.26</td><td class="colsep0 rowsep0" align="char" char=".">5.73 ± 0.11</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="char" char=".">3.78 ± 0.59</td><td class="colsep0 rowsep0" align="char" char=".">10.11</td><td class="colsep0 rowsep0" align="char" char=".">14.06</td><td class="colsep0 rowsep0" align="char" char=".">0.70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4T1<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">28.12 ± 1.14</td><td class="colsep0 rowsep0" align="char" char=".">16.38 ± 0.64</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="char" char=".">1.31 ± 0.82</td><td class="colsep0 rowsep0" align="char" char=".">29.16</td><td class="colsep0 rowsep0" align="char" char=".">40.56</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HBMEC<a class="ref internalNav" href="#t1fn3" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">27.31 ± 1.85</td><td class="colsep0 rowsep0" align="char" char=".">37.14 ± 3.73</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="char" char=".">38.20 ± 2.52</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">1.41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LO2<a class="ref internalNav" href="#t1fn3" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">29.53 ± 1.74</td><td class="colsep0 rowsep0" align="char" char=".">33.21 ± 3.06</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="char" char=".">53.14 ± 3.95</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">2.13</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn4"><div class="footnote" id="t1fn4"><sup><sup>a</sup></sup><p class="last">MTT methods, cells were incubated with indicated compounds for 72 h (means ± SD, <i>n</i> = 3).</p></div><div class="footnote" id="t1fn1"><sup><sup>b</sup></sup><p class="last">PDK-high-expressed cancer cells: MCF-7, human breast cancer cells.</p></div><div class="footnote" id="t1fn2"><sup><sup>c</sup></sup><p class="last">PDK-medium-expressed cancer cells: HCT116, human colon cancer cells; A375, human melanoma cells; 4T1, mouse breast cancer cells.</p></div><div class="footnote" id="t1fn3"><sup><sup>d</sup></sup><p class="last">Human normal cell: HBMEC, brain microvascular endothelial cells; LO2, normal liver cells.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">Selectivity factor: IC<sub>50</sub>(HBMEC)/IC<sub>50</sub>(cancer cells).</p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last">Selectivity factor: IC<sub>50</sub>(LO2)/IC<sub>50</sub>(cancer cells).</p></div></div></div><div class="NLM_p last">Next, to investigate the synergistic effect between AlbA and Na-DCA, the combination index (CI) of AlbA-DCA was calculated. The CI index shows antagonism (CI > 1), additivity (CI = 1), or synergism (CI < 1) between the drugs.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> AlbA and Na-DCA conjugated in AlbA-DCA were synergistic against all cancer cell lines, with CI values of 0.03, 0.22, 0.70, and 0.09 in the MCF-7, HCT116, A375, and 4T1 cell lines, respectively. Especially in MCF-7 cells, the CI value was much lower than that in other cancer cells, indicating the excellent synergistic effect of AlbA-DCA.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Vivo Antitumor Effects and Safety</h3><div class="NLM_p">To test the antitumor efficacy of AlbA-DCA in vivo, nude mice bearing MCF-7 tumors were randomly divided into five groups and injected with negative control saline, positive control 5-Fu, AlbA-DCA, AlbA, and Na-DCA at the indicated dosages. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A,D, moderate therapeutic efficacy of Na-DCA was observed in the mice administrated. This result was consistent with the conclusion that DCA is less active in vivo and requires a large dose to effectively inhibit tumor growth. By comparison, after 14 days of treatment, AlbA could inhibit tumor growth with an observed efficacy that was similar to that of the positive control 5-Fu group. However, AlbA-DCA displayed the best antitumor efficacy and almost completely suppressed tumor progression. After the treatment, tumors were excised for photographing (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D) and weighing (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>E). In addition, no mouse deaths and no significant changes in body weight were observed (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B).</div><div class="NLM_p">To evaluate the safety of AlbA-DCA in vivo application, we determined blood biochemical indexes and histopathology of the major organs. ALT, AST, and ALP evaluated the liver function, while BUN estimated renal function. As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A, compared to the saline group, the four above blood biochemical indexes displayed insignificant changes, and this result suggested that AlbA-DCA had no obvious toxicity of liver and kidney. Meanwhile, we observed the histopathology of the heart, liver, spleen, lung, and kidney of mice treated with AlbA-DCA after being stained with H&E. As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B, no major abnormality was observed in the stained organ slices compared to the saline ones, indicating the good security of AlbA-DCA.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/medium/jm9b00644_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vivo toxicity evaluations of AlbA-DCA. (A) Hematological analysis of treated mice after 14 days. Gray areas represent the normal range of different biosafety indicators. (B) H&E-stained slice images of major organs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00644&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> In Vivo Immune Response</h3><div class="NLM_p">The breast tumor microenvironment comprises immune cells, blood vessel cells, fibrocytes, mesenchymal stem cells, adipocytes, and extracellular matrix, among which tumor-associated macrophages (TAMs) are the prominent components.<a onclick="showRef(event, 'ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38">(36−38)</a> Moreover, recent studies have shown that lactic acid, secreted by enhanced glycolysis as an immunosuppressive mediator, promotes tumor progression by the polarization of functional phenotype of TAMs into more tolerogenic phenotypes (from M1-like to M2-like).<a onclick="showRef(event, 'ref6 ref39 ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref6 ref39 ref40 ref41 ref42">(6,39−42)</a> Therefore, after obtaining the remarkable lactate reduction by AlbA-DCA, we speculated that AlbA-DCA can remold the tumor immunosuppression microenvironment via eliminating M2-TAMs, ultimately inhibiting tumor progression.</div><div class="NLM_p">To confirm this hypothesis, a dual-4T1 tumor model in female BALB/c mice was established. According to <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A, only primary tumors were treated with intratumor-injected AlbA-DCA or saline, while distal primary tumors were allowed to grow naturally without any treatment. Both primary and distal tumors showed obvious rapid proliferation and growth after treatment with saline (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C). The primary tumors in the AlbA-DCA groups presented significant growth inhibition, with tumor volumes of <100 mm<sup>3</sup> at the end of the experiment, which was consistent with the results of nude mice in the MCF-7 tumor experiment, indicating the excellent antitumor effect of AlbA-DCA. Interestingly, AlbA-DCA also revealed effective growth inhibition of distal 4T1 tumors. At the end of the experiment, the tumors in both groups were collected and weighed. The average weight of both primary and distal primary tumors significantly decreased, and the average weight in the AlbA-DCA treatment group was lower than that of the saline group (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B,D). The above findings may be explained by the enhanced immune response generated by the tumor microenvironment after AlbA-DCA treatment of primary tumors, which could then reverse the immunosuppressive environment of both primary and distal tumors and eventually inhibit tumor growth.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/medium/jm9b00644_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. AlbA-DCA inhibits bilateral 4T1 tumor-bearing mice in vivo. (A) Schematic illustration of the experiment design. (B) Visible tumor formation and photographs of representative tumors removed from mice after initiation of treatment. (C) Primary and distant tumor growth curves of mice after various treatments. (D) Tumor weight changes of mice during treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00644&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We then examined the expression of Arg-1 and MRC-1, which are high-expression mannose receptors in M2-TAMs, using Western blot and QPCR. As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A,B, the expression of Arg-1 and MRC-1 mRNA was inhibited 2.1-fold and 3.4-fold, respectively. Similarly, the expression of Arg-1 and MRC-1 protein was also inhibited 2.1-fold and 3.4-fold, respectively (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>C). The depletion of prominent M2-TAMs would down-regulate the secretion of immunosuppressive cytokines (IL-10), which could be beneficial for the polarization of TAMs to form an activated M1 phenotype, and then secrete immunostimulatory cytokines (TNF-α, IL-12, and IFN-γ).<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43,44)</a> To test this, we evaluated the level of cytokine in the serum and the distant tumor using an enzyme-linked immunosorbent assay (ELISA). As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>D, AlbA-DCA exhibited extraordinarily low levels of IL-10 expression in tumors. On the contrary, the ELISA results showed that AlbA-DCA showed much higher levels of TNF-α, IL-12, and IFN-γ in serum and tumors compared to the saline group (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>E–G). The results clarified that AlbA-DCA could remold the tumor immunosuppressive microenvironment via the polarization of TAMs from M2 to M1.</div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/medium/jm9b00644_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. AlbA-DCA promoted M2-TAMs polarization. Expression of Arg-1 and MRC-1 (A, B) and the relative mRNA expression (C) in distant tumor from mice after treatment. (D–K) Cytokine levels in sera and distant tumor from mice after treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00644&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12123" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12123" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we developed a conjugate AlbA-DCA, a natural oleanane triterpenoid saponin AlbA connected to a PDK inhibitor, via a comparatively stable amide linkage. AlbA-DCA could affect the energy metabolism reprogramming of tumor cells and shift cellular metabolism away from aerobic glycolysis to OXPHOS by inhibiting PDK activity. In this way, AlbA-DCA induced a marked increase in intracellular ROS and alleviated the accumulation of lactic acid in TME. Meanwhile, AlbA-DCA selectively killed cancer cells and had an excellent synergistic effect, especially in PDK-high-expressing cancer cells. Importantly, AlbA-DCA-induced apoptosis via a caspase-dependent pathway. We also demonstrated that AlbA-DCA suppressed the GPX4 pathway and induced the accumulation of lipid peroxidation, thereby leading to ferroptosis. Furthermore, the antitumor experiment on nude mice bearing MCF-7 tumors demonstrated that AlbA-DCA would be an effective and safe agent. We also confirmed that AlbA-DCA could remold the tumor immunosuppression microenvironment via eliminating M2-TAMs to inhibit both primary and distal tumor progression in a dual-4T1 tumor model in female BALB/c mice. As a result, such an AlbA-DCA exhibited promising application as a synergetic natural saponin and PDK inhibitor to induce apoptosis-ferroptosis-M2-TAMs polarization for enhanced cancer therapy.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42587" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42587" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry Materials</h3><div class="NLM_p last">All commercial reagents obtained from Sigma-Aldrich, Acros Organics, or Energy Chemical were used without purification unless otherwise specified. Flash-column chromatography was realized with 200–300 mesh silica gel (Qingdao Haiyang Chemical, China). Melting points were measured on a Büchi melting point B-540 apparatus. HPLC chromatograms were obtained on a Waters 1525-2489 with a reverse-phase column (C18, Waters) (4.6 mm × 150 mm) using a mixture of solvent methanol/water (75:25) at the flow rate of 1.0 mL/min and peak detection at 254 nm under UV, injection volume of 20 mL, and injection time of 40 min. The eluent consisted of a water–acetonitrile gradient with a 1.0 mL/min flow rate. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded in pyridine-<i>d</i> on a Bruker ARX 600 MHz spectrometer: chemical shifts and coupling constants (<i>J</i>) were showed in parts per million and in hertz, respectively. HRMS were measured on a Bruker micrOTOF_Q spectrometer.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Synthesis of AlbA-DCA</h3><div class="NLM_p last">Intermediate 1 was synthesized according to our previously reported method.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a><sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.15–8.08 (m, 2H), 8.03–7.94 (m, 4H), 7.58 (dd, <i>J</i> = 14.7, 7.4 Hz, 2H), 7.51–7.44 (m, 3H), 7.38 (t, <i>J</i> = 7.8 Hz, 2H), 7.29–7.22 (m, 2H), 5.53 (d, <i>J</i> = 4.7 Hz, 1H), 5.49 (s, 1H), 5.33 (s, 1H), 5.17 (s, 1H), 5.01–4.95 (m, 1H), 4.81 (dd, <i>J</i> = 11.9, 3.4 Hz, 1H), 4.65 (dd, <i>J</i> = 11.9, 4.9 Hz, 1H), 4.58 (dd, <i>J</i> = 8.3, 4.6 Hz, 1H), 3.86 (d, <i>J</i> = 9.4 Hz, 1H), 3.75–3.65 (m, 2H), 3.13 (dd, <i>J</i> = 11.7, 4.3 Hz, 1H), 2.91–2.85 (m, 1H), 2.79 (dd, <i>J</i> = 13.7, 3.7 Hz, 1H), 2.07 (s, 3H), 2.02 (s, 3H), 1.99–1.11 (m, 23H), 1.06 (s, 3H), 0.96 (s, 3H), 0.93 (s, 3H), 0.91 (s, 3H), 0.74 (s, 3H), 0.72 (s, 3H), 0.66 (d, <i>J</i> = 7.9 Hz, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 183.6, 170.7, 169.8, 166.1, 165.7, 165.2, 143.3, 133.4, 133.0, 130.0, 129.8, 129.7, 129.6, 128.5, 128.3, 122.6, 105.7, 105.6, 89.8, 81.7, 81.3, 77.8, 75.1, 72.8, 69.5, 66.0, 63.7, 56.4, 55.3, 47.4, 46.4, 45.9, 41.4, 40.9, 39.1, 39.1, 38.1, 36.6, 33.8, 33.1, 32.5, 32.4, 30.6, 29.6, 28.4, 27.6, 25.9, 25.8, 23.6, 23.1, 22.8, 20.8, 20.7, 18.1, 17.0, 16.6, 15.0. ESI-MS(<i>m</i>/<i>z</i>): 1410.78 [M + H]<sup>+</sup>. HRMS (ESI): Calcd for [M + Na]<sup>+</sup> C<sub>66</sub>H<sub>83</sub>NNaO<sub>16</sub>, 1168.5610; found, 1168.5604.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Synthesis of AlbA-DCA</h3><div class="NLM_p last">Intermediate 1 (100.0 mg, 0.087 mmol) was dissolved in anhydrous dichloromethane (10 mL), followed by the addition of anhydride (0.11 mmol) and stirring at room temperature for 2 h. The mixture was quenched by addition of methanol (1 mL) and concentrated. Then, to a solution of concentrate in the mixture of dichloromethane and methanol (v:v = 1:1, 10 mL), freshly prepared sodium methylate in methanol solution(1.0 mol/L, 1 mL) was added. After being stirred overnight, the mixture was neutralized with Dowex H<sup>+</sup> resin to pH 7, then filtered, and concentrated. The concentrate was purified using a silica gel column chromatography (7:2:1, dichloromethane–methanol–H<sub>2</sub>O) to obtain AlbA-DCA (74.4%) as a white solid (57.5 mg, yield = 76.6%, purity = 97.8% determined by HPLC). Mp 205.3–207.4 °C. <sup>1</sup>H NMR (600 MHz, Pyr): δ 9.97 (d, <i>J</i> = 8.8 Hz, 1H), 6.86 (s, 1H), 5.42 (s, 1H), 5.05 (d, <i>J</i> = 8.3 Hz, 1H), 4.89 (d, <i>J</i> = 6.7 Hz, 1H), 4.82 (d, <i>J</i> = 10.4 Hz, 1H), 4.54–4.35 (m, 3H), 4.32–4.00 (m, 7H), 3.72 (d, <i>J</i> = 10.8 Hz, 1H), 3.32–3.25 (m, 1H), 3.18 (dd, <i>J</i> = 11.7, 4.3 Hz, 1H), 2.32 (d, <i>J</i> = 10.2 Hz, 1H), 2.18–1.27 (m, 24H), 1.24 (s, 3H), 1.16 (s, 3H), 0.99 (s, 6H), 0.94 (s, 6H), 0.75 (s, 3H). <sup>13</sup>C NMR (150 MHz, Pyr): δ 180.0, 164.7, 144.5, 122.4, 105.2, 104.0, 88.8, 76.4, 75.0, 74.1, 72.4, 72.0, 69.5, 68.9, 68.3, 66.3, 58.4, 55.5, 47.7, 46.4, 46.3, 41.9, 41.7, 39.5, 39.1, 38.3, 36.7, 34.0, 33.1, 32.9, 30.7, 29.8, 28.5, 28.1, 26.3, 25.9, 23.5, 23.4, 18.9, 18.3, 17.1, 16.7, 15.1. HRMS (ESI): Calcd for [M + Na]<sup>+</sup> C<sub>44</sub>H<sub>69</sub>Cl<sub>2</sub>NNaO<sub>12</sub>, 896.4095; found, 896.4090.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Synthesis of AlbA-CA</h3><div class="NLM_p last">The synthesis method is the same as that of AlbA-DCA (52.0 mg, yield = 71.4%, purity = 98.1% determined by HPLC). <sup>1</sup>H NMR (600 MHz, Pyr): δ 9.30 (d, J = 9.0 Hz, 1H), 5.45 (s, 1H), 5.08 (d, J = 8.3 Hz, 1H), 4.94 (d, J = 6.7 Hz, 1H), 4.88 (d, J = 10.1 Hz, 1H), 4.62–4.54 (m, 1H), 4.53–4.43 (m, 2H), 4.41–4.36 (m, 4H), 4.35–4.23 (m, 4H), 4.19 (dd, J = 8.5, 3.3 Hz, 1H), 4.15–4.07 (m, 2H), 3.77 (d, J = 10.5 Hz, 1H), 3.34–3.28 (m, 1H), 3.20 (dd, J = 11.7, 4.5 Hz, 1H), 1.28 (s, 3H), 1.16 (s, 3H), 1.03 (s, 3H), 0.99 (s, 6H), 0.98 (s, 3H), 0.78 (s, 3H). <sup>13</sup>C NMR (150 MHz, Pyr): δ 181.1 166.0, 145.6, 123.5, 105.4, 105.2 90.1, 75.3, 73.4, 73.2, 70.1, 66.5, 59.2, 56.6, 48.8, 47.6, 47.4, 44.8, 43.0, 42.8, 40.6, 40.2, 40.0, 37.8, 35.1, 34.2, 34.0, 31.9, 31.7, 30.9, 29.5, 29.3, 29.2, 27.1, 24.7, 20.3, 18.22, 18.0, 17.9, 16.3, 15.2, 14.7, 12.0. HRMS (ESI): Calcd for [M + Na]<sup>+</sup> C<sub>43</sub>H<sub>68</sub>ClNNaO<sub>12</sub>, 848.4328; found, 848.4322.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Biology Materials</h3><div class="NLM_p last">RPMI 1640 medium, DMEM, pancreatic enzymes, penicillin, streptomycin, and fetal bovine serum (FBS) were purchased from Gibco. z-VAD-fmk, ferrostatin-1 (Fer-1), deferoxamine (DFO), iron dichloride, and vitamin E (VE) were purchased from MCE (Shanghai, China). 3-[4,5-Dimethylthiazol2-yl]-2,5-diphenyltetrazolium bromide (MTT), 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylimidacarbocyanine iodide (JC-1), 2′,7′-dichlorofluorescein diacetate (DCF-DA), and 4′,6-diamidino-2-phenylindole (DAPI) were purchased from Sigma (St. Louis, MO, USA). BODIPY-C11 was purchased from Thermo Fisher (Waltham, MA, USA). Primary antibodies against PDK, cytotochrome <i>c</i>, Bcl-2, caspase-9, GPX4, Arg-1, MRC-1, and GAPDH were purchased from KeyGen (Jiangsu, China). Fluorescent secondary antibodies were purchased from Life Technologies (Grand Island, NY, USA). Annexin V-FITC Apoptosis Detection Kit, MDA Assay Kit, and GSH and GSSG Assay Kit were purchased from Beyotime (Jiangsu, China). ADP-GloTM Kinase Assay was purchased from Promega (Madison, WI, USA). Lactic Acid Assay Kit was purchased from BioVision (Milpitas, CA, USA). ELISA kits were purchased from Dakewe (Beijing, China). The mice used in the conducted in vivo experiment were purchased from Lingchang Biotechnology Co., Ltd. (Shanghai China). The mice were housed in the facility at the Laboratory Animal Center, Academy of Simcere according to the approved guidelines for laboratory animals (IACUC statement: Protocol SL-007-0).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> PDK Kinase Assay</h3><div class="NLM_p last">PDK kinase activity was evaluated by the ADP-Glo Kinase Assays (Promega) as the manufacturer’s protocol. Reagents used in this assay were 50 ng of PDK1/well and 0.2 μg/μL PDK tide. First, enzyme, substrate, ATP, and compounds (10 mM in DMSO) were diluted by MCF-7 cell culture fluid, PBS or plasma. Then, 5 μL compounds (various indicated concentrations), 10 μL of substrate with ATP mix, and 10 μL of enzyme were added into the 96-well plate and incubated at room temperature for 90 min. Next, 25 μL of ADP-Glo reagent was added to each well and incubated for another 40 min. Last, 50 μL of Kinase Detection Reagent was added and incubated for 30 min, and luminescence was recorded by the microplate reader (λ<sub>ex</sub> = 488 nm, ELX800, Bio-Tek, Winooski, VT, USA).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Seahorse XF24 Bioenergetics Assays</h3><div class="NLM_p last">The glycolytic function was investigated using a Seahorse XF glycolysis stress kit. Before assay, XF sensor cartridges were first hydrated. Seahorse Bioscience calibration (1 mL) was added into each well of an XF utility plate and then kept at 37 °C without CO<sub>2</sub> atmosphere for 14 h. MCF-7 cells were cultured in XF24-well cell culture microplates (Seahorse Bioscience) with 5 × 10<sup>4</sup> cells/well in 100 μL of growth medium and incubated at 37 °C with CO<sub>2</sub> for 1 h. Following, the cells were attached, added with culture medium (150 μL), incubated for 24 h at 37 °C in 5% CO<sub>2</sub>, and then treated with AlbA-DCA, AlbA, and Na-DCA at indicated concentrations. All but 50 μL of the culture medium was removed, samples were washed twice with 600 μL of XF stress test glycolysis optimization medium prewarmed to 37 °C, and finally 610 μL of optimization medium was added to each well. ECAR and OCR were measured. Glucose (10 mM), oligomycin (1 μM), and 2-DG (100 mM) were injected consecutively at a specific time gap, and ECAR values were measured after each injection. Oligomycin (1.0 μM), FCCP (2.0 μM), an ionophore that is a mobile ion carrier, and a mixture of antimycin/rotenone (1.0 μM) were injected consecutively at specific time gaps, and OCR values were measured after each injection.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Statistical Analysis</h3><div class="NLM_p last">Results were expressed as mean ± standard deviation. Differences with a <i>P</i> value less than 0.05 were considered significant. All statistical analyses were performed by using Prism 7 (GraphPad Software).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00644" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22482" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22482" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00644" class="ext-link">10.1021/acs.jmedchem.9b00644</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00644/suppl_file/jm9b00644_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Experimental procedures and spectroscopic data for compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00644/suppl_file/jm9b00644_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00644/suppl_file/jm9b00644_si_001.csv">jm9b00644_si_001.csv (0.7 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00644/suppl_file/jm9b00644_si_002.pdf">jm9b00644_si_002.pdf (692.92 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00644" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84848" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84848" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gaofei Wei</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Structure-Based Drug Design & Discovery of Ministry
of Education, Shenyang Pharmaceutical University, Shenyang 110016, China</span>; 
    <span class="hlFld-Affiliation affiliation">Institute
of Medical Research, Northwestern Polytechnical
University, Xi’an 710072, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7601131f111046404643364740455815191b"><span class="__cf_email__" data-cfemail="aaddcfc3cdcc9a9c9a9fea9b9c9984c9c5c7">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maosheng Cheng</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Structure-Based Drug Design & Discovery of Ministry
of Education, Shenyang Pharmaceutical University, Shenyang 110016, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f49987979c919a93b4878d849c81da919081da979a"><span class="__cf_email__" data-cfemail="167b65757e73787156656f667e6338737263387578">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yang Liu</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Structure-Based Drug Design & Discovery of Ministry
of Education, Shenyang Pharmaceutical University, Shenyang 110016, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9284-1944" title="Orcid link">http://orcid.org/0000-0002-9284-1944</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8ff6a1e3e6facffcf6ffe7faa1eaebfaa1ece1"><span class="__cf_email__" data-cfemail="28510644415d685b5158405d064d4c5d064b46">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiahong Sun</span> - <span class="hlFld-Affiliation affiliation">Department
of Biopharmaceutical Science, School of Pharmacy and Health Sciences, Keck Graduate Institute, Claremont, California 91711, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weijing Luan</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Structure-Based Drug Design & Discovery of Ministry
of Education, Shenyang Pharmaceutical University, Shenyang 110016, China</span>; 
    <span class="hlFld-Affiliation affiliation">Yantai
Branch, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), Yantai 264000, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhuang Hou</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Structure-Based Drug Design & Discovery of Ministry
of Education, Shenyang Pharmaceutical University, Shenyang 110016, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shuai Wang</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Structure-Based Drug Design & Discovery of Ministry
of Education, Shenyang Pharmaceutical University, Shenyang 110016, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shanshan Cui</span> - <span class="hlFld-Affiliation affiliation">Key
Laboratory of Structure-Based Drug Design & Discovery of Ministry
of Education, Shenyang Pharmaceutical University, Shenyang 110016, China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66132" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66132" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the National Natural Science Foundation of China (Grant Nos. 81703335, 81703599, and 81473087), the Natural Science Foundation of Guangdong (Grant No. 2017A030313069), and the Medical Research Foundation of Guangdong (Grant No. A2017114). Y.L. expresses thanks for the support by the Program for Liaoning Innovative Talents in University (Grant No. LR2017043) and the Career Development Support Plan for Young and Middle-aged Teachers in Shenyang Pharmaceutical University (Grant No. ZQN2016005).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">4T1</td><td class="NLM_def"><p class="first last">mouse breast cancer cells</p></td></tr><tr><td class="NLM_term">A375</td><td class="NLM_def"><p class="first last">human melanoma cells</p></td></tr><tr><td class="NLM_term">AlbA</td><td class="NLM_def"><p class="first last">albiziabioside A</p></td></tr><tr><td class="NLM_term">CI</td><td class="NLM_def"><p class="first last">combination index</p></td></tr><tr><td class="NLM_term">DCA</td><td class="NLM_def"><p class="first last">dichloroacetate acid</p></td></tr><tr><td class="NLM_term">DCF-DA</td><td class="NLM_def"><p class="first last">2′,7′-dichlorodihydrofluorescin diacetate fluorescence</p></td></tr><tr><td class="NLM_term">DFO</td><td class="NLM_def"><p class="first last">deferoxamine</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">ECAR</td><td class="NLM_def"><p class="first last">extracellular acidification rate</p></td></tr><tr><td class="NLM_term">Fer-1</td><td class="NLM_def"><p class="first last">ferrostatin-1</p></td></tr><tr><td class="NLM_term">GPX4</td><td class="NLM_def"><p class="first last">glutathione peroxidase IV</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr><tr><td class="NLM_term">GSSG</td><td class="NLM_def"><p class="first last">glutathione disulfide</p></td></tr><tr><td class="NLM_term">HCT116</td><td class="NLM_def"><p class="first last">human colon cancer cells</p></td></tr><tr><td class="NLM_term">LDHA</td><td class="NLM_def"><p class="first last">lactate dehydrogenase A</p></td></tr><tr><td class="NLM_term">MCF-7</td><td class="NLM_def"><p class="first last">human breast cancer cells</p></td></tr><tr><td class="NLM_term">OCR</td><td class="NLM_def"><p class="first last">oxygen consumption rate</p></td></tr><tr><td class="NLM_term">OXPHOS</td><td class="NLM_def"><p class="first last">mitochondria oxidative phosphorylation</p></td></tr><tr><td class="NLM_term">PDH</td><td class="NLM_def"><p class="first last">pyruvate dehydrogenase</p></td></tr><tr><td class="NLM_term">PDK</td><td class="NLM_def"><p class="first last">pyruvate dehydrogenase kinase</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">TAMs</td><td class="NLM_def"><p class="first last">tumor-associated macrophages</p></td></tr><tr><td class="NLM_term">TME</td><td class="NLM_def"><p class="first last">tumor microenvironment</p></td></tr><tr><td class="NLM_term">VE</td><td class="NLM_def"><p class="first last">vitamin E</p></td></tr><tr><td class="NLM_term">ΔΨ<sub>m</sub></td><td class="NLM_def"><p class="first last">mitochondrial membrane potential</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45625" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45625" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 44 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Hallmarks of cancer: the next generation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+cancer%3A+the+next+generation&doi=10.1016%2Fj.cell.2011.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0lh7Fe0yY8o1xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520cancer%253A%2520the%2520next%2520generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26spage%3D646%26epage%3D674%26doi%3D10.1016%2Fj.cell.2011.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandel, N. S.</span></span> <span> </span><span class="NLM_article-title">Fundamentals of cancer metabolism</span>. <i>Sci. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">e1600200</span> <span class="refDoi"> DOI: 10.1126/sciadv.1600200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1126%2Fsciadv.1600200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=27386546" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&author=R.+J.+DeBerardinisauthor=N.+S.+Chandel&title=Fundamentals+of+cancer+metabolism&doi=10.1126%2Fsciadv.1600200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fsciadv.1600200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fsciadv.1600200%26sid%3Dliteratum%253Aachs%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DChandel%26aufirst%3DN.%2BS.%26atitle%3DFundamentals%2520of%2520cancer%2520metabolism%26jtitle%3DSci.%2520Adv.%26date%3D2016%26volume%3D2%26doi%3D10.1126%2Fsciadv.1600200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Outschoorn, U. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peiris-Pages, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pestell, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotgia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lisanti, M. P.</span></span> <span> </span><span class="NLM_article-title">Cancer metabolism: a therapeutic perspective</span>. <i>Nat. Rev. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">31</span>, <span class="refDoi"> DOI: 10.1038/nrclinonc.2016.60</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1038%2Fnrclinonc.2016.60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=27141887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsF2qu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=11-31&author=U.+E.+Martinez-Outschoornauthor=M.+Peiris-Pagesauthor=R.+G.+Pestellauthor=F.+Sotgiaauthor=M.+P.+Lisanti&title=Cancer+metabolism%3A+a+therapeutic+perspective&doi=10.1038%2Fnrclinonc.2016.60"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer metabolism: a therapeutic perspective</span></div><div class="casAuthors">Martinez-Outschoorn, Ubaldo E.; Peiris-Pages, Maria; Pestell, Richard G.; Sotgia, Federica; Lisanti, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-31</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Awareness that the metabolic phenotype of cells within tumors is heterogeneous - and distinct from that of their normal counterparts - is growing.  In general, tumor cells metabolize glucose, lactate, pyruvate, hydroxybutyrate, acetate, glutamine, and fatty acids at much higher rates than their nontumor equiv.; however, the metabolic ecol. of tumors is complex because they contain multiple metabolic compartments, which are linked by the transfer of these catabolites.  This metabolic variability and flexibility enables tumor cells to generate ATP as an energy source, while maintaining the redn.-oxidn. (redox) balance and committing resources to biosynthesis - processes that are essential for cell survival, growth, and proliferation.  Importantly, exptl. evidence indicates that metabolic coupling between cell populations with different, complementary metabolic profiles can induce cancer progression.  Thus, targeting the metabolic differences between tumor and normal cells holds promise as a novel anticancer strategy.  In this Review, we discuss how cancer cells reprogramme their metab. and that of other cells within the tumor microenvironment in order to survive and propagate, thus driving disease progression; in particular, we highlight potential metabolic vulnerabilities that might be targeted therapeutically.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNuUI8-igjaLVg90H21EOLACvtfcHk0lh7Fe0yY8o1xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsF2qu7g%253D&md5=a4f92ba92569fca1d35e20ec7acb9394</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2016.60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2016.60%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Outschoorn%26aufirst%3DU.%2BE.%26aulast%3DPeiris-Pages%26aufirst%3DM.%26aulast%3DPestell%26aufirst%3DR.%2BG.%26aulast%3DSotgia%26aufirst%3DF.%26aulast%3DLisanti%26aufirst%3DM.%2BP.%26atitle%3DCancer%2520metabolism%253A%2520a%2520therapeutic%2520perspective%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2017%26volume%3D14%26spage%3D11%26epage%3D31%26doi%3D10.1038%2Fnrclinonc.2016.60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huber, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camisaschi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triulzi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuccitto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagliabue, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivoltini, L.</span></span> <span> </span><span class="NLM_article-title">Cancer acidity: an ultimate frontier of tumor immune escape and a novel target of immunomodulation</span>. <i>Semin. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1016/j.semcancer.2017.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.semcancer.2017.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=28267587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslOqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2017&pages=74-89&author=V.+Huberauthor=C.+Camisaschiauthor=A.+Berziauthor=S.+Ferroauthor=L.+Luginiauthor=T.+Triulziauthor=A.+Tuccittoauthor=E.+Tagliabueauthor=C.+Castelliauthor=L.+Rivoltini&title=Cancer+acidity%3A+an+ultimate+frontier+of+tumor+immune+escape+and+a+novel+target+of+immunomodulation&doi=10.1016%2Fj.semcancer.2017.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation</span></div><div class="casAuthors">Huber, Veronica; Camisaschi, Chiara; Berzi, Angela; Ferro, Simona; Lugini, Luana; Triulzi, Tiziana; Tuccitto, Alessandra; Tagliabue, Elda; Castelli, Chiara; Rivoltini, Licia</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">74-89</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The link between cancer metab. and immunosuppression, inflammation and immune escape has generated major interest in investigating the effects of low pH on tumor immunity.  Indeed, microenvironmental acidity may differentially impact on diverse components of tumor immune surveillance, eventually contributing to immune escape and cancer progression.  Although the mol. pathways underlying acidity-related immune dysfunctions are just emerging, initial evidence indicates that antitumor effectors such as T and NK cells tend to lose their function and undergo a state of mostly reversible anergy followed by apoptosis, when exposed to low pH environment.  At opposite, immunosuppressive components such as myeloid cells and regulatory T cells are engaged by tumor acidity to sustain tumor growth while blocking antitumor immune responses.  Local acidity could also profoundly influence bioactivity and distribution of antibodies, thus potentially interfering with the clin. efficacy of therapeutic antibodies including immune checkpoint inhibitors.  Hence tumor acidity is a central regulator of cancer immunity that orchestrates both local and systemic immunosuppression and that may offer a broad panel of therapeutic targets.  This review outlines the fundamental pathways of acidity-driven immune dysfunctions and sheds light on the potential strategies that could be envisaged to potentiate immune-mediated tumor control in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCzFzY3bg6UrVg90H21EOLACvtfcHk0lh7Fe0yY8o1xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslOqtLY%253D&md5=22bab52b69fad88fdd97b448fe98acca</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2017.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2017.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DV.%26aulast%3DCamisaschi%26aufirst%3DC.%26aulast%3DBerzi%26aufirst%3DA.%26aulast%3DFerro%26aufirst%3DS.%26aulast%3DLugini%26aufirst%3DL.%26aulast%3DTriulzi%26aufirst%3DT.%26aulast%3DTuccitto%26aufirst%3DA.%26aulast%3DTagliabue%26aufirst%3DE.%26aulast%3DCastelli%26aufirst%3DC.%26aulast%3DRivoltini%26aufirst%3DL.%26atitle%3DCancer%2520acidity%253A%2520an%2520ultimate%2520frontier%2520of%2520tumor%2520immune%2520escape%2520and%2520a%2520novel%2520target%2520of%2520immunomodulation%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2017%26volume%3D43%26spage%3D74%26epage%3D89%26doi%3D10.1016%2Fj.semcancer.2017.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carmona-Fontaine, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bucci, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkari, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deforet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xavier, J. B.</span></span> <span> </span><span class="NLM_article-title">Emergence of spatial structure in the tumor microenvironment due to the Warburg effect</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">19402</span>– <span class="NLM_lpage">19407</span>, <span class="refDoi"> DOI: 10.1073/pnas.1311939110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1073%2Fpnas.1311939110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=24218566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFemur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=19402-19407&author=C.+Carmona-Fontaineauthor=V.+Bucciauthor=L.+Akkariauthor=M.+Deforetauthor=J.+A.+Joyceauthor=J.+B.+Xavier&title=Emergence+of+spatial+structure+in+the+tumor+microenvironment+due+to+the+Warburg+effect&doi=10.1073%2Fpnas.1311939110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Emergence of spatial structure in the tumor microenvironment due to the Warburg effect</span></div><div class="casAuthors">Carmona-Fontaine, Carlos; Bucci, Vanni; Akkari, Leila; Deforet, Maxime; Joyce, Johanna A.; Xavier, Joao B.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">19402-19407,S19402/1-S19402/31</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Drastic metabolic alterations, such as the Warburg effect, are found in most if not all types of malignant tumors.  Emerging evidence shows that cancer cells benefit from these alterations, but little is known about how they affect noncancerous stromal cells within the tumor microenvironment.  Here we show that cancer cells are better adapted to metabolic changes in the microenvironment, leading to the emergence of spatial structure.  A clear example of tumor spatial structure is the localization of tumor-assocd. macrophages (TAMs), one of the most common stromal cell types found in tumors.  TAMs are enriched in well-perfused areas, such as perivascular and cortical regions, where they are known to potentiate tumor growth and invasion.  However, the mechanisms of TAM localization are not completely understood.  Computational modeling predicts that gradients-of nutrients, gases, and metabolic byproducts such as lactate-emerge due to altered cell metab. within poorly perfused tumors, creating ischemic regions of the tumor microenvironment where TAMs struggle to survive.  We tested our modeling prediction in a coculture system that mimics the tumor microenvironment.  Using this exptl. approach, we showed that a combination of metabolite gradients and differential sensitivity to lactic acid is sufficient for the emergence of macrophage localization patterns in vitro.  This suggests that cancer metabolic changes create a microenvironment where tumor cells thrive over other cells.  Understanding differences in tumor-stroma sensitivity to these alterations may open therapeutic avenues against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocknTaSVoSa7Vg90H21EOLACvtfcHk0lh5JVAK3J-MeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFemur%252FI&md5=af3a81a01a45321c40c4241269a7c0e4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1311939110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1311939110%26sid%3Dliteratum%253Aachs%26aulast%3DCarmona-Fontaine%26aufirst%3DC.%26aulast%3DBucci%26aufirst%3DV.%26aulast%3DAkkari%26aufirst%3DL.%26aulast%3DDeforet%26aufirst%3DM.%26aulast%3DJoyce%26aufirst%3DJ.%2BA.%26aulast%3DXavier%26aufirst%3DJ.%2BB.%26atitle%3DEmergence%2520of%2520spatial%2520structure%2520in%2520the%2520tumor%2520microenvironment%2520due%2520to%2520the%2520Warburg%2520effect%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D19402%26epage%3D19407%26doi%3D10.1073%2Fpnas.1311939110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colegio, O. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, N. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhebergen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jairam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cyrus, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brokowski, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenbarth, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cline, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medzhitov, R.</span></span> <span> </span><span class="NLM_article-title">Functional polarization of tumour-associated macrophages by tumour-derived lactic acid</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>513</i></span>,  <span class="NLM_fpage">559</span>– <span class="NLM_lpage">563</span>, <span class="refDoi"> DOI: 10.1038/nature13490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1038%2Fnature13490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=25043024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Wjs7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=513&publication_year=2014&pages=559-563&author=O.+R.+Colegioauthor=N.+Q.+Chuauthor=A.+L.+Szaboauthor=T.+Chuauthor=A.+M.+Rhebergenauthor=V.+Jairamauthor=N.+Cyrusauthor=C.+E.+Brokowskiauthor=S.+C.+Eisenbarthauthor=G.+M.+Phillipsauthor=G.+W.+Clineauthor=A.+J.+Phillipsauthor=R.+Medzhitov&title=Functional+polarization+of+tumour-associated+macrophages+by+tumour-derived+lactic+acid&doi=10.1038%2Fnature13490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Functional polarization of tumor-associated macrophages by tumor-derived lactic acid</span></div><div class="casAuthors">Colegio, Oscar R.; Chu, Ngoc-Quynh; Szabo, Alison L.; Chu, Thach; Rhebergen, Anne Marie; Jairam, Vikram; Cyrus, Nika; Brokowski, Carolyn E.; Eisenbarth, Stephanie C.; Phillips, Gillian M.; Cline, Gary W.; Phillips, Andrew J.; Medzhitov, Ruslan</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">513</span>
        (<span class="NLM_cas:issue">7519</span>),
    <span class="NLM_cas:pages">559-563</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Macrophages have an important role in the maintenance of tissue homeostasis.  To perform this function, macrophages must have the capacity to monitor the functional states of their 'client cells': namely, the parenchymal cells in the various tissues in which macrophages reside.  Tumors exhibit many features of abnormally developed organs, including tissue architecture and cellular compn.  Similarly to macrophages in normal tissues and organs, macrophages in tumors (tumor-assocd. macrophages) perform some key homeostatic functions that allow tumor maintenance and growth.  However, the signals involved in communication between tumors and macrophages are poorly defined.  Here we show that lactic acid produced by tumor cells, as a byproduct of aerobic or anaerobic glycolysis, has a crit. function in signaling, through inducing the expression of vascular endothelial growth factor and the M2-like polarization of tumor-assocd. macrophages.  Furthermore, we demonstrate that this effect of lactic acid is mediated by hypoxia-inducible factor 1α (HIF1α).  Finally, we show that the lactate-induced expression of arginase 1 by macrophages has an important role in tumor growth.  Collectively, these findings identify a mechanism of communication between macrophages and their client cells, including tumor cells.  This communication most probably evolved to promote homeostasis in normal tissues but can also be engaged in tumors to promote their growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqslUtHs-WCprVg90H21EOLACvtfcHk0lh5JVAK3J-MeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Wjs7nO&md5=19de6df0a2734ab8037ade191a02ed60</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature13490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13490%26sid%3Dliteratum%253Aachs%26aulast%3DColegio%26aufirst%3DO.%2BR.%26aulast%3DChu%26aufirst%3DN.%2BQ.%26aulast%3DSzabo%26aufirst%3DA.%2BL.%26aulast%3DChu%26aufirst%3DT.%26aulast%3DRhebergen%26aufirst%3DA.%2BM.%26aulast%3DJairam%26aufirst%3DV.%26aulast%3DCyrus%26aufirst%3DN.%26aulast%3DBrokowski%26aufirst%3DC.%2BE.%26aulast%3DEisenbarth%26aufirst%3DS.%2BC.%26aulast%3DPhillips%26aufirst%3DG.%2BM.%26aulast%3DCline%26aufirst%3DG.%2BW.%26aulast%3DPhillips%26aufirst%3DA.%2BJ.%26aulast%3DMedzhitov%26aufirst%3DR.%26atitle%3DFunctional%2520polarization%2520of%2520tumour-associated%2520macrophages%2520by%2520tumour-derived%2520lactic%2520acid%26jtitle%3DNature%26date%3D2014%26volume%3D513%26spage%3D559%26epage%3D563%26doi%3D10.1038%2Fnature13490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehl, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolitzus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoenhammer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruss, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klobuch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastenberger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogdan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleicher, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackensen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ullrich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fichtner-Feigl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kesselring, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mack, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blank, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dettmer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oefner, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walenta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geissler, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouyssegur, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villunger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steven, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seliger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreml, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haferkamp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohl, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karrer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berneburg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herr, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller-Klieser, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutz, M.</span></span> <span> </span><span class="NLM_article-title">LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK Cells</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">657</span>– <span class="NLM_lpage">671</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2016.08.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.cmet.2016.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=27641098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFajsLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=657-671&author=A.+Brandauthor=K.+Singerauthor=G.+E.+Koehlauthor=M.+Kolitzusauthor=G.+Schoenhammerauthor=A.+Thielauthor=C.+Matosauthor=C.+Brussauthor=S.+Klobuchauthor=K.+Peterauthor=M.+Kastenbergerauthor=C.+Bogdanauthor=U.+Schleicherauthor=A.+Mackensenauthor=E.+Ullrichauthor=S.+Fichtner-Feiglauthor=R.+Kesselringauthor=M.+Mackauthor=U.+Ritterauthor=M.+Schmidauthor=C.+Blankauthor=K.+Dettmerauthor=P.+J.+Oefnerauthor=P.+Hoffmannauthor=S.+Walentaauthor=E.+K.+Geisslerauthor=J.+Pouyssegurauthor=A.+Villungerauthor=A.+Stevenauthor=B.+Seligerauthor=S.+Schremlauthor=S.+Haferkampauthor=E.+Kohlauthor=S.+Karrerauthor=M.+Berneburgauthor=W.+Herrauthor=W.+Mueller-Klieserauthor=K.+Rennerauthor=M.+Kreutz&title=LDHA-associated+lactic+acid+production+blunts+tumor+immunosurveillance+by+T+and+NK+Cells&doi=10.1016%2Fj.cmet.2016.08.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells</span></div><div class="casAuthors">Brand, Almut; Singer, Katrin; Koehl, Gudrun E.; Kolitzus, Marlene; Schoenhammer, Gabriele; Thiel, Annette; Matos, Carina; Bruss, Christina; Klobuch, Sebastian; Peter, Katrin; Kastenberger, Michael; Bogdan, Christian; Schleicher, Ulrike; Mackensen, Andreas; Ullrich, Evelyn; Fichtner-Feigl, Stefan; Kesselring, Rebecca; Mack, Matthias; Ritter, Uwe; Schmid, Maximilian; Blank, Christian; Dettmer, Katja; Oefner, Peter J.; Hoffmann, Petra; Walenta, Stefan; Geissler, Edward K.; Pouyssegur, Jacques; Villunger, Andreas; Steven, Andre; Seliger, Barbara; Schreml, Stephan; Haferkamp, Sebastian; Kohl, Elisabeth; Karrer, Sigrid; Berneburg, Mark; Herr, Wolfgang; Mueller-Klieser, Wolfgang; Renner, Kathrin; Kreutz, Marina</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">657-671</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Elevated lactate dehydrogenase A (LDHA) expression is assocd. with poor outcome in tumor patients.  Here we show that LDHA-assocd. lactic acid accumulation in melanomas inhibits tumor surveillance by T and NK cells.  In immunocompetent C57BL/6 mice, tumors with reduced lactic acid prodn. (Ldhalow) developed significantly slower than control tumors and showed increased infiltration with IFN-γ-producing T and NK cells.  However, in Rag2-/-γc-/- mice, lacking lymphocytes and NK cells, and in Ifng-/- mice, Ldhalow and control cells formed tumors at similar rates.  Pathophysiol. concns. of lactic acid prevented upregulation of nuclear factor of activated T cells (NFAT) in T and NK cells, resulting in diminished IFN-γ prodn.  Database analyses revealed neg. correlations between LDHA expression and T cell activation markers in human melanoma patients.  Our results demonstrate that lactic acid is a potent inhibitor of function and survival of T and NK cells leading to tumor immune escape.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEkJBRRuoHRLVg90H21EOLACvtfcHk0lim1Ml8PlX5Zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFajsLbK&md5=99e43d6896d1eed4571fb09a058e5042</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2016.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2016.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DBrand%26aufirst%3DA.%26aulast%3DSinger%26aufirst%3DK.%26aulast%3DKoehl%26aufirst%3DG.%2BE.%26aulast%3DKolitzus%26aufirst%3DM.%26aulast%3DSchoenhammer%26aufirst%3DG.%26aulast%3DThiel%26aufirst%3DA.%26aulast%3DMatos%26aufirst%3DC.%26aulast%3DBruss%26aufirst%3DC.%26aulast%3DKlobuch%26aufirst%3DS.%26aulast%3DPeter%26aufirst%3DK.%26aulast%3DKastenberger%26aufirst%3DM.%26aulast%3DBogdan%26aufirst%3DC.%26aulast%3DSchleicher%26aufirst%3DU.%26aulast%3DMackensen%26aufirst%3DA.%26aulast%3DUllrich%26aufirst%3DE.%26aulast%3DFichtner-Feigl%26aufirst%3DS.%26aulast%3DKesselring%26aufirst%3DR.%26aulast%3DMack%26aufirst%3DM.%26aulast%3DRitter%26aufirst%3DU.%26aulast%3DSchmid%26aufirst%3DM.%26aulast%3DBlank%26aufirst%3DC.%26aulast%3DDettmer%26aufirst%3DK.%26aulast%3DOefner%26aufirst%3DP.%2BJ.%26aulast%3DHoffmann%26aufirst%3DP.%26aulast%3DWalenta%26aufirst%3DS.%26aulast%3DGeissler%26aufirst%3DE.%2BK.%26aulast%3DPouyssegur%26aufirst%3DJ.%26aulast%3DVillunger%26aufirst%3DA.%26aulast%3DSteven%26aufirst%3DA.%26aulast%3DSeliger%26aufirst%3DB.%26aulast%3DSchreml%26aufirst%3DS.%26aulast%3DHaferkamp%26aufirst%3DS.%26aulast%3DKohl%26aufirst%3DE.%26aulast%3DKarrer%26aufirst%3DS.%26aulast%3DBerneburg%26aufirst%3DM.%26aulast%3DHerr%26aufirst%3DW.%26aulast%3DMueller-Klieser%26aufirst%3DW.%26aulast%3DRenner%26aufirst%3DK.%26aulast%3DKreutz%26aufirst%3DM.%26atitle%3DLDHA-associated%2520lactic%2520acid%2520production%2520blunts%2520tumor%2520immunosurveillance%2520by%2520T%2520and%2520NK%2520Cells%26jtitle%3DCell%2520Metab.%26date%3D2016%26volume%3D24%26spage%3D657%26epage%3D671%26doi%3D10.1016%2Fj.cmet.2016.08.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurence, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. P.</span></span> <span> </span><span class="NLM_article-title">Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2alpha-mediated tumor progression</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">646</span>, <span class="refDoi"> DOI: 10.1172/JCI123027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1172%2FJCI123027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=30431439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A280%3ADC%252BB3crgtlWjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2019&pages=631-646&author=N.+Liuauthor=J.+Luoauthor=D.+Kuangauthor=S.+Xuauthor=Y.+Duanauthor=Y.+Xiaauthor=Z.+Weiauthor=X.+Xieauthor=B.+Yinauthor=F.+Chenauthor=S.+Luoauthor=H.+Liuauthor=J.+Wangauthor=K.+Jiangauthor=F.+Gongauthor=Z.+H.+Tangauthor=X.+Chengauthor=H.+Liauthor=Z.+Liauthor=A.+Laurenceauthor=G.+Wangauthor=X.+P.+Yang&title=Lactate+inhibits+ATP6V0d2+expression+in+tumor-associated+macrophages+to+promote+HIF-2alpha-mediated+tumor+progression&doi=10.1172%2FJCI123027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2α-mediated tumor progression</span></div><div class="casAuthors">Liu Na; Luo Jing; Xia Yu; Wei Zhengping; Xie Xiuxiu; Yin Bingjiao; Chen Fang; Liu Huicheng; Wang Jing; Gong Feili; Li Zhuoya; Yang Xiang-Ping; Kuang Dong; Xu Sanpeng; Duan Yaqi; Wang Guoping; Kuang Dong; Xu Sanpeng; Duan Yaqi; Wang Guoping; Luo Shunqun; Jiang Kan; Tang Zhao-Hui; Cheng Xiang; Li Huabin; Laurence Arian</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">631-646</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Macrophages perform key functions in tissue homeostasis that are influenced by the local tissue environment.  Within the tumor microenvironment, tumor-associated macrophages can be altered to acquire properties that enhance tumor growth.  Here, we found that lactate, a metabolite found in high concentration within the anaerobic tumor environment, activated mTORC1 that subsequently suppressed TFEB-mediated expression of the macrophage-specific vacuolar ATPase subunit ATP6V0d2.  Atp6v0d2-/- mice were more susceptible to tumor growth, with enhanced HIF-2α-mediated VEGF production in macrophages that display a more protumoral phenotype.  We found that ATP6V0d2 targeted HIF-2α but not HIF-1α for lysosome-mediated degradation.  Blockade of HIF-2α transcriptional activity reversed the susceptibility of Atp6v0d2-/- mice to tumor development.  Furthermore, in a cohort of patients with lung adenocarcinoma, expression of ATP6V0d2 and HIF-2α was positively and negatively correlated with survival, respectively, suggesting a critical role of the macrophage lactate/ATP6V0d2/HIF-2α axis in maintaining tumor growth in human patients.  Together, our results highlight the ability of tumor cells to modify the function of tumor-infiltrating macrophages to optimize the microenvironment for tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTs0473RL72GkBuFdjgVNKSfW6udTcc2ea5FSLOFCPNHLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3crgtlWjsg%253D%253D&md5=4a3de4470556aaf42a3a3571eaa985e5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1172%2FJCI123027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI123027%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DKuang%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DDuan%26aufirst%3DY.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DZ.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DYin%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DK.%26aulast%3DGong%26aufirst%3DF.%26aulast%3DTang%26aufirst%3DZ.%2BH.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DX.%2BP.%26atitle%3DLactate%2520inhibits%2520ATP6V0d2%2520expression%2520in%2520tumor-associated%2520macrophages%2520to%2520promote%2520HIF-2alpha-mediated%2520tumor%2520progression%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2019%26volume%3D129%26spage%3D631%26epage%3D646%26doi%3D10.1172%2FJCI123027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stacpoole, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunch, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carney, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fennell, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felitsyn, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmore, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neiberger, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quisling, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shroads, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuster, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverstein, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theriaque, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenstein, E.</span></span> <span> </span><span class="NLM_article-title">Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children</span>. <i>Pediatrics</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">1519</span>– <span class="NLM_lpage">1531</span>, <span class="refDoi"> DOI: 10.1542/peds.2005-1226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1542%2Fpeds.2005-1226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=16651305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A280%3ADC%252BD283ksVGmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2006&pages=1519-1531&author=P.+W.+Stacpooleauthor=D.+S.+Kerrauthor=C.+Barnesauthor=S.+T.+Bunchauthor=P.+R.+Carneyauthor=E.+M.+Fennellauthor=N.+M.+Felitsynauthor=R.+L.+Gilmoreauthor=M.+Greerauthor=G.+N.+Hendersonauthor=A.+D.+Hutsonauthor=R.+E.+Neibergerauthor=R.+G.+O%E2%80%99Brienauthor=L.+A.+Perkinsauthor=R.+G.+Quislingauthor=A.+L.+Shroadsauthor=J.+J.+Shusterauthor=J.+H.+Silversteinauthor=D.+W.+Theriaqueauthor=E.+Valenstein&title=Controlled+clinical+trial+of+dichloroacetate+for+treatment+of+congenital+lactic+acidosis+in+children&doi=10.1542%2Fpeds.2005-1226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children</span></div><div class="casAuthors">Stacpoole Peter W; Kerr Douglas S; Barnes Carie; Bunch S Terri; Carney Paul R; Fennell Eileen M; Felitsyn Natalia M; Gilmore Robin L; Greer Melvin; Henderson George N; Hutson Alan D; Neiberger Richard E; O'Brien Ralph G; Perkins Leigh Ann; Quisling Ronald G; Shroads Albert L; Shuster Jonathan J; Silverstein Janet H; Theriaque Douglas W; Valenstein Edward</div><div class="citationInfo"><span class="NLM_cas:title">Pediatrics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1519-31</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Open-label studies indicate that oral dichloroacetate (DCA) may be effective in treating patients with congenital lactic acidosis.  We tested this hypothesis by conducting the first double-blind, randomized, control trial of DCA in this disease.  METHODS:  Forty-three patients who ranged in age from 0.9 to 19 years were enrolled.  All patients had persistent or intermittent hyperlactatemia, and most had severe psychomotor delay.  Eleven patients had pyruvate dehydrogenase deficiency, 25 patients had 1 or more defects in enzymes of the respiratory chain, and 7 patients had a mutation in mitochondrial DNA.  Patients were preconditioned on placebo for 6 months and then were randomly assigned to receive an additional 6 months of placebo or DCA, at a dose of 12.5 mg/kg every 12 hours.  The primary outcome results were (1) a Global Assessment of Treatment Efficacy, which incorporated tests of neuromuscular and behavioral function and quality of life; (2) linear growth; (3) blood lactate concentration in the fasted state and after a carbohydrate meal; (4) frequency and severity of intercurrent illnesses and hospitalizations; and (5) safety, including tests of liver and peripheral nerve function.  OUTCOME:  There were no significant differences in Global Assessment of Treatment Efficacy scores, linear growth, or the frequency or severity of intercurrent illnesses.  DCA significantly decreased the rise in blood lactate caused by carbohydrate feeding.  Chronic DCA administration was associated with a fall in plasma clearance of the drug and with a rise in the urinary excretion of the tyrosine catabolite maleylacetone and the heme precursor delta-aminolevulinate.  CONCLUSIONS:  In this highly heterogeneous population of children with congenital lactic acidosis, oral DCA for 6 months was well tolerated and blunted the postprandial increase in circulating lactate.  However, it did not improve neurologic or other measures of clinical outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSUwUvYVkV0pcXNb62YGmbfW6udTcc2ea5FSLOFCPNHLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD283ksVGmtg%253D%253D&md5=c5673a710c0557d45f6cf517c9fa8a33</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1542%2Fpeds.2005-1226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1542%252Fpeds.2005-1226%26sid%3Dliteratum%253Aachs%26aulast%3DStacpoole%26aufirst%3DP.%2BW.%26aulast%3DKerr%26aufirst%3DD.%2BS.%26aulast%3DBarnes%26aufirst%3DC.%26aulast%3DBunch%26aufirst%3DS.%2BT.%26aulast%3DCarney%26aufirst%3DP.%2BR.%26aulast%3DFennell%26aufirst%3DE.%2BM.%26aulast%3DFelitsyn%26aufirst%3DN.%2BM.%26aulast%3DGilmore%26aufirst%3DR.%2BL.%26aulast%3DGreer%26aufirst%3DM.%26aulast%3DHenderson%26aufirst%3DG.%2BN.%26aulast%3DHutson%26aufirst%3DA.%2BD.%26aulast%3DNeiberger%26aufirst%3DR.%2BE.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DR.%2BG.%26aulast%3DPerkins%26aufirst%3DL.%2BA.%26aulast%3DQuisling%26aufirst%3DR.%2BG.%26aulast%3DShroads%26aufirst%3DA.%2BL.%26aulast%3DShuster%26aufirst%3DJ.%2BJ.%26aulast%3DSilverstein%26aufirst%3DJ.%2BH.%26aulast%3DTheriaque%26aufirst%3DD.%2BW.%26aulast%3DValenstein%26aufirst%3DE.%26atitle%3DControlled%2520clinical%2520trial%2520of%2520dichloroacetate%2520for%2520treatment%2520of%2520congenital%2520lactic%2520acidosis%2520in%2520children%26jtitle%3DPediatrics%26date%3D2006%26volume%3D117%26spage%3D1519%26epage%3D1531%26doi%3D10.1542%2Fpeds.2005-1226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, K. Y.</span></span> <span> </span><span class="NLM_article-title">Development of pyruvate dehydrogenase kinase inhibitors in medicinal chemistry with particular emphasis as anticancer agents</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1112</span>– <span class="NLM_lpage">1119</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2015.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.drudis.2015.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=25842042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A280%3ADC%252BC2MjhtVKmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=1112-1119&author=S.+L.+Zhangauthor=X.+Huauthor=W.+Zhangauthor=H.+Yaoauthor=K.+Y.+Tam&title=Development+of+pyruvate+dehydrogenase+kinase+inhibitors+in+medicinal+chemistry+with+particular+emphasis+as+anticancer+agents&doi=10.1016%2Fj.drudis.2015.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Development of pyruvate dehydrogenase kinase inhibitors in medicinal chemistry with particular emphasis as anticancer agents</span></div><div class="casAuthors">Zhang Shao-Lin; Hu Xiaohui; Zhang Wen; Yao Huankai; Tam Kin Yip</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1112-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Many cancer cells demonstrate a high rate of glucose consumption via glycolysis to provide intermediates for macromolecule biosynthesis.  To accomplish this metabolic change, the expression of pyruvate dehydrogenase kinases (PDKs) is rapidly increased in cancer cells.  Inhibition of PDKs could promote the function of mitochondria by increasing the oxidative metabolism of pyruvate, resulting in the death of cancer cells.  In this review, we provide an overview of the structural information available for PDKs and their connections to known therapeutic effects.  We then describe the development of small molecule PDK inhibitors in medicinal chemistry with particular emphasis as anticancer agents.  Finally, directions for further development of PDK inhibitors as potential anticancer agents are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSoAx3fbmrmKLBItaL1WaVAfW6udTcc2eYJ0dwf00tD-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MjhtVKmsA%253D%253D&md5=5e840ba2e6d722d6e7145e39c9b3e486</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2015.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2015.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%2BL.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DTam%26aufirst%3DK.%2BY.%26atitle%3DDevelopment%2520of%2520pyruvate%2520dehydrogenase%2520kinase%2520inhibitors%2520in%2520medicinal%2520chemistry%2520with%2520particular%2520emphasis%2520as%2520anticancer%2520agents%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2015%26volume%3D20%26spage%3D1112%26epage%3D1119%26doi%3D10.1016%2Fj.drudis.2015.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christofk, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vander Heiden, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerszten, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span> <span> </span><span class="NLM_article-title">The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>452</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1038/nature06734</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1038%2Fnature06734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=18337823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1Gnu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=452&publication_year=2008&pages=230-234&author=H.+R.+Christofkauthor=M.+G.+Vander+Heidenauthor=M.+H.+Harrisauthor=A.+Ramanathanauthor=R.+E.+Gersztenauthor=R.+Weiauthor=M.+D.+Flemingauthor=S.+L.+Schreiberauthor=L.+C.+Cantley&title=The+M2+splice+isoform+of+pyruvate+kinase+is+important+for+cancer+metabolism+and+tumour+growth&doi=10.1038%2Fnature06734"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumor growth</span></div><div class="casAuthors">Christofk, Heather R.; Vander Heiden, Matthew G.; Harris, Marian H.; Ramanathan, Arvind; Gerszten, Robert E.; Wei, Ru; Fleming, Mark D.; Schreiber, Stuart L.; Cantley, Lewis C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">452</span>
        (<span class="NLM_cas:issue">7184</span>),
    <span class="NLM_cas:pages">230-233</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Many tumor cells have elevated rates of glucose uptake but reduced rates of oxidative phosphorylation.  This persistence of high lactate prodn. by tumors in the presence of oxygen, known as aerobic glycolysis, was first noted by Otto Warburg more than 75 yr ago.  How tumor cells establish this altered metabolic phenotype and whether it is essential for tumorigenesis is as yet unknown.  Here we show that a single switch in a splice isoform of the glycolytic enzyme pyruvate kinase is necessary for the shift in cellular metab. to aerobic glycolysis and that this promotes tumorigenesis.  Tumor cells have been shown to express exclusively the embryonic M2 isoform of pyruvate kinase.  Here we use short hairpin RNA to knockdown pyruvate kinase M2 expression in human cancer cell lines and replace it with pyruvate kinase M1.  Switching pyruvate kinase expression to the M1 (adult) isoform leads to reversal of the Warburg effect, as judged by reduced lactate prodn. and increased oxygen consumption, and this correlates with a reduced ability to form tumors in nude mouse xenografts.  These results demonstrate that M2 expression is necessary for aerobic glycolysis and that this metabolic phenotype provides a selective growth advantage for tumor cells in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvmgcXNsSjpbVg90H21EOLACvtfcHk0lizQPLlE_PRgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1Gnu74%253D&md5=e7e6b7cc09477e1f9d270018d1c38be4</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature06734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06734%26sid%3Dliteratum%253Aachs%26aulast%3DChristofk%26aufirst%3DH.%2BR.%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DHarris%26aufirst%3DM.%2BH.%26aulast%3DRamanathan%26aufirst%3DA.%26aulast%3DGerszten%26aufirst%3DR.%2BE.%26aulast%3DWei%26aufirst%3DR.%26aulast%3DFleming%26aufirst%3DM.%2BD.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DThe%2520M2%2520splice%2520isoform%2520of%2520pyruvate%2520kinase%2520is%2520important%2520for%2520cancer%2520metabolism%2520and%2520tumour%2520growth%26jtitle%3DNature%26date%3D2008%26volume%3D452%26spage%3D230%26epage%3D234%26doi%3D10.1038%2Fnature06734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Archer, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allalunis-Turner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haromy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopaschuk, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puttagunta, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrade, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thebaud, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelakis, E. D.</span></span> <span> </span><span class="NLM_article-title">A mitochondria-K<sup>+</sup> channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2006.10.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.ccr.2006.10.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=17222789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFClsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=37-51&author=S.+Bonnetauthor=S.+L.+Archerauthor=J.+Allalunis-Turnerauthor=A.+Haromyauthor=C.+Beaulieuauthor=R.+Thompsonauthor=C.+T.+Leeauthor=G.+D.+Lopaschukauthor=L.+Puttaguntaauthor=S.+Bonnetauthor=G.+Harryauthor=K.+Hashimotoauthor=C.+J.+Porterauthor=M.+A.+Andradeauthor=B.+Thebaudauthor=E.+D.+Michelakis&title=A+mitochondria-K%2B+channel+axis+is+suppressed+in+cancer+and+its+normalization+promotes+apoptosis+and+inhibits+cancer+growth&doi=10.1016%2Fj.ccr.2006.10.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth</span></div><div class="casAuthors">Bonnet, Sebastien; Archer, Stephen L.; Allalunis-Turner, Joan; Haromy, Alois; Beaulieu, Christian; Thompson, Richard; Lee, Christopher T.; Lopaschuk, Gary D.; Puttagunta, Lakshmi; Bonnet, Sandra; Harry, Gwyneth; Hashimoto, Kyoko; Porter, Christopher J.; Andrade, Miguel A.; Thebaud, Bernard; Michelakis, Evangelos D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-51</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The unique metabolic profile of cancer (aerobic glycolysis) might confer apoptosis resistance and be therapeutically targeted.  Compared to normal cells, several human cancers have high mitochondrial membrane potential (ΔΨm) and low expression of the K+ channel Kv1.5, both contributing to apoptosis resistance.  Dichloroacetate (DCA) inhibits mitochondrial pyruvate dehydrogenase kinase (PDK), shifts metab. from glycolysis to glucose oxidn., decreases ΔΨm, increases mitochondrial H2O2, and activates Kv channels in all cancer, but not normal, cells; DCA upregulates Kv1.5 by an NFAT1-dependent mechanism.  DCA induces apoptosis, decreases proliferation, and inhibits tumor growth, without apparent toxicity.  Mol. inhibition of PDK2 by siRNA mimics DCA.  The mitochondria-NFAT-Kv axis and PDK are important therapeutic targets in cancer; the orally available DCA is a promising selective anticancer agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocAukkjsEmZLVg90H21EOLACvtfcHk0lizQPLlE_PRgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFClsLg%253D&md5=ce8b45e3292469a3ce1af91803785bee</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.10.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.10.020%26sid%3Dliteratum%253Aachs%26aulast%3DBonnet%26aufirst%3DS.%26aulast%3DArcher%26aufirst%3DS.%2BL.%26aulast%3DAllalunis-Turner%26aufirst%3DJ.%26aulast%3DHaromy%26aufirst%3DA.%26aulast%3DBeaulieu%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DC.%2BT.%26aulast%3DLopaschuk%26aufirst%3DG.%2BD.%26aulast%3DPuttagunta%26aufirst%3DL.%26aulast%3DBonnet%26aufirst%3DS.%26aulast%3DHarry%26aufirst%3DG.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DPorter%26aufirst%3DC.%2BJ.%26aulast%3DAndrade%26aufirst%3DM.%2BA.%26aulast%3DThebaud%26aufirst%3DB.%26aulast%3DMichelakis%26aufirst%3DE.%2BD.%26atitle%3DA%2520mitochondria-K%252B%2520channel%2520axis%2520is%2520suppressed%2520in%2520cancer%2520and%2520its%2520normalization%2520promotes%2520apoptosis%2520and%2520inhibits%2520cancer%2520growth%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D11%26spage%3D37%26epage%3D51%26doi%3D10.1016%2Fj.ccr.2006.10.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akazawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuze, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, N.</span></span> <span> </span><span class="NLM_article-title">Dichloroacetate improves immune dysfunction caused by tumor-secreted lactic acid and increases antitumor immunoreactivity</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">1107</span>– <span class="NLM_lpage">1118</span>, <span class="refDoi"> DOI: 10.1002/ijc.28114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1002%2Fijc.28114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=23420584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktVKgsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2013&pages=1107-1118&author=T.+Ohashiauthor=T.+Akazawaauthor=M.+Aokiauthor=B.+Kuzeauthor=K.+Mizutaauthor=Y.+Itoauthor=N.+Inoue&title=Dichloroacetate+improves+immune+dysfunction+caused+by+tumor-secreted+lactic+acid+and+increases+antitumor+immunoreactivity&doi=10.1002%2Fijc.28114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Dichloroacetate improves immune dysfunction caused by tumor-secreted lactic acid and increases antitumor immunoreactivity</span></div><div class="casAuthors">Ohashi, Toshimitsu; Akazawa, Takashi; Aoki, Mitsuhiro; Kuze, Bunya; Mizuta, Keisuke; Ito, Yatsuji; Inoue, Norimitsu</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1107-1118</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The activation of oncogenic signaling pathways induces the reprogramming of glucose metab. in tumor cells and increases lactic acid secretion into the tumor microenvironment.  This is a well-known characteristic of tumor cells, termed the Warburg effect, and is a candidate target for antitumor therapy.  Previous reports show that lactic acid secreted by tumor cells is a proinflammatory mediator that activates the IL-23/IL-17 pathway, thereby inducing inflammation, angiogenesis and tissue remodeling.  Here, we show that lactic acid, or more specifically the acidification it causes, increases arginase I (ARG1) expression in macrophages to inhibit T-cell proliferation and activation.  Accordingly, we hypothesized that counteraction of the immune effects by lactic acid might suppress tumor development.  We show that dichloroacetate (DCA), an inhibitor of pyruvate dehydrogenase kinases, targets macrophages to suppress activation of the IL-23/IL-17 pathway and the expression of ARG1 by lactic acid.  Furthermore, lactic acid-pretreated macrophages inhibited CD8+ T-cell proliferation, but CD8+ T-cell proliferation was restored when macrophages were pretreated with lactic acid and DCA.  DCA treatment decreased ARG1 expression in tumor-infiltrating immune cells and increased the no. of IFN-γ-producing CD8+ T cells and NK cells in tumor-bearing mouse spleen.  Although DCA treatment alone did not suppress tumor growth, it increased antitumor immunotherapeutic activity of Poly(IC) in both CD8+ T cell- and NK cell-sensitive tumor models.  Therefore, DCA acts not only on tumor cells to suppress glycolysis but also on immune cells to improve the immune status modulated by lactic acid and to increase the effectiveness of antitumor immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBHFdDNu94dbVg90H21EOLACvtfcHk0liHYJYwWUt9uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktVKgsro%253D&md5=8d94c0db20accab9b7feefe79e332be5</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fijc.28114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.28114%26sid%3Dliteratum%253Aachs%26aulast%3DOhashi%26aufirst%3DT.%26aulast%3DAkazawa%26aufirst%3DT.%26aulast%3DAoki%26aufirst%3DM.%26aulast%3DKuze%26aufirst%3DB.%26aulast%3DMizuta%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DN.%26atitle%3DDichloroacetate%2520improves%2520immune%2520dysfunction%2520caused%2520by%2520tumor-secreted%2520lactic%2520acid%2520and%2520increases%2520antitumor%2520immunoreactivity%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2013%26volume%3D133%26spage%3D1107%26epage%3D1118%26doi%3D10.1002%2Fijc.28114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlstrom, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parish, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Board, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackburn, A. C.</span></span> <span> </span><span class="NLM_article-title">Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo</span>. <i>Breast Cancer Res. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">260</span>, <span class="refDoi"> DOI: 10.1007/s10549-009-0435-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1007%2Fs10549-009-0435-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=19543830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlaruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2010&pages=253-260&author=R.+C.+Sunauthor=M.+Fadiaauthor=J.+E.+Dahlstromauthor=C.+R.+Parishauthor=P.+G.+Boardauthor=A.+C.+Blackburn&title=Reversal+of+the+glycolytic+phenotype+by+dichloroacetate+inhibits+metastatic+breast+cancer+cell+growth+in+vitro+and+in+vivo&doi=10.1007%2Fs10549-009-0435-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo</span></div><div class="casAuthors">Sun, Ramon C.; Fadia, Mitali; Dahlstrom, Jane E.; Parish, Christopher R.; Board, Philip G.; Blackburn, Anneke C.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">253-260</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The glycolytic phenotype is a widespread phenomenon in solid cancer forms, including breast cancer.  Dichloroacetate (DCA) has recently been proposed as a novel and relatively non-toxic anti-cancer agent that can reverse the glycolytic phenotype in cancer cells through the inhibition of pyruvate dehydrogenase kinase.  We have examd. the effect of DCA against breast cancer cells, including in a highly metastatic in vivo model.  The growth of several breast cancer cell lines was found to be inhibited by DCA in vitro.  Further examn. of 13762 MAT rat mammary adenocarcinoma cells found that reversal of the glycolytic phenotype by DCA correlated with the inhibition of proliferation without any increase in cell death.  This was despite a small but significant increase in caspase 3/7 activity, which may sensitize cancer cells to other apoptotic triggers.  In vivo, DCA caused a 58% redn. in the no. of lung metastases obsd. macroscopically after injection of 13,762 MAT cells into the tail vein of rats (P = 0.0001, n ≥ 9 per group).  These results demonstrate that DCA has anti-proliferative properties in addn. to pro-apoptotic properties, and can be effective against highly metastatic disease in vivo, highlighting its potential for clin. use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbbgVFTE8jU7Vg90H21EOLACvtfcHk0liHYJYwWUt9uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlaruw%253D%253D&md5=f681498dd473ee35e2ced31f317109d0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs10549-009-0435-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-009-0435-9%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DR.%2BC.%26aulast%3DFadia%26aufirst%3DM.%26aulast%3DDahlstrom%26aufirst%3DJ.%2BE.%26aulast%3DParish%26aufirst%3DC.%2BR.%26aulast%3DBoard%26aufirst%3DP.%2BG.%26aulast%3DBlackburn%26aufirst%3DA.%2BC.%26atitle%3DReversal%2520of%2520the%2520glycolytic%2520phenotype%2520by%2520dichloroacetate%2520inhibits%2520metastatic%2520breast%2520cancer%2520cell%2520growth%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2010%26volume%3D120%26spage%3D253%26epage%3D260%26doi%3D10.1007%2Fs10549-009-0435-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pathak, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrache, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harn, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, S.</span></span> <span> </span><span class="NLM_article-title">Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1178</span>– <span class="NLM_lpage">1187</span>, <span class="refDoi"> DOI: 10.1021/cb400944y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400944y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktVSit7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1178-1187&author=R.+K.+Pathakauthor=S.+Marracheauthor=D.+A.+Harnauthor=S.+Dhar&title=Mito-DCA%3A+a+mitochondria+targeted+molecular+scaffold+for+efficacious+delivery+of+metabolic+modulator+dichloroacetate&doi=10.1021%2Fcb400944y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Mito-DCA: A Mitochondria Targeted Molecular Scaffold for Efficacious Delivery of Metabolic Modulator Dichloroacetate</span></div><div class="casAuthors">Pathak, Rakesh K.; Marrache, Sean; Harn, Donald A.; Dhar, Shanta</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1178-1187</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tumor growth is fueled by the use of glycolysis, which normal cells use only in the scarcity of oxygen.  Glycolysis makes tumor cells resistant to normal death processes.  Targeting this unique tumor metab. can provide an alternative strategy to selectively destroy the tumor, leaving normal tissue unharmed.  The orphan drug dichloroacetate (DCA) is a mitochondrial kinase inhibitor that has the ability to show such characteristics.  However, its mol. form shows poor uptake and bioavailability and limited ability to reach its target mitochondria.  Here, we describe a targeted mol. scaffold for construction of a multiple DCA loaded compd., Mito-DCA, with three orders of magnitude enhanced potency and cancer cell specificity compared to DCA.  Incorporation of a lipophilic triphenylphosphonium cation through a biodegradable linker in Mito-DCA allowed for mitochondria targeting.  Mito-DCA did not show any significant metabolic effects toward normal cells but tumor cells with dysfunctional mitochondria were affected by Mito-DCA, which caused a switch from glycolysis to glucose oxidn. and subsequent cell death via apoptosis.  Effective delivery of DCA to the mitochondria resulted in significant redn. in lactate levels and played important roles in modulating dendritic cell (DC) phenotype evidenced by secretion of interleukin-12 from DCs upon activation with tumor antigens from Mito-DCA treated cancer cells.  Targeting mitochondrial metabolic inhibitors to the mitochondria could lead to induction of an efficient antitumor immune response, thus introducing the concept of combining glycolysis inhibition with immune system to destroy tumor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_tg-468e5JrVg90H21EOLACvtfcHk0ljtWpCL-LaixQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktVSit7Y%253D&md5=d9a7041a1c8f3417e5bf290e00b092d4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fcb400944y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400944y%26sid%3Dliteratum%253Aachs%26aulast%3DPathak%26aufirst%3DR.%2BK.%26aulast%3DMarrache%26aufirst%3DS.%26aulast%3DHarn%26aufirst%3DD.%2BA.%26aulast%3DDhar%26aufirst%3DS.%26atitle%3DMito-DCA%253A%2520a%2520mitochondria%2520targeted%2520molecular%2520scaffold%2520for%2520efficacious%2520delivery%2520of%2520metabolic%2520modulator%2520dichloroacetate%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1178%26epage%3D1187%26doi%3D10.1021%2Fcb400944y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arambula, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sessler, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, S.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span> <span> </span><span class="NLM_article-title">Overcoming drug resistance by targeting cancer bioenergetics with an activatable prodrug</span>. <i>Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2370</span>– <span class="NLM_lpage">2383</span>, <span class="refDoi"> DOI: 10.1016/j.chempr.2018.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.chempr.2018.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFSqtrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=2370-2383&author=A.+Sharmaauthor=M.-G.+Leeauthor=H.+Shiauthor=M.+Wonauthor=J.+F.+Arambulaauthor=J.+L.+Sesslerauthor=J.+Y.+Leeauthor=S.-G.+Chiauthor=J.+S.+Kim&title=Overcoming+drug+resistance+by+targeting+cancer+bioenergetics+with+an+activatable+prodrug&doi=10.1016%2Fj.chempr.2018.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming Drug Resistance by Targeting Cancer Bioenergetics with an Activatable Prodrug</span></div><div class="casAuthors">Sharma, Amit; Lee, Min-Goo; Shi, Hu; Won, Miae; Arambula, Jonathan F.; Sessler, Jonathan L.; Lee, Jin Yong; Chi, Sung-Gil; Kim, Jong Seung</div><div class="citationInfo"><span class="NLM_cas:title">Chem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2370-2383</span>CODEN:
                <span class="NLM_cas:coden">CHEMVE</span>;
        ISSN:<span class="NLM_cas:issn">2451-9294</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Nearly without exception, all known cancer chemotherapeutics elicit a resistance response over time.  The resulting resistance is correlated with poor clin. outcomes.  Here, we report an approach to overcoming resistance through reprogramming oncogene-directed alterations in mitochondrial metab. before drug activation while simultaneously circumventing drug efflux pumps.  Conjugate C1 increases cancer cell apoptosis and inhibits regrowth of drug-resistant tumors, as inferred from efficacy studies carried out in human cancer cells and in Dox-resistant xenograft tumor models.  It also displays minimal whole-animal toxicity.  These benefits are ascribed to an ability to evade chemoresistance by switching cancer cell metab. back to normal mitochondrial oxidative phosphorylation while helping target the active Dox to first the mitochondrion and then the nucleus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAfLLSZwksDrVg90H21EOLACvtfcHk0ljtWpCL-LaixQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFSqtrzE&md5=40f6f0ff5491fd441e5a8a379cbb2192</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.chempr.2018.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chempr.2018.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DM.-G.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DWon%26aufirst%3DM.%26aulast%3DArambula%26aufirst%3DJ.%2BF.%26aulast%3DSessler%26aufirst%3DJ.%2BL.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DChi%26aufirst%3DS.-G.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26atitle%3DOvercoming%2520drug%2520resistance%2520by%2520targeting%2520cancer%2520bioenergetics%2520with%2520an%2520activatable%2520prodrug%26jtitle%3DChem.%26date%3D2018%26volume%3D4%26spage%3D2370%26epage%3D2383%26doi%3D10.1016%2Fj.chempr.2018.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippard, S. J.</span></span> <span> </span><span class="NLM_article-title">Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">22199</span>– <span class="NLM_lpage">22204</span>, <span class="refDoi"> DOI: 10.1073/pnas.0912276106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1073%2Fpnas.0912276106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=20007777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtlWruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=22199-22204&author=S.+Dharauthor=S.+J.+Lippard&title=Mitaplatin%2C+a+potent+fusion+of+cisplatin+and+the+orphan+drug+dichloroacetate&doi=10.1073%2Fpnas.0912276106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate</span></div><div class="casAuthors">Dhar, Shanta; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">22199-22204, S22199/1-S22199/11</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The unique glycolytic metab. of most solid tumors, known as the Warburg effect, is assocd. with resistance to apoptosis that enables cancer cells to survive.  Dichloroacetate (DCA) is an anticancer agent that can reverse the Warburg effect by inhibiting a key enzyme in cancer cells, pyruvate dehydrogenase kinase (PDK), that is required for the process.  DCA is currently not approved for cancer treatment in the USA.  Here, we present the synthesis, characterization, and anticancer properties of c,t,c-[Pt(NH3)2(02CHCl2)2Cl2], mitaplatin, in which two DCA units are appended to the axial positions of a six-coordinate Pt(IV) center.  The neg. intracellular redox potential reduces the platinum to release cisplatin, a Pt(II) compd., and two equiv. of DCA.  By a unique mechanism, mitaplatin thereby attacks both nuclear DNA with cisplatin and mitochondria with DCA selectively in cancer cells.  The cytotoxicity of mitaplatin in a variety of cancer cell lines equals or exceeds that of all known Pt(IV) compds. and is comparable to that of cisplatin.  Mitaplatin alters the mitochondrial membrane potential gradient (Δψm) of cancer cells, promoting apoptosis by releasing cytochrome c and translocating apoptosis inducing factor from mitochondria to the nucleus.  Cisplatin formed upon cellular redn. of mitaplatin enters the nucleus and targets DNA to form 1,2-intrastrand d(GpG) cross-links characteristic of its own potency as an anticancer drug.  These properties of mitaplatin are manifest in its ability to selectively kill cancer cells cocultured with normal fibroblasts and to partially overcome cisplatin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Dar40eUqpLVg90H21EOLACvtfcHk0lhxNcM3k3sYlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtlWruw%253D%253D&md5=7d8f3946238537b33ff15a49a4b13d3d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0912276106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0912276106%26sid%3Dliteratum%253Aachs%26aulast%3DDhar%26aufirst%3DS.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DMitaplatin%252C%2520a%2520potent%2520fusion%2520of%2520cisplatin%2520and%2520the%2520orphan%2520drug%2520dichloroacetate%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D22199%26epage%3D22204%26doi%3D10.1073%2Fpnas.0912276106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zajac, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostrhunova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrana, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raveendran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span> <span> </span><span class="NLM_article-title">Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2015.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.jinorgbio.2015.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=26780576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1Sltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2016&pages=89-97&author=J.+Zajacauthor=H.+Kostrhunovaauthor=V.+Novohradskyauthor=O.+Vranaauthor=R.+Raveendranauthor=D.+Gibsonauthor=J.+Kasparkovaauthor=V.+Brabec&title=Potentiation+of+mitochondrial+dysfunction+in+tumor+cells+by+conjugates+of+metabolic+modulator+dichloroacetate+with+a+Pt%28IV%29+derivative+of+oxaliplatin&doi=10.1016%2Fj.jinorgbio.2015.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin</span></div><div class="casAuthors">Zajac, Juraj; Kostrhunova, Hana; Novohradsky, Vojtech; Vrana, Oldrich; Raveendran, Raji; Gibson, Dan; Kasparkova, Jana; Brabec, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-97</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The mol. and cellular mechanisms of enhanced toxic effects in tumor cells of the Pt(IV) derivs. of antitumor oxaliplatin contg. axial dichloroacetate (DCA) ligands were investigated.  DCA ligands were chosen because DCA has shown great potential as an apoptosis sensitizer and anticancer agent reverting the Wartburg effect.  In addn., DCA reverses mitochondrial changes in a wide range of cancers, promoting tumor cell apoptosis in a mitochondrial-dependent pathway.  We demonstrate that (i) the transformation of oxaliplatin to its Pt(IV) derivs. contg. axial DCA ligands markedly enhances toxicity in cancer cells and helps overcome inherent and acquired resistance to cisplatin and oxaliplatin; (ii) a significant fraction of the intact mols. of DCA conjugates with Pt(IV) deriv. of oxaliplatin accumulates in cancer cells where it releases free DCA; (iii) mechanism of biol. action of the Pt(IV) derivs. of oxaliplatin contg. DCA ligands is connected with the effects of DCA released in cancer cells from the Pt(IV) prodrugs on mitochondria and metab. of glucose; (iv) treatments with the Pt(IV) derivs. of oxaliplatin contg. DCA ligands activate an autophagic response in human colorectal cancer cells; (v) the toxic effects in cancer cells of the Pt(IV) derivs. of oxaliplatin contg. DCA ligands can be potentiated if cells are treated with these prodrugs in combination with 5-fluorouracil.  These properties of the Pt(IV) derivs. of oxaliplatin contg. DCA ligands provide opportunities for further development of new platinum-based agents with the capability of killing cancer cells resistant to conventional antitumor platinum drugs used in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG2vp2jhBrirVg90H21EOLACvtfcHk0lhxNcM3k3sYlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1Sltr8%253D&md5=3b66039a74fa4741e11698a76d2ef394</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2015.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2015.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DZajac%26aufirst%3DJ.%26aulast%3DKostrhunova%26aufirst%3DH.%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DVrana%26aufirst%3DO.%26aulast%3DRaveendran%26aufirst%3DR.%26aulast%3DGibson%26aufirst%3DD.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DBrabec%26aufirst%3DV.%26atitle%3DPotentiation%2520of%2520mitochondrial%2520dysfunction%2520in%2520tumor%2520cells%2520by%2520conjugates%2520of%2520metabolic%2520modulator%2520dichloroacetate%2520with%2520a%2520Pt%2528IV%2529%2520derivative%2520of%2520oxaliplatin%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2016%26volume%3D156%26spage%3D89%26epage%3D97%26doi%3D10.1016%2Fj.jinorgbio.2015.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petruzzella, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braude, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich-Wright, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span> <span> </span><span class="NLM_article-title">A quadruple-action platinum(IV) prodrug with anticancer activity against KRAS mutated cancer cell lines</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">11539</span>– <span class="NLM_lpage">11544</span>, <span class="refDoi"> DOI: 10.1002/anie.201706739</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1002%2Fanie.201706739" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSlsbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=11539-11544&author=E.+Petruzzellaauthor=J.+P.+Braudeauthor=J.+R.+Aldrich-Wrightauthor=V.+Gandinauthor=D.+Gibson&title=A+quadruple-action+platinum%28IV%29+prodrug+with+anticancer+activity+against+KRAS+mutated+cancer+cell+lines&doi=10.1002%2Fanie.201706739"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A Quadruple-Action Platinum(IV) Prodrug with Anticancer Activity Against KRAS Mutated Cancer Cell Lines</span></div><div class="casAuthors">Petruzzella, Emanuele; Braude, Jeremy Phillip; Aldrich-Wright, Janice R.; Gandin, Valentina; Gibson, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">11539-11544</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We developed a novel PtIV prodrug that simultaneously releases four different bioactive moieties inside the cancer cell.  Its cytotoxicity against monolayer cultures (2D) and spheroid (3D) cancer cells is significantly better than cisplatin.  It is 200-450-fold more potent than cisplatin against KRAS mutated pancreatic and colon cancers and is 40-fold more selective towards KRAS mutated cells compared to non-cancerous.  This is important since RAS proteins play a role in regulating cell differentiation, proliferation, and survival and KRAS is mutated in 90 % of pancreatic adenocarcinomas, 45 % of colorectal cancers, and 35 % of lung adenocarcinomas.  The selectivity index, detd. by dividing the IC50 value in non-cancerous cells by that of a cancerous cell line, is two-fold better than cisplatin, attesting to preferential cytotoxicity towards neoplastic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTQHgQHWGMgbVg90H21EOLACvtfcHk0liua32YY8fc_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSlsbbJ&md5=4a9c4fcc8d6006775b09c9e4c246d175</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fanie.201706739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201706739%26sid%3Dliteratum%253Aachs%26aulast%3DPetruzzella%26aufirst%3DE.%26aulast%3DBraude%26aufirst%3DJ.%2BP.%26aulast%3DAldrich-Wright%26aufirst%3DJ.%2BR.%26aulast%3DGandin%26aufirst%3DV.%26aulast%3DGibson%26aufirst%3DD.%26atitle%3DA%2520quadruple-action%2520platinum%2528IV%2529%2520prodrug%2520with%2520anticancer%2520activity%2520against%2520KRAS%2520mutated%2520cancer%2520cell%2520lines%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26spage%3D11539%26epage%3D11544%26doi%3D10.1002%2Fanie.201706739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z. W.</span></span> <span> </span><span class="NLM_article-title">Targeted reversal and phosphorescence lifetime imaging of cancer cell metabolism via a theranostic rhenium(I)-DCA conjugate</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2018.05.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.biomaterials.2018.05.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=29870900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVKnurrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2018&pages=94-105&author=J.+Yangauthor=Q.+Caoauthor=H.+Zhangauthor=L.+Haoauthor=D.+Zhouauthor=Z.+Ganauthor=Z.+Liauthor=Y.+X.+Tongauthor=L.+N.+Jiauthor=Z.+W.+Mao&title=Targeted+reversal+and+phosphorescence+lifetime+imaging+of+cancer+cell+metabolism+via+a+theranostic+rhenium%28I%29-DCA+conjugate&doi=10.1016%2Fj.biomaterials.2018.05.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted reversal and phosphorescence lifetime imaging of cancer cell metabolism via a theranostic rhenium(I)-DCA conjugate</span></div><div class="casAuthors">Yang, Jing; Cao, Qian; Zhang, Hang; Hao, Liang; Zhou, Danxia; Gan, Zhenji; Li, Zhiwei; Tong, Ye-Xiang; Ji, Liang-Nian; Mao, Zong-Wan</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">94-105</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Cancer cell metab. is quite different from normal cells.  Targeting cancer metab. and untuning the tumor metabolic machine has emerged as a promising strategy for cancer therapy.  We have developed a multi-functional Re-dca conjugate (Re-dca 2) by conjugating the metabolic modulator dichloroacetate (DCA) to mitochondria-targeted rhenium(I) complex, allowing its efficient penetration into cancer cells and selective accumulation in mitochondria, thus achieving the cancer cell metab. reversal from glycolysis to glucose oxidn. at pharmacol. relevant DCA doses.  Mechanism studies confirm the inhibition effect of Re-dca 2 on the activity of pyruvate dehydrogenase kinase (PDK) and capture the metabolic reversal window in Re-dca 2 treated NCI-1229 cells at the early stage of drug treatment, resulting in selective killing of malignant cells cocultured with normal cells, significant inhibition of cancer cell metastasis and invasion, as well as excellent anti-angiogenesis activities in zebrafish embryos.  By comparison, DCA-free Re(I) analog is also investigated under the same conditions.  Although this analog also exhibits cytotoxicity due to the Re(I) core, metabolic reversal is not induced by this analog and its anti-metastasis activity is much lower than Re-dca 2, indicating the synergistic effect of Re(I) core and DCA moiety on cancer therapy.  In vivo anti-cancer investigations also indicate that the mitochondria-targeted Re-dca 2 can effectively inhibit the tumor growth without affecting the body wt. of nude mice, and the therapeutic effect is much better than the DCA-free Re(I) analog 2a.  Simultaneously, the O2-sensitive phosphorescent lifetimes of Re-dca 2 can be utilized for PLIM imaging of intracellular oxygen consumption, thus reflecting the Re-dca 2 induced glycolysis-to-glucose oxidn. reversal at the early drug treatment stage.  The excellent phosphorescence of Re-dca 2 can also be utilized for real-time tracking of mitochondrial morphol. changes during treatment.  In a word, rational design of phosphorescent metallodrug and metabolic modulator conjugates for synergistic treatment is a promising strategy for simultaneous untuning and tracking tumor metabolic machine, thus providing new clues for cancer therapy and mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIE-woq3L6CrVg90H21EOLACvtfcHk0liua32YY8fc_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVKnurrM&md5=33ab833eedefbd929010c1f7647c706b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2018.05.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2018.05.040%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHao%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DGan%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DTong%26aufirst%3DY.%2BX.%26aulast%3DJi%26aufirst%3DL.%2BN.%26aulast%3DMao%26aufirst%3DZ.%2BW.%26atitle%3DTargeted%2520reversal%2520and%2520phosphorescence%2520lifetime%2520imaging%2520of%2520cancer%2520cell%2520metabolism%2520via%2520a%2520theranostic%2520rhenium%2528I%2529-DCA%2520conjugate%26jtitle%3DBiomaterials%26date%3D2018%26volume%3D176%26spage%3D94%26epage%3D105%26doi%3D10.1016%2Fj.biomaterials.2018.05.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, P.</span></span> <span> </span><span class="NLM_article-title">Mitochondria-targeted lupane triterpenoid derivatives and their selective apoptosis-inducing anticancer mechanisms</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6353</span>– <span class="NLM_lpage">6363</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00679</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00679" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtV2qsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6353-6363&author=Y.+Yeauthor=T.+Zhangauthor=H.+Yuanauthor=D.+Liauthor=H.+Louauthor=P.+Fan&title=Mitochondria-targeted+lupane+triterpenoid+derivatives+and+their+selective+apoptosis-inducing+anticancer+mechanisms&doi=10.1021%2Facs.jmedchem.7b00679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-Targeted Lupane Triterpenoid Derivatives and Their Selective Apoptosis-Inducing Anticancer Mechanisms</span></div><div class="casAuthors">Ye, Yaqing; Zhang, Tao; Yuan, Huiqing; Li, Defeng; Lou, Hongxiang; Fan, Peihong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6353-6363</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Betulin and betulinic acid have been widely studied for their anticancer activities.  However, their further development is limited due to low bioavailability, poor aq. soly., and limited intracellular accumulation.  In the present study, a triphenylphosphonium cation moiety was linked to betulin and betulinic acid to specifically target them to cancer cell mitochondria.  Biol. characterization established that uptake of mitochondria-targeted compd. 1a in the mitochondria of cancer cells was increased compared to betulin.  The mitochondria-targeted derivs. of betulin and betulinic acid showed stronger cytotoxicity than their parent drugs and exhibited more cytotoxic effects in cancer cells than normal cells.  The mechanisms may involve the mitochondrial apoptotic pathway, probably caused by the induction of reactive oxygen species prodn. and reducing mitochondrial membrane potential.  More importantly, 1a significantly inhibited cancer cell proliferation and migration in an in vivo zebrafish xenograft model.  Collectively, these results encourage further study of 1a analogs as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotxRCv4fRMcbVg90H21EOLACvtfcHk0liF-sIhArN95Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtV2qsr3E&md5=b1461bf97acb75e7c68e976462804065</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00679%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DLou%26aufirst%3DH.%26aulast%3DFan%26aufirst%3DP.%26atitle%3DMitochondria-targeted%2520lupane%2520triterpenoid%2520derivatives%2520and%2520their%2520selective%2520apoptosis-inducing%2520anticancer%2520mechanisms%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D6353%26epage%3D6363%26doi%3D10.1021%2Facs.jmedchem.7b00679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samadi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmermann, B. N.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic oleanane-type saponins from Albiziainundata</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">482</span>, <span class="refDoi"> DOI: 10.1021/np100702p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np100702p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVWisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2011&pages=477-482&author=H.+Zhangauthor=A.+K.+Samadiauthor=K.+V.+Raoauthor=M.+S.+Cohenauthor=B.+N.+Timmermann&title=Cytotoxic+oleanane-type+saponins+from+Albiziainundata&doi=10.1021%2Fnp100702p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic Oleanane-Type Saponins from Albizia inundata</span></div><div class="casAuthors">Zhang, Huaping; Samadi, Abbas K.; Rao, Karumanchi V.; Cohen, Mark S.; Timmermann, Barbara N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">477-482</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Bioassay-guided fractionation of a CH2Cl2-MeOH ext. of the aerial parts of Albizia inundata resulted in the isolation of two new natural oleanane-type triterpene saponins {3-O-[α-L-arabinopyranosyl(1→6)]-2-acetamido-2-deoxy-β-D-glucopyranosyl oleanolic acid (1) and 3-O-[α-L-arabinopyranosyl(1→2)-α-L-arabinopyranosyl(1→6)]-2-acetamido-2-deoxy-β-D-glucopyranosyl acacic acid lactone (2)} along with seven known saponins 3-O-[α-L-arabinopyranosyl(1→6)]-2-acetamido-2-deoxy-β-D-glucopyranosyl echinocystic acid (3), 3-O-[β-D-xylopyranosyl(1→2)-α-L-arabinopyranosyl(1→6)]-2-acetamido-2-deoxy-β-D-glucopyranosyl acacic acid lactone (concinnoside D) (4), 3-O-[β-D-glucopyranosyl(1→2)]-β-D-glucopyranosyl oleanolic acid (5), 3-O-[α-L-arabinopyranosyl(1→2)-α-L-arabinopyranosyl(1→6)]-β-D-glucopyranosyl oleanolic acid (6), 3-O-[β-D-xylopyranosyl(1→2)-α-L-arabinopyranosyl(1→6)]-β-D-glucopyranosyl oleanolic acid (7), 3-O-[α-L-arabinopyranosyl(1→2)-α-L-arabinopyranosyl(1→6)-β-D-glucopyranosyl(1→2)]-β-D-glucopyranoside echinocystic acid (8), and 3-O-[β-D-xylopyranosyl(1→2)-α-L-arabinopyranosyl(1→6)-β-D-glucopyranosyl(1→2)]-β-D-glucopyranoside echinocystic acid (9).  The structures of 1 and 2 were established on the basis of extensive 2D NMR (1H-1H COSY or DQF-COSY, HSQC, HMBC, TOCSY, and HSQC-TOCSY) spectroscopic, ESIMS, and chem. methods.  Saponins 1, 3, 6, and 7 showed cytotoxicity against human head and neck squamous cells (JMAR, MDA1986) and melanoma cells (B16F10, SKMEL28) with IC50 values in the range 1.8-12.4 μM, using the MTS assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxBqtVu8GpJLVg90H21EOLACvtfcHk0liF-sIhArN95Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVWisLY%253D&md5=c8278add0fb4e3550ab096d83799920e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fnp100702p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp100702p%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSamadi%26aufirst%3DA.%2BK.%26aulast%3DRao%26aufirst%3DK.%2BV.%26aulast%3DCohen%26aufirst%3DM.%2BS.%26aulast%3DTimmermann%26aufirst%3DB.%2BN.%26atitle%3DCytotoxic%2520oleanane-type%2520saponins%2520from%2520Albiziainundata%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2011%26volume%3D74%26spage%3D477%26epage%3D482%26doi%3D10.1021%2Fnp100702p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of the anticancer activity of albiziabioside A and its analogues as apoptosis inducers against human melanoma cells</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">5928</span>– <span class="NLM_lpage">5935</span>, <span class="refDoi"> DOI: 10.1039/C4OB00874J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1039%2FC4OB00874J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=24985523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVyltbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=5928-5935&author=G.+Weiauthor=S.+Wangauthor=S.+Cuiauthor=J.+Guoauthor=Y.+Liuauthor=Y.+Liuauthor=M.+Cheng&title=Synthesis+and+evaluation+of+the+anticancer+activity+of+albiziabioside+A+and+its+analogues+as+apoptosis+inducers+against+human+melanoma+cells&doi=10.1039%2FC4OB00874J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of the anticancer activity of albiziabioside A and its analogues as apoptosis inducers against human melanoma cells</span></div><div class="casAuthors">Wei, Gaofei; Wang, Shuai; Cui, Shanshan; Guo, Jia; Liu, Yongxiang; Liu, Yang; Cheng, Maosheng</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">5928-5935</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We have efficiently synthesized albiziabioside A (I) together with its six disaccharide analogs through a linear synthesis, and evaluated their cytotoxicity against six different skin cancer cells.  All of the analogs showed weak cytotoxicity, with the exception of compd. I, which exhibited strong cytotoxicity against A375 cells.  Albiziabioside A can induce cell cycle arrest in both the S and G2/M phases.  Moreover, albiziabioside A can induce A375 cell apoptosis via mitochondrial pathways involving a caspase cascade.  These results provide for the first time a basic mechanism for the anticancer activity of I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEyYYeP_ng57Vg90H21EOLACvtfcHk0liprCf8OcDTEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVyltbjI&md5=848516492bbf76110a50bbd29004a586</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1039%2FC4OB00874J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4OB00874J%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520the%2520anticancer%2520activity%2520of%2520albiziabioside%2520A%2520and%2520its%2520analogues%2520as%2520apoptosis%2520inducers%2520against%2520human%2520melanoma%2520cells%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2014%26volume%3D12%26spage%3D5928%26epage%3D5935%26doi%3D10.1039%2FC4OB00874J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.</span></span> <span> </span><span class="NLM_article-title">Natural product-based design, synthesis and biological evaluation of Albiziabioside A derivatives that selectively induce HCT116 cell death</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">92</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.12.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.ejmech.2015.12.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=26922223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1yqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=92-101&author=G.+Weiauthor=S.+Cuiauthor=W.+Luanauthor=S.+Wangauthor=Z.+Houauthor=Y.+Liuauthor=Y.+Liuauthor=M.+Cheng&title=Natural+product-based+design%2C+synthesis+and+biological+evaluation+of+Albiziabioside+A+derivatives+that+selectively+induce+HCT116+cell+death&doi=10.1016%2Fj.ejmech.2015.12.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Natural product-based design, synthesis and biological evaluation of Albiziabioside A derivatives that selectively induce HCT116 cell death</span></div><div class="casAuthors">Wei, Gaofei; Cui, Shanshan; Luan, Weijing; Wang, Shuai; Hou, Zhuang; Liu, Yongxiang; Liu, Yang; Cheng, Maosheng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">92-101</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of Albiziabioside A coupled substituents of cinnamoyl derivs. were designed and synthesized.  The synthesized compds., e.g. I, were screened for anticancer activity against a panel of six human cancer cell lines using a MTT assay.  Synthetic derivs. showed excellent selectivity, as they were toxic against only HCT116 cell line.  Some compds. exhibited better anti-cancer activity against HCT116 compared to pos. controls, such as 5-fluorouracil and Albiziabioside A.  Compd. I was the most active deriv.  Importantly, it was also found that the anti-proliferative activity of I could be attributed to the induction of cell cycle arrest and apoptosis in HCT116 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAI3fVFT24grVg90H21EOLACvtfcHk0liprCf8OcDTEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1yqtb4%253D&md5=9b255dae3d6f0e5f4ba6a69d1ec8ac79</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.12.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.12.034%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DG.%26aulast%3DCui%26aufirst%3DS.%26aulast%3DLuan%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHou%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DM.%26atitle%3DNatural%2520product-based%2520design%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520Albiziabioside%2520A%2520derivatives%2520that%2520selectively%2520induce%2520HCT116%2520cell%2520death%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D113%26spage%3D92%26epage%3D101%26doi%3D10.1016%2Fj.ejmech.2015.12.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span> <span> </span><span class="NLM_article-title">Novel antitumor compound optimized from natural saponin Albiziabioside A induced caspase-dependent apoptosis and ferroptosis as a p53 activator through the mitochondrial pathway</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">759</span>– <span class="NLM_lpage">772</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.08.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.ejmech.2018.08.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=30142612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFOqsLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2018&pages=759-772&author=G.+Weiauthor=J.+Sunauthor=Z.+Houauthor=W.+Luanauthor=S.+Wangauthor=S.+Cuiauthor=M.+Chengauthor=Y.+Liu&title=Novel+antitumor+compound+optimized+from+natural+saponin+Albiziabioside+A+induced+caspase-dependent+apoptosis+and+ferroptosis+as+a+p53+activator+through+the+mitochondrial+pathway&doi=10.1016%2Fj.ejmech.2018.08.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Novel antitumor compound optimized from natural saponin Albiziabioside A induced caspase-dependent apoptosis and ferroptosis as a p53 activator through the mitochondrial pathway</span></div><div class="casAuthors">Wei, Gaofei; Sun, Jiahong; Hou, Zhuang; Luan, Weijing; Wang, Shuai; Cui, Shanshan; Cheng, Maosheng; Liu, Yang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">759-772</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">It is highly desirable to activate p53 function with small-mol. compds. for colon cancer therapy.  Triterpene saponin has been characterized with the favorable selectivity and safety profiles.  However, the application of triterpene saponin as cancer chemotherapy drugs was hampered primarily by moderate anticancer potency and the lack the mechanism of action.  In this study, the authors synthesized a series of Albiziabioside A derivs. and evaluated the antitumor activity both in vitro and in vivo.  Compds. D13 possessed strong inhibitory activity against HCT116 cells with IC50 values of 5.19 μM.  More importantly, compd. D13 (28-O-((1-(3-acetylphenyl)-1H-1,2,3-triazol-4-yl)methyl)-3-O-[α-L-arabinopyranosyl-(1→6)-2-acetamido-2-deoxy-β-D-glucopyranosy] oleanolic ester) had a favorable selectivity and was efficacious against MDR cancer cells.  Moreover, compd. D13 could induce apoptosis and ferroptosis through the mitochondrial pathway as a p53 activator.  In addn., compd. D13 significantly suppressed tumorigenesis without inducing toxicity in normal organs in vivo.  Collectively, this study provides a clin. relevant argument for considering triterpene saponin derivs. D13 as potential cancer therapeutic candidates with enhanced activity, acceptable safety and novel mechanisms of action.  To the best of the authors' knowledge, this compd. is the first drug candidate which can induce apoptosis and ferroptosis as a p53 activator.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhhmVSy2TA3rVg90H21EOLACvtfcHk0ljJosOFvRHU3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFOqsLfF&md5=4c40c677ce6ce7c7a4a3b797a60fb71a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.08.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.08.036%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DG.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DHou%26aufirst%3DZ.%26aulast%3DLuan%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DNovel%2520antitumor%2520compound%2520optimized%2520from%2520natural%2520saponin%2520Albiziabioside%2520A%2520induced%2520caspase-dependent%2520apoptosis%2520and%2520ferroptosis%2520as%2520a%2520p53%2520activator%2520through%2520the%2520mitochondrial%2520pathway%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D157%26spage%3D759%26epage%3D772%26doi%3D10.1016%2Fj.ejmech.2018.08.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortorella, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ververis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karagiannis, T. C.</span></span> <span> </span><span class="NLM_article-title">The Warburg effect: molecular aspects and therapeutic possibilities</span>. <i>Mol. Biol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">825</span>– <span class="NLM_lpage">834</span>, <span class="refDoi"> DOI: 10.1007/s11033-014-3764-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1007%2Fs11033-014-3764-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=25253100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1WjsrjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2015&pages=825-834&author=H.+Ngoauthor=S.+M.+Tortorellaauthor=K.+Ververisauthor=T.+C.+Karagiannis&title=The+Warburg+effect%3A+molecular+aspects+and+therapeutic+possibilities&doi=10.1007%2Fs11033-014-3764-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The Warburg effect: molecular aspects and therapeutic possibilities</span></div><div class="casAuthors">Ngo, Hanh; Tortorella, Stephanie M.; Ververis, Katherine; Karagiannis, Tom C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">825-834</span>CODEN:
                <span class="NLM_cas:coden">MLBRBU</span>;
        ISSN:<span class="NLM_cas:issn">0301-4851</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  It has been about nine decades since the proposal of Otto Warburg on the metab. of cancer cells.  Unlike normal cells which undergo glycolysis and oxidative phosphorylation in the presence of oxygen, proliferating and cancer cells exhibit an increased uptake of glucose and increased rate of glycolysis and predominantly undergo lactic acid fermn.  Whether this phenomenon is the consequence of genetic dysregulation in cancer or is the cause of cancer still remains unknown.  However, there is certainly a strong link between the genetic factors, epigenetic modulation, cancer immunosurveillance and the Warburg effect, which will be discussed in this review.  Dichloroacetate and 3-bromopyruvate are among the substances that have been studied as potential cancer therapies.  With our expanding knowledge of cellular metab., therapies targeting the Warburg effect appear very promising.  This review discusses different aspects of these emerging therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbYEdx_7JhSLVg90H21EOLACvtfcHk0ljJosOFvRHU3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1WjsrjN&md5=73de89472472d4facee5e0bb6d0ac1cf</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs11033-014-3764-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11033-014-3764-7%26sid%3Dliteratum%253Aachs%26aulast%3DNgo%26aufirst%3DH.%26aulast%3DTortorella%26aufirst%3DS.%2BM.%26aulast%3DVerveris%26aufirst%3DK.%26aulast%3DKaragiannis%26aufirst%3DT.%2BC.%26atitle%3DThe%2520Warburg%2520effect%253A%2520molecular%2520aspects%2520and%2520therapeutic%2520possibilities%26jtitle%3DMol.%2520Biol.%2520Rep.%26date%3D2015%26volume%3D42%26spage%3D825%26epage%3D834%26doi%3D10.1007%2Fs11033-014-3764-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ribas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ruiz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Checa, J. C.</span></span> <span> </span><span class="NLM_article-title">Mitochondria, cholesterol and cancer cell metabolism</span>. <i>Clin. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1186/s40169-016-0106-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1186%2Fs40169-016-0106-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=27455839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A280%3ADC%252BC2s3jvFWnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=22-46&author=V.+Ribasauthor=C.+Garcia-Ruizauthor=J.+C.+Fernandez-Checa&title=Mitochondria%2C+cholesterol+and+cancer+cell+metabolism&doi=10.1186%2Fs40169-016-0106-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria, cholesterol and cancer cell metabolism</span></div><div class="casAuthors">Ribas Vicent; Garcia-Ruiz Carmen; Fernandez-Checa Jose C; Ribas Vicent; Garcia-Ruiz Carmen; Fernandez-Checa Jose C; Garcia-Ruiz Carmen; Fernandez-Checa Jose C</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and translational medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22</span>
        ISSN:<span class="NLM_cas:issn">2001-1326</span>.
    </div><div class="casAbstract">Given the role of mitochondria in oxygen consumption, metabolism and cell death regulation, alterations in mitochondrial function or dysregulation of cell death pathways contribute to the genesis and progression of cancer.  Cancer cells exhibit an array of metabolic transformations induced by mutations leading to gain-of-function of oncogenes and loss-of-function of tumor suppressor genes that include increased glucose consumption, reduced mitochondrial respiration, increased reactive oxygen species generation and cell death resistance, all of which ensure cancer progression.  Cholesterol metabolism is disturbed in cancer cells and supports uncontrolled cell growth.  In particular, the accumulation of cholesterol in mitochondria emerges as a molecular component that orchestrates some of these metabolic alterations in cancer cells by impairing mitochondrial function.  As a consequence, mitochondrial cholesterol loading in cancer cells may contribute, in part, to the Warburg effect stimulating aerobic glycolysis to meet the energetic demand of proliferating cells, while protecting cancer cells against mitochondrial apoptosis due to changes in mitochondrial membrane dynamics.  Further understanding the complexity in the metabolic alterations of cancer cells, mediated largely through alterations in mitochondrial function, may pave the way to identify more efficient strategies for cancer treatment involving the use of small molecules targeting mitochondria, cholesterol homeostasis/trafficking and specific metabolic pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwY5kA-3-wozslzEEsg76ufW6udTcc2eaKWkEWSLq_07ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3jvFWnsg%253D%253D&md5=58aa7c95a432c0714e0654620765c753</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1186%2Fs40169-016-0106-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40169-016-0106-5%26sid%3Dliteratum%253Aachs%26aulast%3DRibas%26aufirst%3DV.%26aulast%3DGarcia-Ruiz%26aufirst%3DC.%26aulast%3DFernandez-Checa%26aufirst%3DJ.%2BC.%26atitle%3DMitochondria%252C%2520cholesterol%2520and%2520cancer%2520cell%2520metabolism%26jtitle%3DClin.%2520Transl.%2520Med.%26date%3D2016%26volume%3D5%26spage%3D22%26epage%3D46%26doi%3D10.1186%2Fs40169-016-0106-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemberg, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamprecht, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skouta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaitsev, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleason, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: an iron-dependent form of nonapoptotic cell death</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">1060</span>– <span class="NLM_lpage">1072</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.03.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.cell.2012.03.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=22632970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslSntrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=1060-1072&author=S.+J.+Dixonauthor=K.+M.+Lembergauthor=M.+R.+Lamprechtauthor=R.+Skoutaauthor=E.+M.+Zaitsevauthor=C.+E.+Gleasonauthor=D.+N.+Patelauthor=A.+J.+Bauerauthor=A.+M.+Cantleyauthor=W.+S.+Yangauthor=B.+Morrisonauthor=B.+R.+Stockwell&title=Ferroptosis%3A+an+iron-dependent+form+of+nonapoptotic+cell+death&doi=10.1016%2Fj.cell.2012.03.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death</span></div><div class="casAuthors">Dixon, Scott J.; Lemberg, Kathryn M.; Lamprecht, Michael R.; Skouta, Rachid; Zaitsev, Eleina M.; Gleason, Caroline E.; Patel, Darpan N.; Bauer, Andras J.; Cantley, Alexandra M.; Yang, Wan Seok; Morrison, Barclay; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1060-1072</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Nonapoptotic forms of cell death may facilitate the selective elimination of some tumor cells or be activated in specific pathol. states.  The oncogenic RAS-selective lethal small mol. erastin triggers a unique iron-dependent form of nonapoptotic cell death that we term ferroptosis.  Ferroptosis is dependent upon intracellular iron, but not other metals, and is morphol., biochem., and genetically distinct from apoptosis, necrosis, and autophagy.  We identify the small mol. ferrostatin-1 as a potent inhibitor of ferroptosis in cancer cells and glutamate-induced cell death in organotypic rat brain slices, suggesting similarities between these two processes.  Indeed, erastin, like glutamate, inhibits cystine uptake by the cystine/glutamate antiporter (system xc-), creating a void in the antioxidant defenses of the cell and ultimately leading to iron-dependent, oxidative death.  Thus, activation of ferroptosis results in the nonapoptotic destruction of certain cancer cells, whereas inhibition of this process may protect organisms from neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzDzMapViBQ7Vg90H21EOLACvtfcHk0lgSjBIfyD9KuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslSntrw%253D&md5=5d3b8c55a053dfde7e758cc1701ef71b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.03.042%26sid%3Dliteratum%253Aachs%26aulast%3DDixon%26aufirst%3DS.%2BJ.%26aulast%3DLemberg%26aufirst%3DK.%2BM.%26aulast%3DLamprecht%26aufirst%3DM.%2BR.%26aulast%3DSkouta%26aufirst%3DR.%26aulast%3DZaitsev%26aufirst%3DE.%2BM.%26aulast%3DGleason%26aufirst%3DC.%2BE.%26aulast%3DPatel%26aufirst%3DD.%2BN.%26aulast%3DBauer%26aufirst%3DA.%2BJ.%26aulast%3DCantley%26aufirst%3DA.%2BM.%26aulast%3DYang%26aufirst%3DW.%2BS.%26aulast%3DMorrison%26aufirst%3DB.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DFerroptosis%253A%2520an%2520iron-dependent%2520form%2520of%2520nonapoptotic%2520cell%2520death%26jtitle%3DCell%26date%3D2012%26volume%3D149%26spage%3D1060%26epage%3D1072%26doi%3D10.1016%2Fj.cell.2012.03.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Louandre, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcq, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouhlal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachaier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saidak, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francois, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debuysscher, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbare, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauffert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galmiche, A.</span></span> <span> </span><span class="NLM_article-title">The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>356</i></span>,  <span class="NLM_fpage">971</span>– <span class="NLM_lpage">977</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2014.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.canlet.2014.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=25444922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGitb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2015&pages=971-977&author=C.+Louandreauthor=I.+Marcqauthor=H.+Bouhlalauthor=E.+Lachaierauthor=C.+Godinauthor=Z.+Saidakauthor=C.+Francoisauthor=D.+Chatelainauthor=V.+Debuysscherauthor=J.+C.+Barbareauthor=B.+Chauffertauthor=A.+Galmiche&title=The+retinoblastoma+%28Rb%29+protein+regulates+ferroptosis+induced+by+sorafenib+in+human+hepatocellular+carcinoma+cells&doi=10.1016%2Fj.canlet.2014.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells</span></div><div class="casAuthors">Louandre, Christophe; Marcq, Ingrid; Bouhlal, Hicham; Lachaier, Emma; Godin, Corinne; Saidak, Zuzana; Francois, Catherine; Chatelain, Denis; Debuysscher, Veronique; Barbare, Jean-Claude; Chauffert, Bruno; Galmiche, Antoine</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">2_Part_B</span>),
    <span class="NLM_cas:pages">971-977</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Sorafenib is the treatment of ref. for advanced hepatocellular carcinoma (HCC), the most frequent form of primary liver tumor.  The loss of function of the retinoblastoma (Rb) protein is an important event during liver carcinogenesis, but it is unclear whether the Rb status modulates the response of HCC cells to sorafenib.  Here, we examd. this question in HCC cells with reduced levels of Rb achieved through stable RNA interference.  We show that HCC cells with reduced levels of Rb exhibit a two- to threefold increase in cell death induction upon exposure to sorafenib compared with controls.  Sorafenib treatment of Balb/c nude mice that received tumor xenografts derived from HCC cells with reduced Rb levels resulted in complete tumor regression in 50% of the animals treated, compared with tumor stabilization in mice that received control cells.  We show that, upon exposure to sorafenib, the Rb-neg. status of HCC cells promotes the occurrence of ferroptosis, a form of oxidative necrosis.  The findings highlight the role of Rb in the response of HCC cells to sorafenib and the regulation of ferroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyULbspsXmPrVg90H21EOLACvtfcHk0lgSjBIfyD9KuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGitb3I&md5=b06b12ef692d8d73cb71a50dc9490ecf</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2014.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2014.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DLouandre%26aufirst%3DC.%26aulast%3DMarcq%26aufirst%3DI.%26aulast%3DBouhlal%26aufirst%3DH.%26aulast%3DLachaier%26aufirst%3DE.%26aulast%3DGodin%26aufirst%3DC.%26aulast%3DSaidak%26aufirst%3DZ.%26aulast%3DFrancois%26aufirst%3DC.%26aulast%3DChatelain%26aufirst%3DD.%26aulast%3DDebuysscher%26aufirst%3DV.%26aulast%3DBarbare%26aufirst%3DJ.%2BC.%26aulast%3DChauffert%26aufirst%3DB.%26aulast%3DGalmiche%26aufirst%3DA.%26atitle%3DThe%2520retinoblastoma%2520%2528Rb%2529%2520protein%2520regulates%2520ferroptosis%2520induced%2520by%2520sorafenib%2520in%2520human%2520hepatocellular%2520carcinoma%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2015%26volume%3D356%26spage%3D971%26epage%3D977%26doi%3D10.1016%2Fj.canlet.2014.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manz, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchette, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torti, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torti, S. V.</span></span> <span> </span><span class="NLM_article-title">Iron and cancer: recent insights</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1368</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1111/nyas.13008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1111%2Fnyas.13008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=26890363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC28XotVSlurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1368&publication_year=2016&pages=149-161&author=D.+H.+Manzauthor=N.+L.+Blanchetteauthor=B.+T.+Paulauthor=F.+M.+Tortiauthor=S.+V.+Torti&title=Iron+and+cancer%3A+recent+insights&doi=10.1111%2Fnyas.13008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Iron and cancer: recent insights</span></div><div class="casAuthors">Manz, David H.; Blanchette, Nicole L.; Paul, Bibbin T.; Torti, Frank M.; Torti, Suzy V.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1368</span>
        (<span class="NLM_cas:issue">1, Cooley's Anemia</span>),
    <span class="NLM_cas:pages">149-161</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Iron is an essential dietary element.  However, the ability of iron to cycle between oxidized and reduced forms also renders it capable of contributing to free radical formation, which can have deleterious effects, including promutagenic effects that can potentiate tumor formation.  Dysregulation of iron metab. can increase cancer risk and promote tumor growth.  Cancer cells exhibit an enhanced dependence on iron relative to their normal counterparts, a phenomenon we have termed iron addiction.  Work conducted in the past few years has revealed new cellular processes and mechanisms that deepen our understanding of the link between iron and cancer.  Control of iron efflux through the combined action of ferroportin, an iron efflux pump, and its regulator hepcidin appears to play an important role in tumorigenesis.  Ferroptosis is a form of iron-dependent cell death involving the prodn. of reactive oxygen species.  Specific mechanisms involved in ferroptosis, including depletion of glutathione and inhibition of glutathione peroxidase 4, have been uncovered.  Ferritinophagy is a newly identified mechanism for degrdn. of the iron storage protein ferritin.  Perturbations of mechanisms that control transcripts encoding proteins that regulate iron have been obsd. in cancer cells, including differences in miRNA, methylation, and acetylation.  These new insights may ultimately provide new therapeutic opportunities for treating cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKgIKbYi8YobVg90H21EOLACvtfcHk0lil4xRyqf0ktQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotVSlurs%253D&md5=95ebb3d87a2ec39a0a67e9538767d21b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fnyas.13008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fnyas.13008%26sid%3Dliteratum%253Aachs%26aulast%3DManz%26aufirst%3DD.%2BH.%26aulast%3DBlanchette%26aufirst%3DN.%2BL.%26aulast%3DPaul%26aufirst%3DB.%2BT.%26aulast%3DTorti%26aufirst%3DF.%2BM.%26aulast%3DTorti%26aufirst%3DS.%2BV.%26atitle%3DIron%2520and%2520cancer%253A%2520recent%2520insights%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2016%26volume%3D1368%26spage%3D149%26epage%3D161%26doi%3D10.1111%2Fnyas.13008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: process and function</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">379</span>, <span class="refDoi"> DOI: 10.1038/cdd.2015.158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1038%2Fcdd.2015.158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=26794443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2jtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=369-379&author=Y.+Xieauthor=W.+Houauthor=X.+Songauthor=Y.+Yuauthor=J.+Huangauthor=X.+Sunauthor=R.+Kangauthor=D.+Tang&title=Ferroptosis%3A+process+and+function&doi=10.1038%2Fcdd.2015.158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis: process and function</span></div><div class="casAuthors">Xie, Y.; Hou, W.; Song, X.; Yu, Y.; Huang, J.; Sun, X.; Kang, R.; Tang, D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">369-379</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ferroptosis is a recently recognized form of regulated cell death.  It is characterized morphol. by the presence of smaller than normal mitochondria with condensed mitochondrial membrane densities, redn. or vanishing of mitochondria crista, and outer mitochondrial membrane rupture.  It can be induced by exptl. compds. (e.g., erastin, Ras-selective lethal small mol. 3, and buthionine sulfoximine) or clin. drugs (e.g., sulfasalazine, sorafenib, and artesunate) in cancer cells and certain normal cells (e.g., kidney tubule cells, neurons, fibroblasts, and T cells).  Activation of mitochondrial voltage-dependent anion channels and mitogen-activated protein kinases, upregulation of endoplasmic reticulum stress, and inhibition of cystine/glutamate antiporter is involved in the induction of ferroptosis.  This process is characterized by the accumulation of lipid peroxidn. products and lethal reactive oxygen species (ROS) derived from iron metab. and can be pharmacol. inhibited by iron chelators (e.g., deferoxamine and desferrioxamine mesylate) and lipid peroxidn. inhibitors (e.g., ferrostatin, liproxstatin, and zileuton).  Glutathione peroxidase 4, heat shock protein beta-1, and nuclear factor erythroid 2-related factor 2 function as neg. regulators of ferroptosis by limiting ROS prodn. and reducing cellular iron uptake, resp.  In contrast, NADPH oxidase and p53 (esp. acetylation-defective mutant p53) act as pos. regulators of ferroptosis by promotion of ROS prodn. and inhibition of expression of SLC7A11 (a specific light-chain subunit of the cystine/glutamate antiporter), resp.  Misregulated ferroptosis has been implicated in multiple physiol. and pathol. processes, including cancer cell death, neurotoxicity, neurodegenerative diseases, acute renal failure, drug-induced hepatotoxicity, hepatic and heart ischemia/reperfusion injury, and T-cell immunity.  In this review, we summarize the regulation mechanisms and signaling pathways of ferroptosis and discuss the role of ferroptosis in disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPYoAemdpXQrVg90H21EOLACvtfcHk0lil4xRyqf0ktQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2jtbk%253D&md5=1d0b55e47c4ed56444149c7ba35efb58</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2015.158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2015.158%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%26aulast%3DHou%26aufirst%3DW.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DKang%26aufirst%3DR.%26aulast%3DTang%26aufirst%3DD.%26atitle%3DFerroptosis%253A%2520process%2520and%2520function%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2016%26volume%3D23%26spage%3D369%26epage%3D379%26doi%3D10.1038%2Fcdd.2015.158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">SriRamaratnam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsch, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skouta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viswanathan, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheah, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemons, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamji, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clish, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girotti, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornish, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span> <span> </span><span class="NLM_article-title">Regulation of ferroptotic cancer cell death by GPX4</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">317</span>– <span class="NLM_lpage">331</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2013.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.cell.2013.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=24439385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtF2is70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2014&pages=317-331&author=W.+S.+Yangauthor=R.+SriRamaratnamauthor=M.+E.+Welschauthor=K.+Shimadaauthor=R.+Skoutaauthor=V.+S.+Viswanathanauthor=J.+H.+Cheahauthor=P.+A.+Clemonsauthor=A.+F.+Shamjiauthor=C.+B.+Clishauthor=L.+M.+Brownauthor=A.+W.+Girottiauthor=V.+W.+Cornishauthor=S.+L.+Schreiberauthor=B.+R.+Stockwell&title=Regulation+of+ferroptotic+cancer+cell+death+by+GPX4&doi=10.1016%2Fj.cell.2013.12.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Ferroptotic Cancer Cell Death by GPX4</span></div><div class="casAuthors">Yang, Wan Seok; SriRamaratnam, Rohitha; Welsch, Matthew E.; Shimada, Kenichi; Skouta, Rachid; Viswanathan, Vasanthi S.; Cheah, Jaime H.; Clemons, Paul A.; Shamji, Alykhan F.; Clish, Clary B.; Brown, Lewis M.; Girotti, Albert W.; Cornish, Virginia W.; Schreiber, Stuart L.; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">317-331</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Ferroptosis is a form of nonapoptotic cell death for which key regulators remain unknown.  We sought a common mediator for the lethality of 12 ferroptosis-inducing small mols.  We used targeted metabolomic profiling to discover that depletion of glutathione causes inactivation of glutathione peroxidases (GPXs) in response to one class of compds. and a chemoproteomics strategy to discover that GPX4 is directly inhibited by a second class of compds.  GPX4 overexpression and knockdown modulated the lethality of 12 ferroptosis inducers, but not of 11 compds. with other lethal mechanisms.  In addn., two representative ferroptosis inducers prevented tumor growth in xenograft mouse tumor models.  Sensitivity profiling in 177 cancer cell lines revealed that diffuse large B cell lymphomas and renal cell carcinomas are particularly susceptible to GPX4-regulated ferroptosis.  Thus, GPX4 is an essential regulator of ferroptotic cancer cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdxNz56kpRuLVg90H21EOLACvtfcHk0lg9y0WXokqmWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtF2is70%253D&md5=f5f607e12540847d9a25d8c205ba2e3c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2013.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2013.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%2BS.%26aulast%3DSriRamaratnam%26aufirst%3DR.%26aulast%3DWelsch%26aufirst%3DM.%2BE.%26aulast%3DShimada%26aufirst%3DK.%26aulast%3DSkouta%26aufirst%3DR.%26aulast%3DViswanathan%26aufirst%3DV.%2BS.%26aulast%3DCheah%26aufirst%3DJ.%2BH.%26aulast%3DClemons%26aufirst%3DP.%2BA.%26aulast%3DShamji%26aufirst%3DA.%2BF.%26aulast%3DClish%26aufirst%3DC.%2BB.%26aulast%3DBrown%26aufirst%3DL.%2BM.%26aulast%3DGirotti%26aufirst%3DA.%2BW.%26aulast%3DCornish%26aufirst%3DV.%2BW.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DRegulation%2520of%2520ferroptotic%2520cancer%2520cell%2520death%2520by%2520GPX4%26jtitle%3DCell%26date%3D2014%26volume%3D156%26spage%3D317%26epage%3D331%26doi%3D10.1016%2Fj.cell.2013.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: death by lipid peroxidation</span>. <i>Trends Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1016/j.tcb.2015.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.tcb.2015.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=26653790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCisbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=165-176&author=W.+S.+Yangauthor=B.+R.+Stockwell&title=Ferroptosis%3A+death+by+lipid+peroxidation&doi=10.1016%2Fj.tcb.2015.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis: Death by Lipid Peroxidation</span></div><div class="casAuthors">Yang, Wan Seok; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">165-176</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ferroptosis is a regulated form of cell death driven by loss of activity of the lipid repair enzyme glutathione peroxidase 4 (GPX4) and subsequent accumulation of lipid-based reactive oxygen species (ROS), particularly lipid hydroperoxides.  This form of iron-dependent cell death is genetically, biochem., and morphol. distinct from other cell death modalities, including apoptosis, unregulated necrosis, and necroptosis.  Ferroptosis is regulated by specific pathways and is involved in diverse biol. contexts.  Here we summarize the discovery of ferroptosis, the mechanism of ferroptosis regulation, and its increasingly appreciated relevance to both normal and pathol. physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs1AaEhcSJa7Vg90H21EOLACvtfcHk0lg9y0WXokqmWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCisbfK&md5=6b46735835ccc4add329d40713a4b6cd</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2015.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2015.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%2BS.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DFerroptosis%253A%2520death%2520by%2520lipid%2520peroxidation%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2016%26volume%3D26%26spage%3D165%26epage%3D176%26doi%3D10.1016%2Fj.tcb.2015.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. Z.</span></span> <span> </span><span class="NLM_article-title">Switching apoptosis to ferroptosis: metal-organic network for high-efficiency anticancer therapy</span>. <i>Nano Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">284</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1021/acs.nanolett.6b04060</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.nanolett.6b04060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFGgtL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=284-291&author=D.+W.+Zhengauthor=Q.+Leiauthor=J.+Y.+Zhuauthor=J.+X.+Fanauthor=C.+X.+Liauthor=C.+Liauthor=Z.+Xuauthor=S.+X.+Chengauthor=X.+Z.+Zhang&title=Switching+apoptosis+to+ferroptosis%3A+metal-organic+network+for+high-efficiency+anticancer+therapy&doi=10.1021%2Facs.nanolett.6b04060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Switching Apoptosis to Ferroptosis: Metal-Organic Network for High-Efficiency Anticancer Therapy</span></div><div class="casAuthors">Zheng, Di-Wei; Lei, Qi; Zhu, Jing-Yi; Fan, Jin-Xuan; Li, Chu-Xin; Li, Cao; Xu, Zushun; Cheng, Si-Xue; Zhang, Xian-Zheng</div><div class="citationInfo"><span class="NLM_cas:title">Nano Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">284-291</span>CODEN:
                <span class="NLM_cas:coden">NALEFD</span>;
        ISSN:<span class="NLM_cas:issn">1530-6984</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Discovering advanced materials for regulating cell death is of great importance in the development of anticancer therapy.  Herein, by harnessing the recently discovered oxidative stress regulation ability of p53 and the Fenton reaction inducing capability of metal-org. network (MON), MON encapsulated with p53 plasmid (MON-p53) was designed to eradicate cancer cells via ferroptosis/apoptosis hybrid pathway.  After confirming the detailed mechanism of MON-p53 in evoking ferroptosis, we further discovered that MON-p53 mediated a "bystander effect" to further sensitize cancer cells toward the MON-p53 induced ferroptosis.  A 75-day anticancer expt. indicated that MON-p53 treatment not only suppressed the tumor growth but also prolonged the life-span of tumor bearing mice.  Owing to its ability to promote intracellular oxidative stress, MON-p53 decreased the blood metastasis, lung metastasis, and liver metastasis.  As a consequence, discovering methods to induce cell ferroptosis would provide a new insight in designing anticancer materials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjk3LQK93MaLVg90H21EOLACvtfcHk0lgtkG6G3WOeCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFGgtL7J&md5=7b98dcde2542944285e9940c7bb62d57</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.nanolett.6b04060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.nanolett.6b04060%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DD.%2BW.%26aulast%3DLei%26aufirst%3DQ.%26aulast%3DZhu%26aufirst%3DJ.%2BY.%26aulast%3DFan%26aufirst%3DJ.%2BX.%26aulast%3DLi%26aufirst%3DC.%2BX.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DS.%2BX.%26aulast%3DZhang%26aufirst%3DX.%2BZ.%26atitle%3DSwitching%2520apoptosis%2520to%2520ferroptosis%253A%2520metal-organic%2520network%2520for%2520high-efficiency%2520anticancer%2520therapy%26jtitle%3DNano%2520Lett.%26date%3D2017%26volume%3D17%26spage%3D284%26epage%3D291%26doi%3D10.1021%2Facs.nanolett.6b04060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chou, T. C.</span></span> <i>Chemotherapy: synergism and antagonismin The Encyclopedia of Cancer</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_year">2002</span>; pp  <span class="NLM_fpage">473</span>– <span class="NLM_lpage">484</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2FB0-12-227555-1%2F00504-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=473-484&author=T.+C.+Chou&title=Chemotherapy%3A+synergism+and+antagonismin+The+Encyclopedia+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FB0-12-227555-1%2F00504-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB0-12-227555-1%252F00504-9%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DT.%2BC.%26btitle%3DChemotherapy%253A%2520synergism%2520and%2520antagonismin%2520The%2520Encyclopedia%2520of%2520Cancer%26pub%3DAcademic%2520Press%26date%3D2002%26spage%3D473%26epage%3D484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chanmee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ontong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konno, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itano, N.</span></span> <span> </span><span class="NLM_article-title">Tumor-associated macrophages as major players in the tumor microenvironment</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1670</span>– <span class="NLM_lpage">1690</span>, <span class="refDoi"> DOI: 10.3390/cancers6031670</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.3390%2Fcancers6031670" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=25125485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252FitFeqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1670-1690&author=T.+Chanmeeauthor=P.+Ontongauthor=K.+Konnoauthor=N.+Itano&title=Tumor-associated+macrophages+as+major+players+in+the+tumor+microenvironment&doi=10.3390%2Fcancers6031670"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-associated macrophages as major players in the tumor microenvironment</span></div><div class="casAuthors">Chanmee Theerawut; Itano Naoki; Ontong Pawared; Konno Kenjiro</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1670-90</span>
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    </div><div class="casAbstract">During tumor progression, circulating monocytes and macrophages are actively recruited into tumors where they alter the tumor microenvironment to accelerate tumor progression.  Macrophages shift their functional phenotypes in response to various microenvironmental signals generated from tumor and stromal cells.  Based on their function, macrophages are divided broadly into two categories: classical M1 and alternative M2 macrophages.  The M1 macrophage is involved in the inflammatory response, pathogen clearance, and antitumor immunity.  In contrast, the M2 macrophage influences an anti-inflammatory response, wound healing, and pro-tumorigenic properties.  Tumor-associated macrophages (TAMs) closely resemble the M2-polarized macrophages and are critical modulators of the tumor microenvironment.  Clinicopathological studies have suggested that TAM accumulation in tumors correlates with a poor clinical outcome.  Consistent with that evidence, experimental and animal studies have supported the notion that TAMs can provide a favorable microenvironment to promote tumor development and progression.  In this review article, we present an overview of mechanisms responsible for TAM recruitment and highlight the roles of TAMs in the regulation of tumor angiogenesis, invasion, metastasis, immunosuppression, and chemotherapeutic resistance.  Finally, we discuss TAM-targeting therapy as a promising novel strategy for an indirect cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3nAZ005HBjHp3bfzSLaX5fW6udTcc2ebRE1gxrVP8yLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252FitFeqsw%253D%253D&md5=3ca0072c54401b6cd75d193327e1c7e2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.3390%2Fcancers6031670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers6031670%26sid%3Dliteratum%253Aachs%26aulast%3DChanmee%26aufirst%3DT.%26aulast%3DOntong%26aufirst%3DP.%26aulast%3DKonno%26aufirst%3DK.%26aulast%3DItano%26aufirst%3DN.%26atitle%3DTumor-associated%2520macrophages%2520as%2520major%2520players%2520in%2520the%2520tumor%2520microenvironment%26jtitle%3DCancers%26date%3D2014%26volume%3D6%26spage%3D1670%26epage%3D1690%26doi%3D10.3390%2Fcancers6031670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyamfi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, J. S.</span></span> <span> </span><span class="NLM_article-title">The role of tumor-associated macrophage in breast cancer biology</span>. <i>Histol. Histopathol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=28681373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlGmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=133-145&author=J.+Choiauthor=J.+Gyamfiauthor=H.+Jangauthor=J.+S.+Koo&title=The+role+of+tumor-associated+macrophage+in+breast+cancer+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The role of tumor-associated macrophage in breast cancer biology</span></div><div class="casAuthors">Choi, Junjeong; Gyamfi, Jones; Jang, Haerin; Koo, Ja Seung</div><div class="citationInfo"><span class="NLM_cas:title">Histology and Histopathology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1,2,3</span>),
    <span class="NLM_cas:pages">133-145</span>CODEN:
                <span class="NLM_cas:coden">HIHIES</span>;
        ISSN:<span class="NLM_cas:issn">0213-3911</span>.
    
            (<span class="NLM_cas:orgname">University of Murcia</span>)
        </div><div class="casAbstract">A review.  Breast cancer is the most commonly diagnosed malignant tumor in women worldwide and contributes significantly as the primary cause of female cancer related mortality.  Hence, research is focused on discovering new and effective treatment targets.  The breast tumor microenvironment (TME) comprising of recruited host stromal cells and tumor cells, has recently emerged as an important player in tumor progression, with the potential for future treatment.  The TME comprises immune system elements (such as macrophages and lymphocytes), cells composing blood vessel, fibroblast, myofibroblast, mesenchymal stem cells, adipocytes and extracellular matrix (ECM).  Among these cells, tumor-assocd. macrophages (TAM) are the prominent components of TME in breast cancers.  Macrophages exhibit a high plasticity in response to various external signals and participate in innate and adoptive immune responses to control numerous factors of TME.  Depending on the microenvironmental signal present, macrophages are polarized into two distinct phenotypes, the classically activated (M1) or the alternative activated (M2) macrophages.  Tumor-assocd. macrophages (TAMs) closely resemble the M2-polarized.  Clinicopathol. studies have suggested that TAM accumulation in tumors correlates with a poor clin. outcome.  In human breast carcinomas, high TAM d. correlates with poor prognosis.  Over the years, studies into the role of TAMs in breast cancer progression have identified TAMs to be capable of inducing angiogenesis, remodelling the tumor extracellular matrix to aid invasion, modeling breast cancer cells to evade host immune system and recruiting immunosuppressive leukocytes to the tumor microenvironment.  Along with these functions, the potential role for TAMs in activation of breast cancer stem cells (CSC) has also emerged.  Thus, TAMs in breast cancer can enhance cancer cell invasion by degrading the ECM, stimulate tumor vascularization and angiogenesis and suppress the antitumor functions of cytotoxic T cells resulting in poor prognosis for patients.  These observations make TAMs an attractive target for therapeutic intervention by targeting various aspects of their function.  This review discusses the mechanisms responsible for TAM recruitment and highlights the roles of TAMs in regulating tumor angiogenesis, invasion, metastasis, immunosuppression, and chemotherapeutic resistance.  Finally, the potential for TAM-targeted therapy as a promising novel strategy is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIKh8NLowpfLVg90H21EOLACvtfcHk0lg6KyvPxjkVVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlGmsLs%253D&md5=f935c2ca750285a65c3fd1d1a1e3cee1</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DGyamfi%26aufirst%3DJ.%26aulast%3DJang%26aufirst%3DH.%26aulast%3DKoo%26aufirst%3DJ.%2BS.%26atitle%3DThe%2520role%2520of%2520tumor-associated%2520macrophage%2520in%2520breast%2520cancer%2520biology%26jtitle%3DHistol.%2520Histopathol.%26date%3D2018%26volume%3D33%26spage%3D133%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaijer, S. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwager, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, E. G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van
der Vegt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, C. P.</span></span> <span> </span><span class="NLM_article-title">Tumor-associated macrophages in breast cancer: innocent bystander or important player?</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">178</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2018.08.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.ctrv.2018.08.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=30227299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslalsLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2018&pages=178-189&author=S.+Q.+Qiuauthor=S.+J.+H.+Waaijerauthor=M.+C.+Zwagerauthor=E.+G.+E.+de+Vriesauthor=B.+van%0Ader+Vegtauthor=C.+P.+Schroder&title=Tumor-associated+macrophages+in+breast+cancer%3A+innocent+bystander+or+important+player%3F&doi=10.1016%2Fj.ctrv.2018.08.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-associated macrophages in breast cancer: Innocent bystander or important player?</span></div><div class="casAuthors">Qiu, Si-Qi; Waaijer, Stijn J. H.; Zwager, Mieke C.; de Vries, Elisabeth G. E.; van der Vegt, Bert; Schroeder, Carolien P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">178-189</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Tumor-assocd. macrophages (TAMs) are important tumor-promoting cells in the breast tumor microenvironment.  Preclinically TAMs stimulate breast tumor progression, including tumor cell growth, invasion and metastasis.  TAMs also induce resistance to multiple types of treatment in breast cancer models.  The underlying mechanisms include: induction and maintenance of tumor-promoting phenotype in TAMs, inhibition of CD8+ T cell function, degrdn. of extracellular matrix, stimulation of angiogenesis and inhibition of phagocytosis.  Several studies reported that high TAM infiltration of breast tumors is correlated with a worse patient prognosis.  Based on these findings, macrophage-targeted treatment strategies have been developed and are currently being evaluated in clin. breast cancer trials.  These strategies include: inhibition of macrophage recruitment, repolarization of TAMs to an antitumor phenotype, and enhancement of macrophage-mediated tumor cell killing or phagocytosis.  This review summarizes the functional aspects of TAMs and the rationale and current evidence for TAMs as a therapeutic target in breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEqjY2hZRtIbVg90H21EOLACvtfcHk0liaXXV4tPGAUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslalsLvI&md5=9d0f7ad9b91a910109f9ac2e9942eee0</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2018.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2018.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DS.%2BQ.%26aulast%3DWaaijer%26aufirst%3DS.%2BJ.%2BH.%26aulast%3DZwager%26aufirst%3DM.%2BC.%26aulast%3Dde%2BVries%26aufirst%3DE.%2BG.%2BE.%26aulast%3Dvan%2Bder%2BVegt%26aufirst%3DB.%26aulast%3DSchroder%26aufirst%3DC.%2BP.%26atitle%3DTumor-associated%2520macrophages%2520in%2520breast%2520cancer%253A%2520innocent%2520bystander%2520or%2520important%2520player%253F%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2018%26volume%3D70%26spage%3D178%26epage%3D189%26doi%3D10.1016%2Fj.ctrv.2018.08.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akazawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuze, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagaoka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, Y.</span></span> <span> </span><span class="NLM_article-title">M2-like macrophage polarization in high lactic acid-producing head and neck cancer</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">1128</span>– <span class="NLM_lpage">1134</span>, <span class="refDoi"> DOI: 10.1111/cas.13244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1111%2Fcas.13244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=28370718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotVKgu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2017&pages=1128-1134&author=T.+Ohashiauthor=M.+Aokiauthor=H.+Tomitaauthor=T.+Akazawaauthor=K.+Satoauthor=B.+Kuzeauthor=K.+Mizutaauthor=A.+Haraauthor=H.+Nagaokaauthor=N.+Inoueauthor=Y.+Ito&title=M2-like+macrophage+polarization+in+high+lactic+acid-producing+head+and+neck+cancer&doi=10.1111%2Fcas.13244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">M2-like macrophage polarization in high lactic acid-producing head and neck cancer</span></div><div class="casAuthors">Ohashi, Toshimitsu; Aoki, Mitsuhiro; Tomita, Hiroyuki; Akazawa, Takashi; Sato, Katsuya; Kuze, Bunya; Mizuta, Keisuke; Hara, Akira; Nagaoka, Hitoshi; Inoue, Norimitsu; Ito, Yatsuji</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1128-1134</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Reprogramming of glucose metab. in tumor cells is referred to as the Warburg effect and results in increased lactic acid secretion into the tumor microenvironment.  We have previously shown that lactic acid has important roles as a pro-inflammatory and immunosuppressive mediator and promotes tumor progression.  In this study, we examd. the relationship between the lactic acid concn. and expression of LDHA and GLUT1, which are related to the Warburg effect, in human head and neck squamous cell carcinoma (HNSCC).  Tumors expressing lower levels of LDHA and GLUT1 had a higher concn. of lactic acid than those with higher LDHA and GLUT1 expression.  Lactic acid also suppressed the expression of LDHA and GLUT1 in vitro.  We previously reported that lactic acid enhances expression of an M2 macrophage marker, ARG1, in murine macrophages.  Therefore, we investigated the relationship between the lactic acid concn. and polarization of M2 macrophages in HNSCC by measuring the expression of M2 macrophage markers, CSF1R and CD163, normalized using a pan-macrophage marker, CD68.  Tumors with lower levels of CD68 showed a higher concn. of lactic acid, whereas those with higher levels of CSF1R showed a significantly higher concn. of lactic acid.  A similar tendency was obsd. for CD163.  These results suggest that tumor-secreted lactic acid is linked to the redn. of macrophages in tumors and promotes induction of M2-like macrophage polarization in human HNSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7VxCipjyQN7Vg90H21EOLACvtfcHk0liaXXV4tPGAUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotVKgu70%253D&md5=c6a911d6af52e81ff75cc6c508881ad2</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fcas.13244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13244%26sid%3Dliteratum%253Aachs%26aulast%3DOhashi%26aufirst%3DT.%26aulast%3DAoki%26aufirst%3DM.%26aulast%3DTomita%26aufirst%3DH.%26aulast%3DAkazawa%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DKuze%26aufirst%3DB.%26aulast%3DMizuta%26aufirst%3DK.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DNagaoka%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DN.%26aulast%3DIto%26aufirst%3DY.%26atitle%3DM2-like%2520macrophage%2520polarization%2520in%2520high%2520lactic%2520acid-producing%2520head%2520and%2520neck%2520cancer%26jtitle%3DCancer%2520Sci.%26date%3D2017%26volume%3D108%26spage%3D1128%26epage%3D1134%26doi%3D10.1111%2Fcas.13244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Netea-Maier, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smit, J. W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netea, M. G.</span></span> <span> </span><span class="NLM_article-title">Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>413</i></span>,  <span class="NLM_fpage">102</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2017.10.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.canlet.2017.10.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=29111350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsleksb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=413&publication_year=2018&pages=102-109&author=R.+T.+Netea-Maierauthor=J.+W.+A.+Smitauthor=M.+G.+Netea&title=Metabolic+changes+in+tumor+cells+and+tumor-associated+macrophages%3A+A+mutual+relationship&doi=10.1016%2Fj.canlet.2017.10.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship</span></div><div class="casAuthors">Netea-Maier, Romana T.; Smit, Johannes W. A.; Netea, Mihai G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">413</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">102-109</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  In order to adapt to the reduced availability of nutrients and oxygen in the tumor microenvironment and the increased requirements of energy and building blocks necessary for maintaining their high proliferation rate, malignant cells undergo metabolic changes that result in an increased prodn. of lactate, nitric oxide, reactive oxygen species, prostaglandins and other byproducts of arachidonic acid metab. that influence both the compn. of the inflammatory microenvironment and the function of the tumor-assocd. macrophages (TAMs).  In response to cues present in the TME, among which products of altered tumor cell metab., TAMs are also required to reprogram their metab., with activation of glycolysis, fatty acid synthesis and altered nitrogen cycle metab.  These changes result in functional reprogramming of TAMs which includes changes in the prodn. of cytokines and angiogenic factors, and contribute to the tumor progression and metastasis.  Understanding the metabolic changes governing the intricate relationship between the tumor cells and the TAMs represents an essential step towards developing novel therapeutic approaches targeting the metabolic reprogramming of the immune cells to potentiate their tumoricidal potential and to circumvent therapy resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUx3g18kQLZbVg90H21EOLACvtfcHk0ljYmTDjfXG6pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsleksb3M&md5=09576f0d282e3f2c2ff08fc8b9e2f7bc</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2017.10.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2017.10.037%26sid%3Dliteratum%253Aachs%26aulast%3DNetea-Maier%26aufirst%3DR.%2BT.%26aulast%3DSmit%26aufirst%3DJ.%2BW.%2BA.%26aulast%3DNetea%26aufirst%3DM.%2BG.%26atitle%3DMetabolic%2520changes%2520in%2520tumor%2520cells%2520and%2520tumor-associated%2520macrophages%253A%2520A%2520mutual%2520relationship%26jtitle%3DCancer%2520Lett.%26date%3D2018%26volume%3D413%26spage%3D102%26epage%3D109%26doi%3D10.1016%2Fj.canlet.2017.10.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, P.</span></span> <span> </span><span class="NLM_article-title">Metabolic reprogramming for cancer cells and their microenvironment: beyond the Warburg effect</span>. <i>Biochim. Biophys. Acta, Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1870</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1016/j.bbcan.2018.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.bbcan.2018.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=29959989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Kms7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1870&publication_year=2018&pages=51-66&author=L.+Sunauthor=C.+Suoauthor=S.+T.+Liauthor=H.+Zhangauthor=P.+Gao&title=Metabolic+reprogramming+for+cancer+cells+and+their+microenvironment%3A+beyond+the+Warburg+effect&doi=10.1016%2Fj.bbcan.2018.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect</span></div><div class="casAuthors">Sun, Linchong; Suo, Caixia; Li, Shi-ting; Zhang, Huafeng; Gao, Ping</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1870</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-66</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">While metabolic reprogramming of cancer cells has long been considered from the standpoint of how and why cancer cells preferentially utilize glucose via aerobic glycolysis, the so-called Warburg Effect, the progress in the following areas during the past several years has substantially advanced our understanding of the rewired metabolic network in cancer cells that is intertwined with oncogenic signaling.  First, in addn. to the major nutrient substrates glucose and glutamine, cancer cells have been discovered to utilize a variety of unconventional nutrient sources for survival.  Second, the deregulated biomass synthesis is intertwined with cell cycle progression to coordinate the accelerated progression of cancer cells.  Third, the reciprocal regulation of cancer cell's metabolic alterations and the microenvironment, involving extensive host immune cells and microbiota, have come into view as crit. mechanisms to regulate cancer progression.  These and other advances are shaping the current and future paradigm of cancer metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo20YUgrxWL67Vg90H21EOLACvtfcHk0ljYmTDjfXG6pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Kms7zE&md5=4a6e4d58cfb56462e1bed23e5a919222</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2018.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2018.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DSuo%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DS.%2BT.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DP.%26atitle%3DMetabolic%2520reprogramming%2520for%2520cancer%2520cells%2520and%2520their%2520microenvironment%253A%2520beyond%2520the%2520Warburg%2520effect%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2018%26volume%3D1870%26spage%3D51%26epage%3D66%26doi%3D10.1016%2Fj.bbcan.2018.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span> <span> </span><span class="NLM_article-title">Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK/STAT3 signaling pathway in breast cancer</span>. <i>Cell Cycle</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">438</span>, <span class="refDoi"> DOI: 10.1080/15384101.2018.1444305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1080%2F15384101.2018.1444305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=29468929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmt1anu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=428-438&author=X.+Muauthor=W.+Shiauthor=Y.+Xuauthor=C.+Xuauthor=T.+Zhaoauthor=B.+Gengauthor=J.+Yangauthor=J.+Panauthor=S.+Huauthor=C.+Zhangauthor=J.+Zhangauthor=C.+Wangauthor=J.+Shenauthor=Y.+Cheauthor=Z.+Liuauthor=Y.+Lvauthor=H.+Wenauthor=Q.+You&title=Tumor-derived+lactate+induces+M2+macrophage+polarization+via+the+activation+of+the+ERK%2FSTAT3+signaling+pathway+in+breast+cancer&doi=10.1080%2F15384101.2018.1444305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK/STAT3 signaling pathway in breast cancer</span></div><div class="casAuthors">Mu, Xianmin; Shi, Wei; Xu, Yue; Xu, Che; Zhao, Ting; Geng, Biao; Yang, Jing; Pan, Jinshun; Hu, Shi; Zhang, Chen; Zhang, Juan; Wang, Chao; Shen, Jiajia; Che, Yin; Liu, Zheng; Lv, Yuanfang; Wen, Hao; You, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">428-438</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1551-4005</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Tumor-assocd. macrophages (TAM) are prominent components of tumor microenvironment (TME) and capable of promoting cancer progression.  However, the mechanisms for the formation of M2-like TAMs remain enigmatic.  Here, we show that lactate is a pivotal oncometabolite in the TME that drives macrophage M2-polarization to promote breast cancer proliferation, migration, and angiogenesis.  In addn., we identified that the activation of ERK/STAT3, major signaling mols. in the lactate signaling pathway, deepens our mol. understanding of how lactate educates TAMs.  Moreover, suppression of ERK/STAT3 signaling diminished tumor growth and angiogenesis by abolishing lactate-induced M2 macrophage polarization.  Finally, research data of the natural compd. withanolide D provide evidence for ERK/STAT3 signaling as a potential therapeutic strategy for the prevention and treatment of breast cancer.  These findings suggest that the lactate-ERK/STAT3 signaling pathway is a driver of breast cancer progression by stimulating macrophage M2-like polarization and reveal potential new therapeutic targets for breast cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIbyqrf8oZ7bVg90H21EOLACvtfcHk0lihRqs0cCjjyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmt1anu7s%253D&md5=eba545f83e1cccb98f745249c704611d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1080%2F15384101.2018.1444305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15384101.2018.1444305%26sid%3Dliteratum%253Aachs%26aulast%3DMu%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DGeng%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLv%26aufirst%3DY.%26aulast%3DWen%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DQ.%26atitle%3DTumor-derived%2520lactate%2520induces%2520M2%2520macrophage%2520polarization%2520via%2520the%2520activation%2520of%2520the%2520ERK%252FSTAT3%2520signaling%2520pathway%2520in%2520breast%2520cancer%26jtitle%3DCell%2520Cycle%26date%3D2018%26volume%3D17%26spage%3D428%26epage%3D438%26doi%3D10.1080%2F15384101.2018.1444305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amantini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabissi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maines, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burattini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berardi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montironi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortora, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cascinu, S.</span></span> <span> </span><span class="NLM_article-title">Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma</span>. <i>Cancer Immunol. Immunother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1757</span>– <span class="NLM_lpage">1768</span>, <span class="refDoi"> DOI: 10.1007/s00262-013-1487-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1007%2Fs00262-013-1487-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=24132754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CrtLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=1757-1768&author=M.+Santoniauthor=F.+Massariauthor=C.+Amantiniauthor=M.+Nabissiauthor=F.+Mainesauthor=L.+Burattiniauthor=R.+Berardiauthor=G.+Santoniauthor=R.+Montironiauthor=G.+Tortoraauthor=S.+Cascinu&title=Emerging+role+of+tumor-associated+macrophages+as+therapeutic+targets+in+patients+with+metastatic+renal+cell+carcinoma&doi=10.1007%2Fs00262-013-1487-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma</span></div><div class="casAuthors">Santoni, Matteo; Massari, Francesco; Amantini, Consuelo; Nabissi, Massimo; Maines, Francesca; Burattini, Luciano; Berardi, Rossana; Santoni, Giorgio; Montironi, Rodolfo; Tortora, Giampaolo; Cascinu, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Immunotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1757-1768</span>CODEN:
                <span class="NLM_cas:coden">CIIMDN</span>;
        ISSN:<span class="NLM_cas:issn">0340-7004</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Tumor-assocd. macrophages (TAMs) derived from peripheral blood monocytes recruited into the renal cell carcinoma (RCC) microenvironment.  In response to inflammatory stimuli, macrophages undergo M1 (classical) or M2 (alternative) activation.  M1 cells produce high levels of inflammatory cytokines, such as tumor necrosis factor-α, interleukin (IL)-12, IL-23 and IL-6, while M2 cells produce anti-inflammatory cytokines, such as IL-10, thus contributing to RCC-related immune dysfunction.  The presence of extensive TAM infiltration in RCC microenvironment contributes to cancer progression and metastasis by stimulating angiogenesis, tumor growth, and cellular migration and invasion.  Moreover, TAMs are involved in epithelial-mesenchymal transition of RCC cancer cells and in the development of tumor resistance to targeted agents.  Interestingly, macrophage autophagy seems to play an important role in RCC.  Based on this scenario, TAMs represent a promising and effective target for cancer therapy in RCC.  Several strategies have been proposed to suppress TAM recruitment, to deplete their no., to switch M2 TAMs into antitumor M1 phenotype and to inhibit TAM-assocd. mols.  In this review, we summarize current data on the essential role of TAMs in RCC angiogenesis, invasion, impaired anti-tumor immune response and development of drug resistance, thus describing the emerging TAM-centered therapies for RCC patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolZG976wpuQbVg90H21EOLACvtfcHk0lihRqs0cCjjyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CrtLvF&md5=1160c0890450df83400121069c437a24</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1007%2Fs00262-013-1487-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00262-013-1487-6%26sid%3Dliteratum%253Aachs%26aulast%3DSantoni%26aufirst%3DM.%26aulast%3DMassari%26aufirst%3DF.%26aulast%3DAmantini%26aufirst%3DC.%26aulast%3DNabissi%26aufirst%3DM.%26aulast%3DMaines%26aufirst%3DF.%26aulast%3DBurattini%26aufirst%3DL.%26aulast%3DBerardi%26aufirst%3DR.%26aulast%3DSantoni%26aufirst%3DG.%26aulast%3DMontironi%26aufirst%3DR.%26aulast%3DTortora%26aufirst%3DG.%26aulast%3DCascinu%26aufirst%3DS.%26atitle%3DEmerging%2520role%2520of%2520tumor-associated%2520macrophages%2520as%2520therapeutic%2520targets%2520in%2520patients%2520with%2520metastatic%2520renal%2520cell%2520carcinoma%26jtitle%3DCancer%2520Immunol.%2520Immunother.%26date%3D2013%26volume%3D62%26spage%3D1757%26epage%3D1768%26doi%3D10.1007%2Fs00262-013-1487-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larghi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubino, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totaro, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimoldi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswas, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allavena, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantovani, A.</span></span> <span> </span><span class="NLM_article-title">Macrophage polarization in tumour progression</span>. <i>Semin. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.1016/j.semcancer.2008.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.semcancer.2008.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=18467122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVGmsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=349-355&author=A.+Sicaauthor=P.+Larghiauthor=A.+Mancinoauthor=L.+Rubinoauthor=C.+Portaauthor=M.+G.+Totaroauthor=M.+Rimoldiauthor=S.+K.+Biswasauthor=P.+Allavenaauthor=A.+Mantovani&title=Macrophage+polarization+in+tumour+progression&doi=10.1016%2Fj.semcancer.2008.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage polarization in tumour progression</span></div><div class="casAuthors">Sica, Antonio; Larghi, Paola; Mancino, Alessandra; Rubino, Luca; Porta, Chiara; Totaro, Maria Grazia; Rimoldi, Monica; Biswas, Subhra Kumar; Allavena, Paola; Mantovani, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">349-355</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Macrophages are a fundamental part of the innate defense mechanisms, which can promote specific immunity by inducing T cell recruitment and activation.  Despite this, their presence within the tumor microenvironment has been assocd. with enhanced tumor progression and shown to promote cancer cell growth and spread, angiogenesis and immunosuppression.  This paradoxical role of macrophages in cancer finds an explanation in their functional plasticity, that may result in the polarized expression of either pro- or anti-tumoral functions.  Key players in the setting of their phenotype are the microenvironmental signals to which macrophages are exposed, which selectively tune their functions within a functional spectrum encompassing the M1 and M2 extremes.  Here, we discuss recent findings suggesting that targeting tumor-assocd. macrophages (TAMs) polarization may represent a novel therapeutic strategy against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphZcYy9ySqx7Vg90H21EOLACvtfcHk0li-lzEyi_ILmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVGmsLo%253D&md5=a786b03442ac65bb774e8b87ea84e0b1</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2008.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2008.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DSica%26aufirst%3DA.%26aulast%3DLarghi%26aufirst%3DP.%26aulast%3DMancino%26aufirst%3DA.%26aulast%3DRubino%26aufirst%3DL.%26aulast%3DPorta%26aufirst%3DC.%26aulast%3DTotaro%26aufirst%3DM.%2BG.%26aulast%3DRimoldi%26aufirst%3DM.%26aulast%3DBiswas%26aufirst%3DS.%2BK.%26aulast%3DAllavena%26aufirst%3DP.%26aulast%3DMantovani%26aufirst%3DA.%26atitle%3DMacrophage%2520polarization%2520in%2520tumour%2520progression%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2008%26volume%3D18%26spage%3D349%26epage%3D355%26doi%3D10.1016%2Fj.semcancer.2008.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 7 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Zheng</span>, <span class="hlFld-ContribAuthor ">Yun  Dong</span>, <span class="hlFld-ContribAuthor ">Rong  Yang</span>, <span class="hlFld-ContribAuthor ">Youfang  Liang</span>, <span class="hlFld-ContribAuthor ">Haiqiang  Wu</span>, <span class="hlFld-ContribAuthor ">Zhendan  He</span>. </span><span class="cited-content_cbyCitation_article-title">Regulation of ferroptosis by bioactive phytochemicals: Implications for medical nutritional therapy. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2021,</strong> <em>168 </em>, 105580. <a href="https://doi.org/10.1016/j.phrs.2021.105580" title="DOI URL">https://doi.org/10.1016/j.phrs.2021.105580</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2021.105580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2021.105580%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DRegulation%252Bof%252Bferroptosis%252Bby%252Bbioactive%252Bphytochemicals%25253A%252BImplications%252Bfor%252Bmedical%252Bnutritional%252Btherapy%26aulast%3DZheng%26aufirst%3DKai%26date%3D2021%26volume%3D168%26spage%3D105580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dwaipayan  Bhattacharya</span>, <span class="hlFld-ContribAuthor ">Kalyani  Sakhare</span>, <span class="hlFld-ContribAuthor ">Kumar Pranav  Narayan</span>, <span class="hlFld-ContribAuthor ">Rajkumar  Banerjee</span>. </span><span class="cited-content_cbyCitation_article-title">The prospects of nanotherapeutic approaches for targeting tumor-associated macrophages in oral cancer. </span><span class="cited-content_cbyCitation_journal-name">Nanomedicine: Nanotechnology, Biology and Medicine</span><span> <strong>2021,</strong> <em>34 </em>, 102371. <a href="https://doi.org/10.1016/j.nano.2021.102371" title="DOI URL">https://doi.org/10.1016/j.nano.2021.102371</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nano.2021.102371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nano.2021.102371%26sid%3Dliteratum%253Aachs%26jtitle%3DNanomedicine%253A%2520Nanotechnology%252C%2520Biology%2520and%2520Medicine%26atitle%3DThe%252Bprospects%252Bof%252Bnanotherapeutic%252Bapproaches%252Bfor%252Btargeting%252Btumor-associated%252Bmacrophages%252Bin%252Boral%252Bcancer%26aulast%3DBhattacharya%26aufirst%3DDwaipayan%26date%3D2021%26volume%3D34%26spage%3D102371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giulia  Greco</span>, <span class="hlFld-ContribAuthor ">Elena  Catanzaro</span>, <span class="hlFld-ContribAuthor ">Carmela  Fimognari</span>. </span><span class="cited-content_cbyCitation_article-title">Natural Products as Inducers of Non-Canonical Cell Death: A Weapon against Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (2)
                                     , 304. <a href="https://doi.org/10.3390/cancers13020304" title="DOI URL">https://doi.org/10.3390/cancers13020304</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13020304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13020304%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DNatural%252BProducts%252Bas%252BInducers%252Bof%252BNon-Canonical%252BCell%252BDeath%25253A%252BA%252BWeapon%252Bagainst%252BCancer%26aulast%3DGreco%26aufirst%3DGiulia%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D2%26spage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-Pu  Juang</span>, <span class="hlFld-ContribAuthor ">Pi-Hui  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Biological and Pharmacological Effects of Synthetic Saponins. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (21)
                                     , 4974. <a href="https://doi.org/10.3390/molecules25214974" title="DOI URL">https://doi.org/10.3390/molecules25214974</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25214974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25214974%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DBiological%252Band%252BPharmacological%252BEffects%252Bof%252BSynthetic%252BSaponins%26aulast%3DJuang%26aufirst%3DYu-Pu%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D21%26spage%3D4974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yinan  Wu</span>, <span class="hlFld-ContribAuthor ">Chengcheng  Yu</span>, <span class="hlFld-ContribAuthor ">Meng  Luo</span>, <span class="hlFld-ContribAuthor ">Chen  Cen</span>, <span class="hlFld-ContribAuthor ">Jili  Qiu</span>, <span class="hlFld-ContribAuthor ">Suzhan  Zhang</span>, <span class="hlFld-ContribAuthor ">Kaimin  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Ferroptosis in Cancer Treatment: Another Way to Rome. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.3389/fonc.2020.571127" title="DOI URL">https://doi.org/10.3389/fonc.2020.571127</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2020.571127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2020.571127%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DFerroptosis%252Bin%252BCancer%252BTreatment%25253A%252BAnother%252BWay%252Bto%252BRome%26aulast%3DWu%26aufirst%3DYinan%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-Pu  Juang</span>, <span class="hlFld-ContribAuthor ">You-Yu  Lin</span>, <span class="hlFld-ContribAuthor ">She-Hung  Chan</span>, <span class="hlFld-ContribAuthor ">Chun-Kai  Chang</span>, <span class="hlFld-ContribAuthor ">Jiun-Jie  Shie</span>, <span class="hlFld-ContribAuthor ">Yves S.Y.  Hsieh</span>, <span class="hlFld-ContribAuthor ">Jih-Hwa  Guh</span>, <span class="hlFld-ContribAuthor ">Pi-Hui  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, distribution analysis and mechanism studies of N-acyl glucosamine-bearing oleanolic saponins. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>99 </em>, 103835. <a href="https://doi.org/10.1016/j.bioorg.2020.103835" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103835</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103835%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%25252C%252Bdistribution%252Banalysis%252Band%252Bmechanism%252Bstudies%252Bof%252BN-acyl%252Bglucosamine-bearing%252Boleanolic%252Bsaponins%26aulast%3DJuang%26aufirst%3DYu-Pu%26date%3D2020%26volume%3D99%26spage%3D103835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heqi  Bu</span>, <span class="hlFld-ContribAuthor ">Dianlei  Liu</span>, <span class="hlFld-ContribAuthor ">Guolin  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  Chen</span>, <span class="hlFld-ContribAuthor ">Zhangfa  Song</span>. </span><span class="cited-content_cbyCitation_article-title"><p>AMPK/mTOR/ULK1 Axis-Mediated Pathway Participates in Apoptosis and Autophagy Induction by Oridonin in Colon Cancer DLD-1 Cells</p>. </span><span class="cited-content_cbyCitation_journal-name">OncoTargets and Therapy</span><span> <strong>2020,</strong> <em>Volume 13 </em>, 8533-8545. <a href="https://doi.org/10.2147/OTT.S262022" title="DOI URL">https://doi.org/10.2147/OTT.S262022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/OTT.S262022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FOTT.S262022%26sid%3Dliteratum%253Aachs%26jtitle%3DOncoTargets%2520and%2520Therapy%26atitle%3D%25253Cp%25253EAMPK%25252FmTOR%25252FULK1%252BAxis-Mediated%252BPathway%252BParticipates%252Bin%252BApoptosis%252Band%252BAutophagy%252BInduction%252Bby%252BOridonin%252Bin%252BColon%252BCancer%252BDLD-1%252BCells%25253C%25252Fp%25253E%26aulast%3DBu%26aufirst%3DHeqi%26date%3D2020%26date%3D2020%26volume%3DVolume%252013%26spage%3D8533%26epage%3D8545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/medium/jm9b00644_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00644&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/medium/jm9b00644_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Schematic Illustration of Mechanism for Combined Cancer Therapy by AlbA-DCA</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00644&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/medium/jm9b00644_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of AlbA-DCA and Control (AlbA-CA)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00644&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reaction conditions: Anhydride, DCM, rt, 2 h; then MeONa, MeOH, DCM, rt, overnight.</p></p></figure><figure data-id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/medium/jm9b00644_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. AlbA-DCA altered energy metabolism from aerobic glycolysis back to OXPHOS in MCF-7 cells by inhibiting PDK. (A) PDK kinase activity assay in the presence of various inhibitors; (B, C) Expression of PDK in MCF-7 cells. GAPDH was used as internal control. (D) Effects of AlbA-DCA, AlbA, and Na-DCA on MCF-7 cell glycolysis. MCF-7 cells were treated with AlbA-DCA (2 μM), AlbA (10 μM), and Na-DCA (30 μM) for 4 h and subsequently treated with glucose, oligomycin, and 2-DG. ECAR traces were measured by a Seahorse XF24 Extracellular Flux Analyzer (D1). Calculations of glycolysis (D2), glycolytic capacity (D3), and glycolytic reserve (D4). (E) Effects of AlbA-DCA, AlbA, and Na-DCA on MCF-7 cells’ mitochondrial OXPHOS. MCF-7 cells were treated with AlbA-DCA (2 μM), AlbA (10 μM), and Na-DCA (30 μM) for 4 h and AlbA-DCA (2 μM) for 2 h. Determination of OCR traces using a Seahorse XF24 Extracellular Flux Analyzer (E1). Calculations of basal respiration (E2), ATP produvtion (E3), and spare respiration capacity (E4). Data are represented as mean ± SD of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00644&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/medium/jm9b00644_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Effect of AlbA-DCA (2 μM), AlbA (10 μM), and Na-DCA (30 μM) on the mitochondria membrane potential of MCF-7 cells by flow cytometry using JC-1 staining. (B) Effect of AlbA-DCA (2 μM), AlbA (10 μM), and Na-DCA (30 μM) on the generation of intracellular ROS by flow cytometry using DCF-DA staining. (C, D) Intracellular lactate levels and in the media lactate levels in MCF-7 cells and MCF-7 cells after treatment with AlbA-DCA (2 μM), AlbA (10 μM), and Na-DCA (30 μM) at indicated concentrations for 6 h. Data are represented as mean ± SD of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00644&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/medium/jm9b00644_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. AlbA-DCA-induced apoptosis of MCF-7 cells. (A, B) Effect of AlbA-DCA, AlbA, and Na-DCA on apoptosis in MCF-7 cells. MCF-7 cells were incubated with AlbA-DCA (2 μM), AlbA (10 μM), and Na-DCA (30 μM). After 24 h of incubation, cells were collected and stained with Annexin V/PI, followed by flow cytometric analysis. (C, D) Expression of apoptosis-related protein. GAPDH was used as internal control. (E) Cell cytotoxicity of AlbA-DCA (2 μM), AlbA (10 μM), and Na-DCA (30 μM) in MCF-7 cells pretreated with z-VAD-fmk. Data are represented as mean ± SD of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00644&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/medium/jm9b00644_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. AlbA-DCA-induced MCF-7 cells ferroptosis. Cell cytotoxicity of AlbA-DCA (2 μM), AlbA (10 μM), and Na-DCA (30 μM) in MCF-7 cells pretreated with 200 nM Fer-1 (A), 100 mM DFO (B), 25 mM Fe<sup>2+</sup> (C), and 20 mM VE (D). GSH/GSSG level (E) and MDA level (H). Expression of GPX4 (F, G) and lipid peroxides of MCF-7 cells stained with BODIPY-C11 (I) in MCF-7 cells treated with AlbA-DCA (2 μM), AlbA (10 μM), and Na-DCA (30 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00644&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/medium/jm9b00644_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. AlbA-DCA inhibits MCF-7 cells xenograft growth in vivo. MCF-7 cells were subcutaneously inoculated into the right flank of nude mice. Mice were treated intravenously with saline, AlbA-DCA (2 mg/kg), AlbA (10 mg/kg), Na-DCA (30 mg/kg), and 5-Fu (10 mg/kg) every 2 days for 2 weeks. (A) Image of a tumor-bearing mouse after initiation of treatment. (B) Body weight, (C) tumor volume, and (E) tumor weight changes of nude mice in the experimental process. (D) Photograph of tumors removed from nude mice after treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00644&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/medium/jm9b00644_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. In vivo toxicity evaluations of AlbA-DCA. (A) Hematological analysis of treated mice after 14 days. Gray areas represent the normal range of different biosafety indicators. (B) H&E-stained slice images of major organs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00644&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/medium/jm9b00644_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. AlbA-DCA inhibits bilateral 4T1 tumor-bearing mice in vivo. (A) Schematic illustration of the experiment design. (B) Visible tumor formation and photographs of representative tumors removed from mice after initiation of treatment. (C) Primary and distant tumor growth curves of mice after various treatments. (D) Tumor weight changes of mice during treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00644&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/medium/jm9b00644_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. AlbA-DCA promoted M2-TAMs polarization. Expression of Arg-1 and MRC-1 (A, B) and the relative mRNA expression (C) in distant tumor from mice after treatment. (D–K) Cytokine levels in sera and distant tumor from mice after treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-19/acs.jmedchem.9b00644/20191008/images/large/jm9b00644_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00644&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81671" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81671" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 44 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanahan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Hallmarks of cancer: the next generation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+cancer%3A+the+next+generation&doi=10.1016%2Fj.cell.2011.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0lg4MiY0rOZjTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520cancer%253A%2520the%2520next%2520generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26spage%3D646%26epage%3D674%26doi%3D10.1016%2Fj.cell.2011.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandel, N. S.</span></span> <span> </span><span class="NLM_article-title">Fundamentals of cancer metabolism</span>. <i>Sci. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">e1600200</span> <span class="refDoi"> DOI: 10.1126/sciadv.1600200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1126%2Fsciadv.1600200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=27386546" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&author=R.+J.+DeBerardinisauthor=N.+S.+Chandel&title=Fundamentals+of+cancer+metabolism&doi=10.1126%2Fsciadv.1600200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fsciadv.1600200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fsciadv.1600200%26sid%3Dliteratum%253Aachs%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DChandel%26aufirst%3DN.%2BS.%26atitle%3DFundamentals%2520of%2520cancer%2520metabolism%26jtitle%3DSci.%2520Adv.%26date%3D2016%26volume%3D2%26doi%3D10.1126%2Fsciadv.1600200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Outschoorn, U. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peiris-Pages, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pestell, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotgia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lisanti, M. P.</span></span> <span> </span><span class="NLM_article-title">Cancer metabolism: a therapeutic perspective</span>. <i>Nat. Rev. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">31</span>, <span class="refDoi"> DOI: 10.1038/nrclinonc.2016.60</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1038%2Fnrclinonc.2016.60" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=27141887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsF2qu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=11-31&author=U.+E.+Martinez-Outschoornauthor=M.+Peiris-Pagesauthor=R.+G.+Pestellauthor=F.+Sotgiaauthor=M.+P.+Lisanti&title=Cancer+metabolism%3A+a+therapeutic+perspective&doi=10.1038%2Fnrclinonc.2016.60"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer metabolism: a therapeutic perspective</span></div><div class="casAuthors">Martinez-Outschoorn, Ubaldo E.; Peiris-Pages, Maria; Pestell, Richard G.; Sotgia, Federica; Lisanti, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-31</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Awareness that the metabolic phenotype of cells within tumors is heterogeneous - and distinct from that of their normal counterparts - is growing.  In general, tumor cells metabolize glucose, lactate, pyruvate, hydroxybutyrate, acetate, glutamine, and fatty acids at much higher rates than their nontumor equiv.; however, the metabolic ecol. of tumors is complex because they contain multiple metabolic compartments, which are linked by the transfer of these catabolites.  This metabolic variability and flexibility enables tumor cells to generate ATP as an energy source, while maintaining the redn.-oxidn. (redox) balance and committing resources to biosynthesis - processes that are essential for cell survival, growth, and proliferation.  Importantly, exptl. evidence indicates that metabolic coupling between cell populations with different, complementary metabolic profiles can induce cancer progression.  Thus, targeting the metabolic differences between tumor and normal cells holds promise as a novel anticancer strategy.  In this Review, we discuss how cancer cells reprogramme their metab. and that of other cells within the tumor microenvironment in order to survive and propagate, thus driving disease progression; in particular, we highlight potential metabolic vulnerabilities that might be targeted therapeutically.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNuUI8-igjaLVg90H21EOLACvtfcHk0liRE6nE749SBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsF2qu7g%253D&md5=a4f92ba92569fca1d35e20ec7acb9394</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2016.60&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2016.60%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Outschoorn%26aufirst%3DU.%2BE.%26aulast%3DPeiris-Pages%26aufirst%3DM.%26aulast%3DPestell%26aufirst%3DR.%2BG.%26aulast%3DSotgia%26aufirst%3DF.%26aulast%3DLisanti%26aufirst%3DM.%2BP.%26atitle%3DCancer%2520metabolism%253A%2520a%2520therapeutic%2520perspective%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2017%26volume%3D14%26spage%3D11%26epage%3D31%26doi%3D10.1038%2Fnrclinonc.2016.60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huber, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camisaschi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triulzi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuccitto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagliabue, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivoltini, L.</span></span> <span> </span><span class="NLM_article-title">Cancer acidity: an ultimate frontier of tumor immune escape and a novel target of immunomodulation</span>. <i>Semin. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1016/j.semcancer.2017.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.semcancer.2017.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=28267587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslOqtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2017&pages=74-89&author=V.+Huberauthor=C.+Camisaschiauthor=A.+Berziauthor=S.+Ferroauthor=L.+Luginiauthor=T.+Triulziauthor=A.+Tuccittoauthor=E.+Tagliabueauthor=C.+Castelliauthor=L.+Rivoltini&title=Cancer+acidity%3A+an+ultimate+frontier+of+tumor+immune+escape+and+a+novel+target+of+immunomodulation&doi=10.1016%2Fj.semcancer.2017.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation</span></div><div class="casAuthors">Huber, Veronica; Camisaschi, Chiara; Berzi, Angela; Ferro, Simona; Lugini, Luana; Triulzi, Tiziana; Tuccitto, Alessandra; Tagliabue, Elda; Castelli, Chiara; Rivoltini, Licia</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">74-89</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The link between cancer metab. and immunosuppression, inflammation and immune escape has generated major interest in investigating the effects of low pH on tumor immunity.  Indeed, microenvironmental acidity may differentially impact on diverse components of tumor immune surveillance, eventually contributing to immune escape and cancer progression.  Although the mol. pathways underlying acidity-related immune dysfunctions are just emerging, initial evidence indicates that antitumor effectors such as T and NK cells tend to lose their function and undergo a state of mostly reversible anergy followed by apoptosis, when exposed to low pH environment.  At opposite, immunosuppressive components such as myeloid cells and regulatory T cells are engaged by tumor acidity to sustain tumor growth while blocking antitumor immune responses.  Local acidity could also profoundly influence bioactivity and distribution of antibodies, thus potentially interfering with the clin. efficacy of therapeutic antibodies including immune checkpoint inhibitors.  Hence tumor acidity is a central regulator of cancer immunity that orchestrates both local and systemic immunosuppression and that may offer a broad panel of therapeutic targets.  This review outlines the fundamental pathways of acidity-driven immune dysfunctions and sheds light on the potential strategies that could be envisaged to potentiate immune-mediated tumor control in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCzFzY3bg6UrVg90H21EOLACvtfcHk0liRE6nE749SBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslOqtLY%253D&md5=22bab52b69fad88fdd97b448fe98acca</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2017.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2017.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DHuber%26aufirst%3DV.%26aulast%3DCamisaschi%26aufirst%3DC.%26aulast%3DBerzi%26aufirst%3DA.%26aulast%3DFerro%26aufirst%3DS.%26aulast%3DLugini%26aufirst%3DL.%26aulast%3DTriulzi%26aufirst%3DT.%26aulast%3DTuccitto%26aufirst%3DA.%26aulast%3DTagliabue%26aufirst%3DE.%26aulast%3DCastelli%26aufirst%3DC.%26aulast%3DRivoltini%26aufirst%3DL.%26atitle%3DCancer%2520acidity%253A%2520an%2520ultimate%2520frontier%2520of%2520tumor%2520immune%2520escape%2520and%2520a%2520novel%2520target%2520of%2520immunomodulation%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2017%26volume%3D43%26spage%3D74%26epage%3D89%26doi%3D10.1016%2Fj.semcancer.2017.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carmona-Fontaine, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bucci, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkari, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deforet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xavier, J. B.</span></span> <span> </span><span class="NLM_article-title">Emergence of spatial structure in the tumor microenvironment due to the Warburg effect</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">19402</span>– <span class="NLM_lpage">19407</span>, <span class="refDoi"> DOI: 10.1073/pnas.1311939110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1073%2Fpnas.1311939110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=24218566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFemur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=19402-19407&author=C.+Carmona-Fontaineauthor=V.+Bucciauthor=L.+Akkariauthor=M.+Deforetauthor=J.+A.+Joyceauthor=J.+B.+Xavier&title=Emergence+of+spatial+structure+in+the+tumor+microenvironment+due+to+the+Warburg+effect&doi=10.1073%2Fpnas.1311939110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Emergence of spatial structure in the tumor microenvironment due to the Warburg effect</span></div><div class="casAuthors">Carmona-Fontaine, Carlos; Bucci, Vanni; Akkari, Leila; Deforet, Maxime; Joyce, Johanna A.; Xavier, Joao B.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">19402-19407,S19402/1-S19402/31</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Drastic metabolic alterations, such as the Warburg effect, are found in most if not all types of malignant tumors.  Emerging evidence shows that cancer cells benefit from these alterations, but little is known about how they affect noncancerous stromal cells within the tumor microenvironment.  Here we show that cancer cells are better adapted to metabolic changes in the microenvironment, leading to the emergence of spatial structure.  A clear example of tumor spatial structure is the localization of tumor-assocd. macrophages (TAMs), one of the most common stromal cell types found in tumors.  TAMs are enriched in well-perfused areas, such as perivascular and cortical regions, where they are known to potentiate tumor growth and invasion.  However, the mechanisms of TAM localization are not completely understood.  Computational modeling predicts that gradients-of nutrients, gases, and metabolic byproducts such as lactate-emerge due to altered cell metab. within poorly perfused tumors, creating ischemic regions of the tumor microenvironment where TAMs struggle to survive.  We tested our modeling prediction in a coculture system that mimics the tumor microenvironment.  Using this exptl. approach, we showed that a combination of metabolite gradients and differential sensitivity to lactic acid is sufficient for the emergence of macrophage localization patterns in vitro.  This suggests that cancer metabolic changes create a microenvironment where tumor cells thrive over other cells.  Understanding differences in tumor-stroma sensitivity to these alterations may open therapeutic avenues against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocknTaSVoSa7Vg90H21EOLACvtfcHk0li4vD0-wBGDSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFemur%252FI&md5=af3a81a01a45321c40c4241269a7c0e4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1311939110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1311939110%26sid%3Dliteratum%253Aachs%26aulast%3DCarmona-Fontaine%26aufirst%3DC.%26aulast%3DBucci%26aufirst%3DV.%26aulast%3DAkkari%26aufirst%3DL.%26aulast%3DDeforet%26aufirst%3DM.%26aulast%3DJoyce%26aufirst%3DJ.%2BA.%26aulast%3DXavier%26aufirst%3DJ.%2BB.%26atitle%3DEmergence%2520of%2520spatial%2520structure%2520in%2520the%2520tumor%2520microenvironment%2520due%2520to%2520the%2520Warburg%2520effect%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D19402%26epage%3D19407%26doi%3D10.1073%2Fpnas.1311939110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colegio, O. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, N. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhebergen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jairam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cyrus, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brokowski, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenbarth, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cline, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medzhitov, R.</span></span> <span> </span><span class="NLM_article-title">Functional polarization of tumour-associated macrophages by tumour-derived lactic acid</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>513</i></span>,  <span class="NLM_fpage">559</span>– <span class="NLM_lpage">563</span>, <span class="refDoi"> DOI: 10.1038/nature13490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1038%2Fnature13490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=25043024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Wjs7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=513&publication_year=2014&pages=559-563&author=O.+R.+Colegioauthor=N.+Q.+Chuauthor=A.+L.+Szaboauthor=T.+Chuauthor=A.+M.+Rhebergenauthor=V.+Jairamauthor=N.+Cyrusauthor=C.+E.+Brokowskiauthor=S.+C.+Eisenbarthauthor=G.+M.+Phillipsauthor=G.+W.+Clineauthor=A.+J.+Phillipsauthor=R.+Medzhitov&title=Functional+polarization+of+tumour-associated+macrophages+by+tumour-derived+lactic+acid&doi=10.1038%2Fnature13490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Functional polarization of tumor-associated macrophages by tumor-derived lactic acid</span></div><div class="casAuthors">Colegio, Oscar R.; Chu, Ngoc-Quynh; Szabo, Alison L.; Chu, Thach; Rhebergen, Anne Marie; Jairam, Vikram; Cyrus, Nika; Brokowski, Carolyn E.; Eisenbarth, Stephanie C.; Phillips, Gillian M.; Cline, Gary W.; Phillips, Andrew J.; Medzhitov, Ruslan</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">513</span>
        (<span class="NLM_cas:issue">7519</span>),
    <span class="NLM_cas:pages">559-563</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Macrophages have an important role in the maintenance of tissue homeostasis.  To perform this function, macrophages must have the capacity to monitor the functional states of their 'client cells': namely, the parenchymal cells in the various tissues in which macrophages reside.  Tumors exhibit many features of abnormally developed organs, including tissue architecture and cellular compn.  Similarly to macrophages in normal tissues and organs, macrophages in tumors (tumor-assocd. macrophages) perform some key homeostatic functions that allow tumor maintenance and growth.  However, the signals involved in communication between tumors and macrophages are poorly defined.  Here we show that lactic acid produced by tumor cells, as a byproduct of aerobic or anaerobic glycolysis, has a crit. function in signaling, through inducing the expression of vascular endothelial growth factor and the M2-like polarization of tumor-assocd. macrophages.  Furthermore, we demonstrate that this effect of lactic acid is mediated by hypoxia-inducible factor 1α (HIF1α).  Finally, we show that the lactate-induced expression of arginase 1 by macrophages has an important role in tumor growth.  Collectively, these findings identify a mechanism of communication between macrophages and their client cells, including tumor cells.  This communication most probably evolved to promote homeostasis in normal tissues but can also be engaged in tumors to promote their growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqslUtHs-WCprVg90H21EOLACvtfcHk0li4vD0-wBGDSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Wjs7nO&md5=19de6df0a2734ab8037ade191a02ed60</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature13490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13490%26sid%3Dliteratum%253Aachs%26aulast%3DColegio%26aufirst%3DO.%2BR.%26aulast%3DChu%26aufirst%3DN.%2BQ.%26aulast%3DSzabo%26aufirst%3DA.%2BL.%26aulast%3DChu%26aufirst%3DT.%26aulast%3DRhebergen%26aufirst%3DA.%2BM.%26aulast%3DJairam%26aufirst%3DV.%26aulast%3DCyrus%26aufirst%3DN.%26aulast%3DBrokowski%26aufirst%3DC.%2BE.%26aulast%3DEisenbarth%26aufirst%3DS.%2BC.%26aulast%3DPhillips%26aufirst%3DG.%2BM.%26aulast%3DCline%26aufirst%3DG.%2BW.%26aulast%3DPhillips%26aufirst%3DA.%2BJ.%26aulast%3DMedzhitov%26aufirst%3DR.%26atitle%3DFunctional%2520polarization%2520of%2520tumour-associated%2520macrophages%2520by%2520tumour-derived%2520lactic%2520acid%26jtitle%3DNature%26date%3D2014%26volume%3D513%26spage%3D559%26epage%3D563%26doi%3D10.1038%2Fnature13490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brand, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehl, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolitzus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoenhammer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruss, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klobuch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastenberger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogdan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleicher, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackensen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ullrich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fichtner-Feigl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kesselring, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mack, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blank, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dettmer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oefner, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walenta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geissler, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouyssegur, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villunger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steven, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seliger, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreml, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haferkamp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohl, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karrer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berneburg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herr, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller-Klieser, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutz, M.</span></span> <span> </span><span class="NLM_article-title">LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK Cells</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">657</span>– <span class="NLM_lpage">671</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2016.08.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.cmet.2016.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=27641098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFajsLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=657-671&author=A.+Brandauthor=K.+Singerauthor=G.+E.+Koehlauthor=M.+Kolitzusauthor=G.+Schoenhammerauthor=A.+Thielauthor=C.+Matosauthor=C.+Brussauthor=S.+Klobuchauthor=K.+Peterauthor=M.+Kastenbergerauthor=C.+Bogdanauthor=U.+Schleicherauthor=A.+Mackensenauthor=E.+Ullrichauthor=S.+Fichtner-Feiglauthor=R.+Kesselringauthor=M.+Mackauthor=U.+Ritterauthor=M.+Schmidauthor=C.+Blankauthor=K.+Dettmerauthor=P.+J.+Oefnerauthor=P.+Hoffmannauthor=S.+Walentaauthor=E.+K.+Geisslerauthor=J.+Pouyssegurauthor=A.+Villungerauthor=A.+Stevenauthor=B.+Seligerauthor=S.+Schremlauthor=S.+Haferkampauthor=E.+Kohlauthor=S.+Karrerauthor=M.+Berneburgauthor=W.+Herrauthor=W.+Mueller-Klieserauthor=K.+Rennerauthor=M.+Kreutz&title=LDHA-associated+lactic+acid+production+blunts+tumor+immunosurveillance+by+T+and+NK+Cells&doi=10.1016%2Fj.cmet.2016.08.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells</span></div><div class="casAuthors">Brand, Almut; Singer, Katrin; Koehl, Gudrun E.; Kolitzus, Marlene; Schoenhammer, Gabriele; Thiel, Annette; Matos, Carina; Bruss, Christina; Klobuch, Sebastian; Peter, Katrin; Kastenberger, Michael; Bogdan, Christian; Schleicher, Ulrike; Mackensen, Andreas; Ullrich, Evelyn; Fichtner-Feigl, Stefan; Kesselring, Rebecca; Mack, Matthias; Ritter, Uwe; Schmid, Maximilian; Blank, Christian; Dettmer, Katja; Oefner, Peter J.; Hoffmann, Petra; Walenta, Stefan; Geissler, Edward K.; Pouyssegur, Jacques; Villunger, Andreas; Steven, Andre; Seliger, Barbara; Schreml, Stephan; Haferkamp, Sebastian; Kohl, Elisabeth; Karrer, Sigrid; Berneburg, Mark; Herr, Wolfgang; Mueller-Klieser, Wolfgang; Renner, Kathrin; Kreutz, Marina</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">657-671</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Elevated lactate dehydrogenase A (LDHA) expression is assocd. with poor outcome in tumor patients.  Here we show that LDHA-assocd. lactic acid accumulation in melanomas inhibits tumor surveillance by T and NK cells.  In immunocompetent C57BL/6 mice, tumors with reduced lactic acid prodn. (Ldhalow) developed significantly slower than control tumors and showed increased infiltration with IFN-γ-producing T and NK cells.  However, in Rag2-/-γc-/- mice, lacking lymphocytes and NK cells, and in Ifng-/- mice, Ldhalow and control cells formed tumors at similar rates.  Pathophysiol. concns. of lactic acid prevented upregulation of nuclear factor of activated T cells (NFAT) in T and NK cells, resulting in diminished IFN-γ prodn.  Database analyses revealed neg. correlations between LDHA expression and T cell activation markers in human melanoma patients.  Our results demonstrate that lactic acid is a potent inhibitor of function and survival of T and NK cells leading to tumor immune escape.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEkJBRRuoHRLVg90H21EOLACvtfcHk0lhqLmQA1q_Pqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFajsLbK&md5=99e43d6896d1eed4571fb09a058e5042</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2016.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2016.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DBrand%26aufirst%3DA.%26aulast%3DSinger%26aufirst%3DK.%26aulast%3DKoehl%26aufirst%3DG.%2BE.%26aulast%3DKolitzus%26aufirst%3DM.%26aulast%3DSchoenhammer%26aufirst%3DG.%26aulast%3DThiel%26aufirst%3DA.%26aulast%3DMatos%26aufirst%3DC.%26aulast%3DBruss%26aufirst%3DC.%26aulast%3DKlobuch%26aufirst%3DS.%26aulast%3DPeter%26aufirst%3DK.%26aulast%3DKastenberger%26aufirst%3DM.%26aulast%3DBogdan%26aufirst%3DC.%26aulast%3DSchleicher%26aufirst%3DU.%26aulast%3DMackensen%26aufirst%3DA.%26aulast%3DUllrich%26aufirst%3DE.%26aulast%3DFichtner-Feigl%26aufirst%3DS.%26aulast%3DKesselring%26aufirst%3DR.%26aulast%3DMack%26aufirst%3DM.%26aulast%3DRitter%26aufirst%3DU.%26aulast%3DSchmid%26aufirst%3DM.%26aulast%3DBlank%26aufirst%3DC.%26aulast%3DDettmer%26aufirst%3DK.%26aulast%3DOefner%26aufirst%3DP.%2BJ.%26aulast%3DHoffmann%26aufirst%3DP.%26aulast%3DWalenta%26aufirst%3DS.%26aulast%3DGeissler%26aufirst%3DE.%2BK.%26aulast%3DPouyssegur%26aufirst%3DJ.%26aulast%3DVillunger%26aufirst%3DA.%26aulast%3DSteven%26aufirst%3DA.%26aulast%3DSeliger%26aufirst%3DB.%26aulast%3DSchreml%26aufirst%3DS.%26aulast%3DHaferkamp%26aufirst%3DS.%26aulast%3DKohl%26aufirst%3DE.%26aulast%3DKarrer%26aufirst%3DS.%26aulast%3DBerneburg%26aufirst%3DM.%26aulast%3DHerr%26aufirst%3DW.%26aulast%3DMueller-Klieser%26aufirst%3DW.%26aulast%3DRenner%26aufirst%3DK.%26aulast%3DKreutz%26aufirst%3DM.%26atitle%3DLDHA-associated%2520lactic%2520acid%2520production%2520blunts%2520tumor%2520immunosurveillance%2520by%2520T%2520and%2520NK%2520Cells%26jtitle%3DCell%2520Metab.%26date%3D2016%26volume%3D24%26spage%3D657%26epage%3D671%26doi%3D10.1016%2Fj.cmet.2016.08.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurence, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X. P.</span></span> <span> </span><span class="NLM_article-title">Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2alpha-mediated tumor progression</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">646</span>, <span class="refDoi"> DOI: 10.1172/JCI123027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1172%2FJCI123027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=30431439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A280%3ADC%252BB3crgtlWjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2019&pages=631-646&author=N.+Liuauthor=J.+Luoauthor=D.+Kuangauthor=S.+Xuauthor=Y.+Duanauthor=Y.+Xiaauthor=Z.+Weiauthor=X.+Xieauthor=B.+Yinauthor=F.+Chenauthor=S.+Luoauthor=H.+Liuauthor=J.+Wangauthor=K.+Jiangauthor=F.+Gongauthor=Z.+H.+Tangauthor=X.+Chengauthor=H.+Liauthor=Z.+Liauthor=A.+Laurenceauthor=G.+Wangauthor=X.+P.+Yang&title=Lactate+inhibits+ATP6V0d2+expression+in+tumor-associated+macrophages+to+promote+HIF-2alpha-mediated+tumor+progression&doi=10.1172%2FJCI123027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2α-mediated tumor progression</span></div><div class="casAuthors">Liu Na; Luo Jing; Xia Yu; Wei Zhengping; Xie Xiuxiu; Yin Bingjiao; Chen Fang; Liu Huicheng; Wang Jing; Gong Feili; Li Zhuoya; Yang Xiang-Ping; Kuang Dong; Xu Sanpeng; Duan Yaqi; Wang Guoping; Kuang Dong; Xu Sanpeng; Duan Yaqi; Wang Guoping; Luo Shunqun; Jiang Kan; Tang Zhao-Hui; Cheng Xiang; Li Huabin; Laurence Arian</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">631-646</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Macrophages perform key functions in tissue homeostasis that are influenced by the local tissue environment.  Within the tumor microenvironment, tumor-associated macrophages can be altered to acquire properties that enhance tumor growth.  Here, we found that lactate, a metabolite found in high concentration within the anaerobic tumor environment, activated mTORC1 that subsequently suppressed TFEB-mediated expression of the macrophage-specific vacuolar ATPase subunit ATP6V0d2.  Atp6v0d2-/- mice were more susceptible to tumor growth, with enhanced HIF-2α-mediated VEGF production in macrophages that display a more protumoral phenotype.  We found that ATP6V0d2 targeted HIF-2α but not HIF-1α for lysosome-mediated degradation.  Blockade of HIF-2α transcriptional activity reversed the susceptibility of Atp6v0d2-/- mice to tumor development.  Furthermore, in a cohort of patients with lung adenocarcinoma, expression of ATP6V0d2 and HIF-2α was positively and negatively correlated with survival, respectively, suggesting a critical role of the macrophage lactate/ATP6V0d2/HIF-2α axis in maintaining tumor growth in human patients.  Together, our results highlight the ability of tumor cells to modify the function of tumor-infiltrating macrophages to optimize the microenvironment for tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTs0473RL72GkBuFdjgVNKSfW6udTcc2ea6qECq472FO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3crgtlWjsg%253D%253D&md5=4a3de4470556aaf42a3a3571eaa985e5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1172%2FJCI123027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI123027%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DKuang%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DDuan%26aufirst%3DY.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DZ.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DYin%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DF.%26aulast%3DLuo%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DK.%26aulast%3DGong%26aufirst%3DF.%26aulast%3DTang%26aufirst%3DZ.%2BH.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DX.%2BP.%26atitle%3DLactate%2520inhibits%2520ATP6V0d2%2520expression%2520in%2520tumor-associated%2520macrophages%2520to%2520promote%2520HIF-2alpha-mediated%2520tumor%2520progression%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2019%26volume%3D129%26spage%3D631%26epage%3D646%26doi%3D10.1172%2FJCI123027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stacpoole, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerr, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunch, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carney, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fennell, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felitsyn, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmore, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neiberger, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perkins, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quisling, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shroads, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuster, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silverstein, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theriaque, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenstein, E.</span></span> <span> </span><span class="NLM_article-title">Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children</span>. <i>Pediatrics</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">1519</span>– <span class="NLM_lpage">1531</span>, <span class="refDoi"> DOI: 10.1542/peds.2005-1226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1542%2Fpeds.2005-1226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=16651305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A280%3ADC%252BD283ksVGmtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2006&pages=1519-1531&author=P.+W.+Stacpooleauthor=D.+S.+Kerrauthor=C.+Barnesauthor=S.+T.+Bunchauthor=P.+R.+Carneyauthor=E.+M.+Fennellauthor=N.+M.+Felitsynauthor=R.+L.+Gilmoreauthor=M.+Greerauthor=G.+N.+Hendersonauthor=A.+D.+Hutsonauthor=R.+E.+Neibergerauthor=R.+G.+O%E2%80%99Brienauthor=L.+A.+Perkinsauthor=R.+G.+Quislingauthor=A.+L.+Shroadsauthor=J.+J.+Shusterauthor=J.+H.+Silversteinauthor=D.+W.+Theriaqueauthor=E.+Valenstein&title=Controlled+clinical+trial+of+dichloroacetate+for+treatment+of+congenital+lactic+acidosis+in+children&doi=10.1542%2Fpeds.2005-1226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children</span></div><div class="casAuthors">Stacpoole Peter W; Kerr Douglas S; Barnes Carie; Bunch S Terri; Carney Paul R; Fennell Eileen M; Felitsyn Natalia M; Gilmore Robin L; Greer Melvin; Henderson George N; Hutson Alan D; Neiberger Richard E; O'Brien Ralph G; Perkins Leigh Ann; Quisling Ronald G; Shroads Albert L; Shuster Jonathan J; Silverstein Janet H; Theriaque Douglas W; Valenstein Edward</div><div class="citationInfo"><span class="NLM_cas:title">Pediatrics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1519-31</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Open-label studies indicate that oral dichloroacetate (DCA) may be effective in treating patients with congenital lactic acidosis.  We tested this hypothesis by conducting the first double-blind, randomized, control trial of DCA in this disease.  METHODS:  Forty-three patients who ranged in age from 0.9 to 19 years were enrolled.  All patients had persistent or intermittent hyperlactatemia, and most had severe psychomotor delay.  Eleven patients had pyruvate dehydrogenase deficiency, 25 patients had 1 or more defects in enzymes of the respiratory chain, and 7 patients had a mutation in mitochondrial DNA.  Patients were preconditioned on placebo for 6 months and then were randomly assigned to receive an additional 6 months of placebo or DCA, at a dose of 12.5 mg/kg every 12 hours.  The primary outcome results were (1) a Global Assessment of Treatment Efficacy, which incorporated tests of neuromuscular and behavioral function and quality of life; (2) linear growth; (3) blood lactate concentration in the fasted state and after a carbohydrate meal; (4) frequency and severity of intercurrent illnesses and hospitalizations; and (5) safety, including tests of liver and peripheral nerve function.  OUTCOME:  There were no significant differences in Global Assessment of Treatment Efficacy scores, linear growth, or the frequency or severity of intercurrent illnesses.  DCA significantly decreased the rise in blood lactate caused by carbohydrate feeding.  Chronic DCA administration was associated with a fall in plasma clearance of the drug and with a rise in the urinary excretion of the tyrosine catabolite maleylacetone and the heme precursor delta-aminolevulinate.  CONCLUSIONS:  In this highly heterogeneous population of children with congenital lactic acidosis, oral DCA for 6 months was well tolerated and blunted the postprandial increase in circulating lactate.  However, it did not improve neurologic or other measures of clinical outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSUwUvYVkV0pcXNb62YGmbfW6udTcc2eYTgkKm1xj2W7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD283ksVGmtg%253D%253D&md5=c5673a710c0557d45f6cf517c9fa8a33</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1542%2Fpeds.2005-1226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1542%252Fpeds.2005-1226%26sid%3Dliteratum%253Aachs%26aulast%3DStacpoole%26aufirst%3DP.%2BW.%26aulast%3DKerr%26aufirst%3DD.%2BS.%26aulast%3DBarnes%26aufirst%3DC.%26aulast%3DBunch%26aufirst%3DS.%2BT.%26aulast%3DCarney%26aufirst%3DP.%2BR.%26aulast%3DFennell%26aufirst%3DE.%2BM.%26aulast%3DFelitsyn%26aufirst%3DN.%2BM.%26aulast%3DGilmore%26aufirst%3DR.%2BL.%26aulast%3DGreer%26aufirst%3DM.%26aulast%3DHenderson%26aufirst%3DG.%2BN.%26aulast%3DHutson%26aufirst%3DA.%2BD.%26aulast%3DNeiberger%26aufirst%3DR.%2BE.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DR.%2BG.%26aulast%3DPerkins%26aufirst%3DL.%2BA.%26aulast%3DQuisling%26aufirst%3DR.%2BG.%26aulast%3DShroads%26aufirst%3DA.%2BL.%26aulast%3DShuster%26aufirst%3DJ.%2BJ.%26aulast%3DSilverstein%26aufirst%3DJ.%2BH.%26aulast%3DTheriaque%26aufirst%3DD.%2BW.%26aulast%3DValenstein%26aufirst%3DE.%26atitle%3DControlled%2520clinical%2520trial%2520of%2520dichloroacetate%2520for%2520treatment%2520of%2520congenital%2520lactic%2520acidosis%2520in%2520children%26jtitle%3DPediatrics%26date%3D2006%26volume%3D117%26spage%3D1519%26epage%3D1531%26doi%3D10.1542%2Fpeds.2005-1226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, K. Y.</span></span> <span> </span><span class="NLM_article-title">Development of pyruvate dehydrogenase kinase inhibitors in medicinal chemistry with particular emphasis as anticancer agents</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1112</span>– <span class="NLM_lpage">1119</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2015.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.drudis.2015.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=25842042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A280%3ADC%252BC2MjhtVKmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=1112-1119&author=S.+L.+Zhangauthor=X.+Huauthor=W.+Zhangauthor=H.+Yaoauthor=K.+Y.+Tam&title=Development+of+pyruvate+dehydrogenase+kinase+inhibitors+in+medicinal+chemistry+with+particular+emphasis+as+anticancer+agents&doi=10.1016%2Fj.drudis.2015.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Development of pyruvate dehydrogenase kinase inhibitors in medicinal chemistry with particular emphasis as anticancer agents</span></div><div class="casAuthors">Zhang Shao-Lin; Hu Xiaohui; Zhang Wen; Yao Huankai; Tam Kin Yip</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1112-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Many cancer cells demonstrate a high rate of glucose consumption via glycolysis to provide intermediates for macromolecule biosynthesis.  To accomplish this metabolic change, the expression of pyruvate dehydrogenase kinases (PDKs) is rapidly increased in cancer cells.  Inhibition of PDKs could promote the function of mitochondria by increasing the oxidative metabolism of pyruvate, resulting in the death of cancer cells.  In this review, we provide an overview of the structural information available for PDKs and their connections to known therapeutic effects.  We then describe the development of small molecule PDK inhibitors in medicinal chemistry with particular emphasis as anticancer agents.  Finally, directions for further development of PDK inhibitors as potential anticancer agents are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSoAx3fbmrmKLBItaL1WaVAfW6udTcc2eYTgkKm1xj2W7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MjhtVKmsA%253D%253D&md5=5e840ba2e6d722d6e7145e39c9b3e486</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2015.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2015.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%2BL.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DTam%26aufirst%3DK.%2BY.%26atitle%3DDevelopment%2520of%2520pyruvate%2520dehydrogenase%2520kinase%2520inhibitors%2520in%2520medicinal%2520chemistry%2520with%2520particular%2520emphasis%2520as%2520anticancer%2520agents%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2015%26volume%3D20%26spage%3D1112%26epage%3D1119%26doi%3D10.1016%2Fj.drudis.2015.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christofk, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vander Heiden, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerszten, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span> <span> </span><span class="NLM_article-title">The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>452</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1038/nature06734</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1038%2Fnature06734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=18337823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjt1Gnu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=452&publication_year=2008&pages=230-234&author=H.+R.+Christofkauthor=M.+G.+Vander+Heidenauthor=M.+H.+Harrisauthor=A.+Ramanathanauthor=R.+E.+Gersztenauthor=R.+Weiauthor=M.+D.+Flemingauthor=S.+L.+Schreiberauthor=L.+C.+Cantley&title=The+M2+splice+isoform+of+pyruvate+kinase+is+important+for+cancer+metabolism+and+tumour+growth&doi=10.1038%2Fnature06734"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumor growth</span></div><div class="casAuthors">Christofk, Heather R.; Vander Heiden, Matthew G.; Harris, Marian H.; Ramanathan, Arvind; Gerszten, Robert E.; Wei, Ru; Fleming, Mark D.; Schreiber, Stuart L.; Cantley, Lewis C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">452</span>
        (<span class="NLM_cas:issue">7184</span>),
    <span class="NLM_cas:pages">230-233</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Many tumor cells have elevated rates of glucose uptake but reduced rates of oxidative phosphorylation.  This persistence of high lactate prodn. by tumors in the presence of oxygen, known as aerobic glycolysis, was first noted by Otto Warburg more than 75 yr ago.  How tumor cells establish this altered metabolic phenotype and whether it is essential for tumorigenesis is as yet unknown.  Here we show that a single switch in a splice isoform of the glycolytic enzyme pyruvate kinase is necessary for the shift in cellular metab. to aerobic glycolysis and that this promotes tumorigenesis.  Tumor cells have been shown to express exclusively the embryonic M2 isoform of pyruvate kinase.  Here we use short hairpin RNA to knockdown pyruvate kinase M2 expression in human cancer cell lines and replace it with pyruvate kinase M1.  Switching pyruvate kinase expression to the M1 (adult) isoform leads to reversal of the Warburg effect, as judged by reduced lactate prodn. and increased oxygen consumption, and this correlates with a reduced ability to form tumors in nude mouse xenografts.  These results demonstrate that M2 expression is necessary for aerobic glycolysis and that this metabolic phenotype provides a selective growth advantage for tumor cells in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvmgcXNsSjpbVg90H21EOLACvtfcHk0lhBiSOlgFL0Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjt1Gnu74%253D&md5=e7e6b7cc09477e1f9d270018d1c38be4</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature06734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06734%26sid%3Dliteratum%253Aachs%26aulast%3DChristofk%26aufirst%3DH.%2BR.%26aulast%3DVander%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DHarris%26aufirst%3DM.%2BH.%26aulast%3DRamanathan%26aufirst%3DA.%26aulast%3DGerszten%26aufirst%3DR.%2BE.%26aulast%3DWei%26aufirst%3DR.%26aulast%3DFleming%26aufirst%3DM.%2BD.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DThe%2520M2%2520splice%2520isoform%2520of%2520pyruvate%2520kinase%2520is%2520important%2520for%2520cancer%2520metabolism%2520and%2520tumour%2520growth%26jtitle%3DNature%26date%3D2008%26volume%3D452%26spage%3D230%26epage%3D234%26doi%3D10.1038%2Fnature06734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Archer, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allalunis-Turner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haromy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopaschuk, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puttagunta, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrade, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thebaud, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelakis, E. D.</span></span> <span> </span><span class="NLM_article-title">A mitochondria-K<sup>+</sup> channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2006.10.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.ccr.2006.10.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=17222789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFClsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=37-51&author=S.+Bonnetauthor=S.+L.+Archerauthor=J.+Allalunis-Turnerauthor=A.+Haromyauthor=C.+Beaulieuauthor=R.+Thompsonauthor=C.+T.+Leeauthor=G.+D.+Lopaschukauthor=L.+Puttaguntaauthor=S.+Bonnetauthor=G.+Harryauthor=K.+Hashimotoauthor=C.+J.+Porterauthor=M.+A.+Andradeauthor=B.+Thebaudauthor=E.+D.+Michelakis&title=A+mitochondria-K%2B+channel+axis+is+suppressed+in+cancer+and+its+normalization+promotes+apoptosis+and+inhibits+cancer+growth&doi=10.1016%2Fj.ccr.2006.10.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth</span></div><div class="casAuthors">Bonnet, Sebastien; Archer, Stephen L.; Allalunis-Turner, Joan; Haromy, Alois; Beaulieu, Christian; Thompson, Richard; Lee, Christopher T.; Lopaschuk, Gary D.; Puttagunta, Lakshmi; Bonnet, Sandra; Harry, Gwyneth; Hashimoto, Kyoko; Porter, Christopher J.; Andrade, Miguel A.; Thebaud, Bernard; Michelakis, Evangelos D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-51</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The unique metabolic profile of cancer (aerobic glycolysis) might confer apoptosis resistance and be therapeutically targeted.  Compared to normal cells, several human cancers have high mitochondrial membrane potential (ΔΨm) and low expression of the K+ channel Kv1.5, both contributing to apoptosis resistance.  Dichloroacetate (DCA) inhibits mitochondrial pyruvate dehydrogenase kinase (PDK), shifts metab. from glycolysis to glucose oxidn., decreases ΔΨm, increases mitochondrial H2O2, and activates Kv channels in all cancer, but not normal, cells; DCA upregulates Kv1.5 by an NFAT1-dependent mechanism.  DCA induces apoptosis, decreases proliferation, and inhibits tumor growth, without apparent toxicity.  Mol. inhibition of PDK2 by siRNA mimics DCA.  The mitochondria-NFAT-Kv axis and PDK are important therapeutic targets in cancer; the orally available DCA is a promising selective anticancer agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocAukkjsEmZLVg90H21EOLACvtfcHk0lhBiSOlgFL0Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFClsLg%253D&md5=ce8b45e3292469a3ce1af91803785bee</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.10.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.10.020%26sid%3Dliteratum%253Aachs%26aulast%3DBonnet%26aufirst%3DS.%26aulast%3DArcher%26aufirst%3DS.%2BL.%26aulast%3DAllalunis-Turner%26aufirst%3DJ.%26aulast%3DHaromy%26aufirst%3DA.%26aulast%3DBeaulieu%26aufirst%3DC.%26aulast%3DThompson%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DC.%2BT.%26aulast%3DLopaschuk%26aufirst%3DG.%2BD.%26aulast%3DPuttagunta%26aufirst%3DL.%26aulast%3DBonnet%26aufirst%3DS.%26aulast%3DHarry%26aufirst%3DG.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DPorter%26aufirst%3DC.%2BJ.%26aulast%3DAndrade%26aufirst%3DM.%2BA.%26aulast%3DThebaud%26aufirst%3DB.%26aulast%3DMichelakis%26aufirst%3DE.%2BD.%26atitle%3DA%2520mitochondria-K%252B%2520channel%2520axis%2520is%2520suppressed%2520in%2520cancer%2520and%2520its%2520normalization%2520promotes%2520apoptosis%2520and%2520inhibits%2520cancer%2520growth%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D11%26spage%3D37%26epage%3D51%26doi%3D10.1016%2Fj.ccr.2006.10.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akazawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuze, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, N.</span></span> <span> </span><span class="NLM_article-title">Dichloroacetate improves immune dysfunction caused by tumor-secreted lactic acid and increases antitumor immunoreactivity</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">1107</span>– <span class="NLM_lpage">1118</span>, <span class="refDoi"> DOI: 10.1002/ijc.28114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1002%2Fijc.28114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=23420584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktVKgsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2013&pages=1107-1118&author=T.+Ohashiauthor=T.+Akazawaauthor=M.+Aokiauthor=B.+Kuzeauthor=K.+Mizutaauthor=Y.+Itoauthor=N.+Inoue&title=Dichloroacetate+improves+immune+dysfunction+caused+by+tumor-secreted+lactic+acid+and+increases+antitumor+immunoreactivity&doi=10.1002%2Fijc.28114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Dichloroacetate improves immune dysfunction caused by tumor-secreted lactic acid and increases antitumor immunoreactivity</span></div><div class="casAuthors">Ohashi, Toshimitsu; Akazawa, Takashi; Aoki, Mitsuhiro; Kuze, Bunya; Mizuta, Keisuke; Ito, Yatsuji; Inoue, Norimitsu</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1107-1118</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The activation of oncogenic signaling pathways induces the reprogramming of glucose metab. in tumor cells and increases lactic acid secretion into the tumor microenvironment.  This is a well-known characteristic of tumor cells, termed the Warburg effect, and is a candidate target for antitumor therapy.  Previous reports show that lactic acid secreted by tumor cells is a proinflammatory mediator that activates the IL-23/IL-17 pathway, thereby inducing inflammation, angiogenesis and tissue remodeling.  Here, we show that lactic acid, or more specifically the acidification it causes, increases arginase I (ARG1) expression in macrophages to inhibit T-cell proliferation and activation.  Accordingly, we hypothesized that counteraction of the immune effects by lactic acid might suppress tumor development.  We show that dichloroacetate (DCA), an inhibitor of pyruvate dehydrogenase kinases, targets macrophages to suppress activation of the IL-23/IL-17 pathway and the expression of ARG1 by lactic acid.  Furthermore, lactic acid-pretreated macrophages inhibited CD8+ T-cell proliferation, but CD8+ T-cell proliferation was restored when macrophages were pretreated with lactic acid and DCA.  DCA treatment decreased ARG1 expression in tumor-infiltrating immune cells and increased the no. of IFN-γ-producing CD8+ T cells and NK cells in tumor-bearing mouse spleen.  Although DCA treatment alone did not suppress tumor growth, it increased antitumor immunotherapeutic activity of Poly(IC) in both CD8+ T cell- and NK cell-sensitive tumor models.  Therefore, DCA acts not only on tumor cells to suppress glycolysis but also on immune cells to improve the immune status modulated by lactic acid and to increase the effectiveness of antitumor immunotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBHFdDNu94dbVg90H21EOLACvtfcHk0lgAWtWV8FsG9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktVKgsro%253D&md5=8d94c0db20accab9b7feefe79e332be5</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1002%2Fijc.28114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.28114%26sid%3Dliteratum%253Aachs%26aulast%3DOhashi%26aufirst%3DT.%26aulast%3DAkazawa%26aufirst%3DT.%26aulast%3DAoki%26aufirst%3DM.%26aulast%3DKuze%26aufirst%3DB.%26aulast%3DMizuta%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DN.%26atitle%3DDichloroacetate%2520improves%2520immune%2520dysfunction%2520caused%2520by%2520tumor-secreted%2520lactic%2520acid%2520and%2520increases%2520antitumor%2520immunoreactivity%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2013%26volume%3D133%26spage%3D1107%26epage%3D1118%26doi%3D10.1002%2Fijc.28114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fadia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlstrom, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parish, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Board, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackburn, A. C.</span></span> <span> </span><span class="NLM_article-title">Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo</span>. <i>Breast Cancer Res. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>120</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">260</span>, <span class="refDoi"> DOI: 10.1007/s10549-009-0435-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1007%2Fs10549-009-0435-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=19543830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlaruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2010&pages=253-260&author=R.+C.+Sunauthor=M.+Fadiaauthor=J.+E.+Dahlstromauthor=C.+R.+Parishauthor=P.+G.+Boardauthor=A.+C.+Blackburn&title=Reversal+of+the+glycolytic+phenotype+by+dichloroacetate+inhibits+metastatic+breast+cancer+cell+growth+in+vitro+and+in+vivo&doi=10.1007%2Fs10549-009-0435-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo</span></div><div class="casAuthors">Sun, Ramon C.; Fadia, Mitali; Dahlstrom, Jane E.; Parish, Christopher R.; Board, Philip G.; Blackburn, Anneke C.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">120</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">253-260</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The glycolytic phenotype is a widespread phenomenon in solid cancer forms, including breast cancer.  Dichloroacetate (DCA) has recently been proposed as a novel and relatively non-toxic anti-cancer agent that can reverse the glycolytic phenotype in cancer cells through the inhibition of pyruvate dehydrogenase kinase.  We have examd. the effect of DCA against breast cancer cells, including in a highly metastatic in vivo model.  The growth of several breast cancer cell lines was found to be inhibited by DCA in vitro.  Further examn. of 13762 MAT rat mammary adenocarcinoma cells found that reversal of the glycolytic phenotype by DCA correlated with the inhibition of proliferation without any increase in cell death.  This was despite a small but significant increase in caspase 3/7 activity, which may sensitize cancer cells to other apoptotic triggers.  In vivo, DCA caused a 58% redn. in the no. of lung metastases obsd. macroscopically after injection of 13,762 MAT cells into the tail vein of rats (P = 0.0001, n ≥ 9 per group).  These results demonstrate that DCA has anti-proliferative properties in addn. to pro-apoptotic properties, and can be effective against highly metastatic disease in vivo, highlighting its potential for clin. use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbbgVFTE8jU7Vg90H21EOLACvtfcHk0lgAWtWV8FsG9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlaruw%253D%253D&md5=f681498dd473ee35e2ced31f317109d0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs10549-009-0435-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-009-0435-9%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DR.%2BC.%26aulast%3DFadia%26aufirst%3DM.%26aulast%3DDahlstrom%26aufirst%3DJ.%2BE.%26aulast%3DParish%26aufirst%3DC.%2BR.%26aulast%3DBoard%26aufirst%3DP.%2BG.%26aulast%3DBlackburn%26aufirst%3DA.%2BC.%26atitle%3DReversal%2520of%2520the%2520glycolytic%2520phenotype%2520by%2520dichloroacetate%2520inhibits%2520metastatic%2520breast%2520cancer%2520cell%2520growth%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2010%26volume%3D120%26spage%3D253%26epage%3D260%26doi%3D10.1007%2Fs10549-009-0435-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pathak, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrache, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harn, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, S.</span></span> <span> </span><span class="NLM_article-title">Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1178</span>– <span class="NLM_lpage">1187</span>, <span class="refDoi"> DOI: 10.1021/cb400944y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400944y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktVSit7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1178-1187&author=R.+K.+Pathakauthor=S.+Marracheauthor=D.+A.+Harnauthor=S.+Dhar&title=Mito-DCA%3A+a+mitochondria+targeted+molecular+scaffold+for+efficacious+delivery+of+metabolic+modulator+dichloroacetate&doi=10.1021%2Fcb400944y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Mito-DCA: A Mitochondria Targeted Molecular Scaffold for Efficacious Delivery of Metabolic Modulator Dichloroacetate</span></div><div class="casAuthors">Pathak, Rakesh K.; Marrache, Sean; Harn, Donald A.; Dhar, Shanta</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1178-1187</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tumor growth is fueled by the use of glycolysis, which normal cells use only in the scarcity of oxygen.  Glycolysis makes tumor cells resistant to normal death processes.  Targeting this unique tumor metab. can provide an alternative strategy to selectively destroy the tumor, leaving normal tissue unharmed.  The orphan drug dichloroacetate (DCA) is a mitochondrial kinase inhibitor that has the ability to show such characteristics.  However, its mol. form shows poor uptake and bioavailability and limited ability to reach its target mitochondria.  Here, we describe a targeted mol. scaffold for construction of a multiple DCA loaded compd., Mito-DCA, with three orders of magnitude enhanced potency and cancer cell specificity compared to DCA.  Incorporation of a lipophilic triphenylphosphonium cation through a biodegradable linker in Mito-DCA allowed for mitochondria targeting.  Mito-DCA did not show any significant metabolic effects toward normal cells but tumor cells with dysfunctional mitochondria were affected by Mito-DCA, which caused a switch from glycolysis to glucose oxidn. and subsequent cell death via apoptosis.  Effective delivery of DCA to the mitochondria resulted in significant redn. in lactate levels and played important roles in modulating dendritic cell (DC) phenotype evidenced by secretion of interleukin-12 from DCs upon activation with tumor antigens from Mito-DCA treated cancer cells.  Targeting mitochondrial metabolic inhibitors to the mitochondria could lead to induction of an efficient antitumor immune response, thus introducing the concept of combining glycolysis inhibition with immune system to destroy tumor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_tg-468e5JrVg90H21EOLACvtfcHk0lh-StM6M6IxKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktVSit7Y%253D&md5=d9a7041a1c8f3417e5bf290e00b092d4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fcb400944y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400944y%26sid%3Dliteratum%253Aachs%26aulast%3DPathak%26aufirst%3DR.%2BK.%26aulast%3DMarrache%26aufirst%3DS.%26aulast%3DHarn%26aufirst%3DD.%2BA.%26aulast%3DDhar%26aufirst%3DS.%26atitle%3DMito-DCA%253A%2520a%2520mitochondria%2520targeted%2520molecular%2520scaffold%2520for%2520efficacious%2520delivery%2520of%2520metabolic%2520modulator%2520dichloroacetate%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1178%26epage%3D1187%26doi%3D10.1021%2Fcb400944y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arambula, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sessler, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, S.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span> <span> </span><span class="NLM_article-title">Overcoming drug resistance by targeting cancer bioenergetics with an activatable prodrug</span>. <i>Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2370</span>– <span class="NLM_lpage">2383</span>, <span class="refDoi"> DOI: 10.1016/j.chempr.2018.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.chempr.2018.08.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFSqtrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=2370-2383&author=A.+Sharmaauthor=M.-G.+Leeauthor=H.+Shiauthor=M.+Wonauthor=J.+F.+Arambulaauthor=J.+L.+Sesslerauthor=J.+Y.+Leeauthor=S.-G.+Chiauthor=J.+S.+Kim&title=Overcoming+drug+resistance+by+targeting+cancer+bioenergetics+with+an+activatable+prodrug&doi=10.1016%2Fj.chempr.2018.08.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming Drug Resistance by Targeting Cancer Bioenergetics with an Activatable Prodrug</span></div><div class="casAuthors">Sharma, Amit; Lee, Min-Goo; Shi, Hu; Won, Miae; Arambula, Jonathan F.; Sessler, Jonathan L.; Lee, Jin Yong; Chi, Sung-Gil; Kim, Jong Seung</div><div class="citationInfo"><span class="NLM_cas:title">Chem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2370-2383</span>CODEN:
                <span class="NLM_cas:coden">CHEMVE</span>;
        ISSN:<span class="NLM_cas:issn">2451-9294</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Nearly without exception, all known cancer chemotherapeutics elicit a resistance response over time.  The resulting resistance is correlated with poor clin. outcomes.  Here, we report an approach to overcoming resistance through reprogramming oncogene-directed alterations in mitochondrial metab. before drug activation while simultaneously circumventing drug efflux pumps.  Conjugate C1 increases cancer cell apoptosis and inhibits regrowth of drug-resistant tumors, as inferred from efficacy studies carried out in human cancer cells and in Dox-resistant xenograft tumor models.  It also displays minimal whole-animal toxicity.  These benefits are ascribed to an ability to evade chemoresistance by switching cancer cell metab. back to normal mitochondrial oxidative phosphorylation while helping target the active Dox to first the mitochondrion and then the nucleus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAfLLSZwksDrVg90H21EOLACvtfcHk0lh-StM6M6IxKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFSqtrzE&md5=40f6f0ff5491fd441e5a8a379cbb2192</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.chempr.2018.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chempr.2018.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DM.-G.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DWon%26aufirst%3DM.%26aulast%3DArambula%26aufirst%3DJ.%2BF.%26aulast%3DSessler%26aufirst%3DJ.%2BL.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DChi%26aufirst%3DS.-G.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26atitle%3DOvercoming%2520drug%2520resistance%2520by%2520targeting%2520cancer%2520bioenergetics%2520with%2520an%2520activatable%2520prodrug%26jtitle%3DChem.%26date%3D2018%26volume%3D4%26spage%3D2370%26epage%3D2383%26doi%3D10.1016%2Fj.chempr.2018.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippard, S. J.</span></span> <span> </span><span class="NLM_article-title">Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">22199</span>– <span class="NLM_lpage">22204</span>, <span class="refDoi"> DOI: 10.1073/pnas.0912276106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1073%2Fpnas.0912276106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=20007777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtlWruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=22199-22204&author=S.+Dharauthor=S.+J.+Lippard&title=Mitaplatin%2C+a+potent+fusion+of+cisplatin+and+the+orphan+drug+dichloroacetate&doi=10.1073%2Fpnas.0912276106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate</span></div><div class="casAuthors">Dhar, Shanta; Lippard, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">22199-22204, S22199/1-S22199/11</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The unique glycolytic metab. of most solid tumors, known as the Warburg effect, is assocd. with resistance to apoptosis that enables cancer cells to survive.  Dichloroacetate (DCA) is an anticancer agent that can reverse the Warburg effect by inhibiting a key enzyme in cancer cells, pyruvate dehydrogenase kinase (PDK), that is required for the process.  DCA is currently not approved for cancer treatment in the USA.  Here, we present the synthesis, characterization, and anticancer properties of c,t,c-[Pt(NH3)2(02CHCl2)2Cl2], mitaplatin, in which two DCA units are appended to the axial positions of a six-coordinate Pt(IV) center.  The neg. intracellular redox potential reduces the platinum to release cisplatin, a Pt(II) compd., and two equiv. of DCA.  By a unique mechanism, mitaplatin thereby attacks both nuclear DNA with cisplatin and mitochondria with DCA selectively in cancer cells.  The cytotoxicity of mitaplatin in a variety of cancer cell lines equals or exceeds that of all known Pt(IV) compds. and is comparable to that of cisplatin.  Mitaplatin alters the mitochondrial membrane potential gradient (Δψm) of cancer cells, promoting apoptosis by releasing cytochrome c and translocating apoptosis inducing factor from mitochondria to the nucleus.  Cisplatin formed upon cellular redn. of mitaplatin enters the nucleus and targets DNA to form 1,2-intrastrand d(GpG) cross-links characteristic of its own potency as an anticancer drug.  These properties of mitaplatin are manifest in its ability to selectively kill cancer cells cocultured with normal fibroblasts and to partially overcome cisplatin resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_Dar40eUqpLVg90H21EOLACvtfcHk0lioj6Uo7XMJbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtlWruw%253D%253D&md5=7d8f3946238537b33ff15a49a4b13d3d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0912276106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0912276106%26sid%3Dliteratum%253Aachs%26aulast%3DDhar%26aufirst%3DS.%26aulast%3DLippard%26aufirst%3DS.%2BJ.%26atitle%3DMitaplatin%252C%2520a%2520potent%2520fusion%2520of%2520cisplatin%2520and%2520the%2520orphan%2520drug%2520dichloroacetate%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D22199%26epage%3D22204%26doi%3D10.1073%2Fpnas.0912276106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zajac, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostrhunova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novohradsky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrana, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raveendran, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparkova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brabec, V.</span></span> <span> </span><span class="NLM_article-title">Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2015.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.jinorgbio.2015.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=26780576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1Sltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2016&pages=89-97&author=J.+Zajacauthor=H.+Kostrhunovaauthor=V.+Novohradskyauthor=O.+Vranaauthor=R.+Raveendranauthor=D.+Gibsonauthor=J.+Kasparkovaauthor=V.+Brabec&title=Potentiation+of+mitochondrial+dysfunction+in+tumor+cells+by+conjugates+of+metabolic+modulator+dichloroacetate+with+a+Pt%28IV%29+derivative+of+oxaliplatin&doi=10.1016%2Fj.jinorgbio.2015.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin</span></div><div class="casAuthors">Zajac, Juraj; Kostrhunova, Hana; Novohradsky, Vojtech; Vrana, Oldrich; Raveendran, Raji; Gibson, Dan; Kasparkova, Jana; Brabec, Viktor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-97</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The mol. and cellular mechanisms of enhanced toxic effects in tumor cells of the Pt(IV) derivs. of antitumor oxaliplatin contg. axial dichloroacetate (DCA) ligands were investigated.  DCA ligands were chosen because DCA has shown great potential as an apoptosis sensitizer and anticancer agent reverting the Wartburg effect.  In addn., DCA reverses mitochondrial changes in a wide range of cancers, promoting tumor cell apoptosis in a mitochondrial-dependent pathway.  We demonstrate that (i) the transformation of oxaliplatin to its Pt(IV) derivs. contg. axial DCA ligands markedly enhances toxicity in cancer cells and helps overcome inherent and acquired resistance to cisplatin and oxaliplatin; (ii) a significant fraction of the intact mols. of DCA conjugates with Pt(IV) deriv. of oxaliplatin accumulates in cancer cells where it releases free DCA; (iii) mechanism of biol. action of the Pt(IV) derivs. of oxaliplatin contg. DCA ligands is connected with the effects of DCA released in cancer cells from the Pt(IV) prodrugs on mitochondria and metab. of glucose; (iv) treatments with the Pt(IV) derivs. of oxaliplatin contg. DCA ligands activate an autophagic response in human colorectal cancer cells; (v) the toxic effects in cancer cells of the Pt(IV) derivs. of oxaliplatin contg. DCA ligands can be potentiated if cells are treated with these prodrugs in combination with 5-fluorouracil.  These properties of the Pt(IV) derivs. of oxaliplatin contg. DCA ligands provide opportunities for further development of new platinum-based agents with the capability of killing cancer cells resistant to conventional antitumor platinum drugs used in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG2vp2jhBrirVg90H21EOLACvtfcHk0lioj6Uo7XMJbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1Sltr8%253D&md5=3b66039a74fa4741e11698a76d2ef394</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2015.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2015.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DZajac%26aufirst%3DJ.%26aulast%3DKostrhunova%26aufirst%3DH.%26aulast%3DNovohradsky%26aufirst%3DV.%26aulast%3DVrana%26aufirst%3DO.%26aulast%3DRaveendran%26aufirst%3DR.%26aulast%3DGibson%26aufirst%3DD.%26aulast%3DKasparkova%26aufirst%3DJ.%26aulast%3DBrabec%26aufirst%3DV.%26atitle%3DPotentiation%2520of%2520mitochondrial%2520dysfunction%2520in%2520tumor%2520cells%2520by%2520conjugates%2520of%2520metabolic%2520modulator%2520dichloroacetate%2520with%2520a%2520Pt%2528IV%2529%2520derivative%2520of%2520oxaliplatin%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2016%26volume%3D156%26spage%3D89%26epage%3D97%26doi%3D10.1016%2Fj.jinorgbio.2015.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petruzzella, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braude, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aldrich-Wright, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, D.</span></span> <span> </span><span class="NLM_article-title">A quadruple-action platinum(IV) prodrug with anticancer activity against KRAS mutated cancer cell lines</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">11539</span>– <span class="NLM_lpage">11544</span>, <span class="refDoi"> DOI: 10.1002/anie.201706739</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1002%2Fanie.201706739" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSlsbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=11539-11544&author=E.+Petruzzellaauthor=J.+P.+Braudeauthor=J.+R.+Aldrich-Wrightauthor=V.+Gandinauthor=D.+Gibson&title=A+quadruple-action+platinum%28IV%29+prodrug+with+anticancer+activity+against+KRAS+mutated+cancer+cell+lines&doi=10.1002%2Fanie.201706739"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A Quadruple-Action Platinum(IV) Prodrug with Anticancer Activity Against KRAS Mutated Cancer Cell Lines</span></div><div class="casAuthors">Petruzzella, Emanuele; Braude, Jeremy Phillip; Aldrich-Wright, Janice R.; Gandin, Valentina; Gibson, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">11539-11544</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We developed a novel PtIV prodrug that simultaneously releases four different bioactive moieties inside the cancer cell.  Its cytotoxicity against monolayer cultures (2D) and spheroid (3D) cancer cells is significantly better than cisplatin.  It is 200-450-fold more potent than cisplatin against KRAS mutated pancreatic and colon cancers and is 40-fold more selective towards KRAS mutated cells compared to non-cancerous.  This is important since RAS proteins play a role in regulating cell differentiation, proliferation, and survival and KRAS is mutated in 90 % of pancreatic adenocarcinomas, 45 % of colorectal cancers, and 35 % of lung adenocarcinomas.  The selectivity index, detd. by dividing the IC50 value in non-cancerous cells by that of a cancerous cell line, is two-fold better than cisplatin, attesting to preferential cytotoxicity towards neoplastic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTQHgQHWGMgbVg90H21EOLACvtfcHk0lhIsLeLoGtmyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSlsbbJ&md5=4a9c4fcc8d6006775b09c9e4c246d175</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fanie.201706739&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201706739%26sid%3Dliteratum%253Aachs%26aulast%3DPetruzzella%26aufirst%3DE.%26aulast%3DBraude%26aufirst%3DJ.%2BP.%26aulast%3DAldrich-Wright%26aufirst%3DJ.%2BR.%26aulast%3DGandin%26aufirst%3DV.%26aulast%3DGibson%26aufirst%3DD.%26atitle%3DA%2520quadruple-action%2520platinum%2528IV%2529%2520prodrug%2520with%2520anticancer%2520activity%2520against%2520KRAS%2520mutated%2520cancer%2520cell%2520lines%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26spage%3D11539%26epage%3D11544%26doi%3D10.1002%2Fanie.201706739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Z. W.</span></span> <span> </span><span class="NLM_article-title">Targeted reversal and phosphorescence lifetime imaging of cancer cell metabolism via a theranostic rhenium(I)-DCA conjugate</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2018.05.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.biomaterials.2018.05.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=29870900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVKnurrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2018&pages=94-105&author=J.+Yangauthor=Q.+Caoauthor=H.+Zhangauthor=L.+Haoauthor=D.+Zhouauthor=Z.+Ganauthor=Z.+Liauthor=Y.+X.+Tongauthor=L.+N.+Jiauthor=Z.+W.+Mao&title=Targeted+reversal+and+phosphorescence+lifetime+imaging+of+cancer+cell+metabolism+via+a+theranostic+rhenium%28I%29-DCA+conjugate&doi=10.1016%2Fj.biomaterials.2018.05.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted reversal and phosphorescence lifetime imaging of cancer cell metabolism via a theranostic rhenium(I)-DCA conjugate</span></div><div class="casAuthors">Yang, Jing; Cao, Qian; Zhang, Hang; Hao, Liang; Zhou, Danxia; Gan, Zhenji; Li, Zhiwei; Tong, Ye-Xiang; Ji, Liang-Nian; Mao, Zong-Wan</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">94-105</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Cancer cell metab. is quite different from normal cells.  Targeting cancer metab. and untuning the tumor metabolic machine has emerged as a promising strategy for cancer therapy.  We have developed a multi-functional Re-dca conjugate (Re-dca 2) by conjugating the metabolic modulator dichloroacetate (DCA) to mitochondria-targeted rhenium(I) complex, allowing its efficient penetration into cancer cells and selective accumulation in mitochondria, thus achieving the cancer cell metab. reversal from glycolysis to glucose oxidn. at pharmacol. relevant DCA doses.  Mechanism studies confirm the inhibition effect of Re-dca 2 on the activity of pyruvate dehydrogenase kinase (PDK) and capture the metabolic reversal window in Re-dca 2 treated NCI-1229 cells at the early stage of drug treatment, resulting in selective killing of malignant cells cocultured with normal cells, significant inhibition of cancer cell metastasis and invasion, as well as excellent anti-angiogenesis activities in zebrafish embryos.  By comparison, DCA-free Re(I) analog is also investigated under the same conditions.  Although this analog also exhibits cytotoxicity due to the Re(I) core, metabolic reversal is not induced by this analog and its anti-metastasis activity is much lower than Re-dca 2, indicating the synergistic effect of Re(I) core and DCA moiety on cancer therapy.  In vivo anti-cancer investigations also indicate that the mitochondria-targeted Re-dca 2 can effectively inhibit the tumor growth without affecting the body wt. of nude mice, and the therapeutic effect is much better than the DCA-free Re(I) analog 2a.  Simultaneously, the O2-sensitive phosphorescent lifetimes of Re-dca 2 can be utilized for PLIM imaging of intracellular oxygen consumption, thus reflecting the Re-dca 2 induced glycolysis-to-glucose oxidn. reversal at the early drug treatment stage.  The excellent phosphorescence of Re-dca 2 can also be utilized for real-time tracking of mitochondrial morphol. changes during treatment.  In a word, rational design of phosphorescent metallodrug and metabolic modulator conjugates for synergistic treatment is a promising strategy for simultaneous untuning and tracking tumor metabolic machine, thus providing new clues for cancer therapy and mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIE-woq3L6CrVg90H21EOLACvtfcHk0lhIsLeLoGtmyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVKnurrM&md5=33ab833eedefbd929010c1f7647c706b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2018.05.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2018.05.040%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHao%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DGan%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DTong%26aufirst%3DY.%2BX.%26aulast%3DJi%26aufirst%3DL.%2BN.%26aulast%3DMao%26aufirst%3DZ.%2BW.%26atitle%3DTargeted%2520reversal%2520and%2520phosphorescence%2520lifetime%2520imaging%2520of%2520cancer%2520cell%2520metabolism%2520via%2520a%2520theranostic%2520rhenium%2528I%2529-DCA%2520conjugate%26jtitle%3DBiomaterials%26date%3D2018%26volume%3D176%26spage%3D94%26epage%3D105%26doi%3D10.1016%2Fj.biomaterials.2018.05.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, P.</span></span> <span> </span><span class="NLM_article-title">Mitochondria-targeted lupane triterpenoid derivatives and their selective apoptosis-inducing anticancer mechanisms</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6353</span>– <span class="NLM_lpage">6363</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00679</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00679" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtV2qsr3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6353-6363&author=Y.+Yeauthor=T.+Zhangauthor=H.+Yuanauthor=D.+Liauthor=H.+Louauthor=P.+Fan&title=Mitochondria-targeted+lupane+triterpenoid+derivatives+and+their+selective+apoptosis-inducing+anticancer+mechanisms&doi=10.1021%2Facs.jmedchem.7b00679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-Targeted Lupane Triterpenoid Derivatives and Their Selective Apoptosis-Inducing Anticancer Mechanisms</span></div><div class="casAuthors">Ye, Yaqing; Zhang, Tao; Yuan, Huiqing; Li, Defeng; Lou, Hongxiang; Fan, Peihong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6353-6363</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Betulin and betulinic acid have been widely studied for their anticancer activities.  However, their further development is limited due to low bioavailability, poor aq. soly., and limited intracellular accumulation.  In the present study, a triphenylphosphonium cation moiety was linked to betulin and betulinic acid to specifically target them to cancer cell mitochondria.  Biol. characterization established that uptake of mitochondria-targeted compd. 1a in the mitochondria of cancer cells was increased compared to betulin.  The mitochondria-targeted derivs. of betulin and betulinic acid showed stronger cytotoxicity than their parent drugs and exhibited more cytotoxic effects in cancer cells than normal cells.  The mechanisms may involve the mitochondrial apoptotic pathway, probably caused by the induction of reactive oxygen species prodn. and reducing mitochondrial membrane potential.  More importantly, 1a significantly inhibited cancer cell proliferation and migration in an in vivo zebrafish xenograft model.  Collectively, these results encourage further study of 1a analogs as anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotxRCv4fRMcbVg90H21EOLACvtfcHk0ljYk8PrNBQeew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtV2qsr3E&md5=b1461bf97acb75e7c68e976462804065</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00679%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DLou%26aufirst%3DH.%26aulast%3DFan%26aufirst%3DP.%26atitle%3DMitochondria-targeted%2520lupane%2520triterpenoid%2520derivatives%2520and%2520their%2520selective%2520apoptosis-inducing%2520anticancer%2520mechanisms%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D6353%26epage%3D6363%26doi%3D10.1021%2Facs.jmedchem.7b00679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samadi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmermann, B. N.</span></span> <span> </span><span class="NLM_article-title">Cytotoxic oleanane-type saponins from Albiziainundata</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">482</span>, <span class="refDoi"> DOI: 10.1021/np100702p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np100702p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVWisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2011&pages=477-482&author=H.+Zhangauthor=A.+K.+Samadiauthor=K.+V.+Raoauthor=M.+S.+Cohenauthor=B.+N.+Timmermann&title=Cytotoxic+oleanane-type+saponins+from+Albiziainundata&doi=10.1021%2Fnp100702p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cytotoxic Oleanane-Type Saponins from Albizia inundata</span></div><div class="casAuthors">Zhang, Huaping; Samadi, Abbas K.; Rao, Karumanchi V.; Cohen, Mark S.; Timmermann, Barbara N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">477-482</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Bioassay-guided fractionation of a CH2Cl2-MeOH ext. of the aerial parts of Albizia inundata resulted in the isolation of two new natural oleanane-type triterpene saponins {3-O-[α-L-arabinopyranosyl(1→6)]-2-acetamido-2-deoxy-β-D-glucopyranosyl oleanolic acid (1) and 3-O-[α-L-arabinopyranosyl(1→2)-α-L-arabinopyranosyl(1→6)]-2-acetamido-2-deoxy-β-D-glucopyranosyl acacic acid lactone (2)} along with seven known saponins 3-O-[α-L-arabinopyranosyl(1→6)]-2-acetamido-2-deoxy-β-D-glucopyranosyl echinocystic acid (3), 3-O-[β-D-xylopyranosyl(1→2)-α-L-arabinopyranosyl(1→6)]-2-acetamido-2-deoxy-β-D-glucopyranosyl acacic acid lactone (concinnoside D) (4), 3-O-[β-D-glucopyranosyl(1→2)]-β-D-glucopyranosyl oleanolic acid (5), 3-O-[α-L-arabinopyranosyl(1→2)-α-L-arabinopyranosyl(1→6)]-β-D-glucopyranosyl oleanolic acid (6), 3-O-[β-D-xylopyranosyl(1→2)-α-L-arabinopyranosyl(1→6)]-β-D-glucopyranosyl oleanolic acid (7), 3-O-[α-L-arabinopyranosyl(1→2)-α-L-arabinopyranosyl(1→6)-β-D-glucopyranosyl(1→2)]-β-D-glucopyranoside echinocystic acid (8), and 3-O-[β-D-xylopyranosyl(1→2)-α-L-arabinopyranosyl(1→6)-β-D-glucopyranosyl(1→2)]-β-D-glucopyranoside echinocystic acid (9).  The structures of 1 and 2 were established on the basis of extensive 2D NMR (1H-1H COSY or DQF-COSY, HSQC, HMBC, TOCSY, and HSQC-TOCSY) spectroscopic, ESIMS, and chem. methods.  Saponins 1, 3, 6, and 7 showed cytotoxicity against human head and neck squamous cells (JMAR, MDA1986) and melanoma cells (B16F10, SKMEL28) with IC50 values in the range 1.8-12.4 μM, using the MTS assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxBqtVu8GpJLVg90H21EOLACvtfcHk0ljYk8PrNBQeew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVWisLY%253D&md5=c8278add0fb4e3550ab096d83799920e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fnp100702p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp100702p%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSamadi%26aufirst%3DA.%2BK.%26aulast%3DRao%26aufirst%3DK.%2BV.%26aulast%3DCohen%26aufirst%3DM.%2BS.%26aulast%3DTimmermann%26aufirst%3DB.%2BN.%26atitle%3DCytotoxic%2520oleanane-type%2520saponins%2520from%2520Albiziainundata%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2011%26volume%3D74%26spage%3D477%26epage%3D482%26doi%3D10.1021%2Fnp100702p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of the anticancer activity of albiziabioside A and its analogues as apoptosis inducers against human melanoma cells</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">5928</span>– <span class="NLM_lpage">5935</span>, <span class="refDoi"> DOI: 10.1039/C4OB00874J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1039%2FC4OB00874J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=24985523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVyltbjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2014&pages=5928-5935&author=G.+Weiauthor=S.+Wangauthor=S.+Cuiauthor=J.+Guoauthor=Y.+Liuauthor=Y.+Liuauthor=M.+Cheng&title=Synthesis+and+evaluation+of+the+anticancer+activity+of+albiziabioside+A+and+its+analogues+as+apoptosis+inducers+against+human+melanoma+cells&doi=10.1039%2FC4OB00874J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of the anticancer activity of albiziabioside A and its analogues as apoptosis inducers against human melanoma cells</span></div><div class="casAuthors">Wei, Gaofei; Wang, Shuai; Cui, Shanshan; Guo, Jia; Liu, Yongxiang; Liu, Yang; Cheng, Maosheng</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">5928-5935</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We have efficiently synthesized albiziabioside A (I) together with its six disaccharide analogs through a linear synthesis, and evaluated their cytotoxicity against six different skin cancer cells.  All of the analogs showed weak cytotoxicity, with the exception of compd. I, which exhibited strong cytotoxicity against A375 cells.  Albiziabioside A can induce cell cycle arrest in both the S and G2/M phases.  Moreover, albiziabioside A can induce A375 cell apoptosis via mitochondrial pathways involving a caspase cascade.  These results provide for the first time a basic mechanism for the anticancer activity of I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEyYYeP_ng57Vg90H21EOLACvtfcHk0ljnMr0lb3uk3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVyltbjI&md5=848516492bbf76110a50bbd29004a586</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1039%2FC4OB00874J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4OB00874J%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520the%2520anticancer%2520activity%2520of%2520albiziabioside%2520A%2520and%2520its%2520analogues%2520as%2520apoptosis%2520inducers%2520against%2520human%2520melanoma%2520cells%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2014%26volume%3D12%26spage%3D5928%26epage%3D5935%26doi%3D10.1039%2FC4OB00874J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.</span></span> <span> </span><span class="NLM_article-title">Natural product-based design, synthesis and biological evaluation of Albiziabioside A derivatives that selectively induce HCT116 cell death</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">92</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.12.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.ejmech.2015.12.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=26922223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1yqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=92-101&author=G.+Weiauthor=S.+Cuiauthor=W.+Luanauthor=S.+Wangauthor=Z.+Houauthor=Y.+Liuauthor=Y.+Liuauthor=M.+Cheng&title=Natural+product-based+design%2C+synthesis+and+biological+evaluation+of+Albiziabioside+A+derivatives+that+selectively+induce+HCT116+cell+death&doi=10.1016%2Fj.ejmech.2015.12.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Natural product-based design, synthesis and biological evaluation of Albiziabioside A derivatives that selectively induce HCT116 cell death</span></div><div class="casAuthors">Wei, Gaofei; Cui, Shanshan; Luan, Weijing; Wang, Shuai; Hou, Zhuang; Liu, Yongxiang; Liu, Yang; Cheng, Maosheng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">92-101</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of Albiziabioside A coupled substituents of cinnamoyl derivs. were designed and synthesized.  The synthesized compds., e.g. I, were screened for anticancer activity against a panel of six human cancer cell lines using a MTT assay.  Synthetic derivs. showed excellent selectivity, as they were toxic against only HCT116 cell line.  Some compds. exhibited better anti-cancer activity against HCT116 compared to pos. controls, such as 5-fluorouracil and Albiziabioside A.  Compd. I was the most active deriv.  Importantly, it was also found that the anti-proliferative activity of I could be attributed to the induction of cell cycle arrest and apoptosis in HCT116 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAI3fVFT24grVg90H21EOLACvtfcHk0ljnMr0lb3uk3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1yqtb4%253D&md5=9b255dae3d6f0e5f4ba6a69d1ec8ac79</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.12.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.12.034%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DG.%26aulast%3DCui%26aufirst%3DS.%26aulast%3DLuan%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHou%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DM.%26atitle%3DNatural%2520product-based%2520design%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520Albiziabioside%2520A%2520derivatives%2520that%2520selectively%2520induce%2520HCT116%2520cell%2520death%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D113%26spage%3D92%26epage%3D101%26doi%3D10.1016%2Fj.ejmech.2015.12.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span> <span> </span><span class="NLM_article-title">Novel antitumor compound optimized from natural saponin Albiziabioside A induced caspase-dependent apoptosis and ferroptosis as a p53 activator through the mitochondrial pathway</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">759</span>– <span class="NLM_lpage">772</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.08.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.ejmech.2018.08.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=30142612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFOqsLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2018&pages=759-772&author=G.+Weiauthor=J.+Sunauthor=Z.+Houauthor=W.+Luanauthor=S.+Wangauthor=S.+Cuiauthor=M.+Chengauthor=Y.+Liu&title=Novel+antitumor+compound+optimized+from+natural+saponin+Albiziabioside+A+induced+caspase-dependent+apoptosis+and+ferroptosis+as+a+p53+activator+through+the+mitochondrial+pathway&doi=10.1016%2Fj.ejmech.2018.08.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Novel antitumor compound optimized from natural saponin Albiziabioside A induced caspase-dependent apoptosis and ferroptosis as a p53 activator through the mitochondrial pathway</span></div><div class="casAuthors">Wei, Gaofei; Sun, Jiahong; Hou, Zhuang; Luan, Weijing; Wang, Shuai; Cui, Shanshan; Cheng, Maosheng; Liu, Yang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">759-772</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">It is highly desirable to activate p53 function with small-mol. compds. for colon cancer therapy.  Triterpene saponin has been characterized with the favorable selectivity and safety profiles.  However, the application of triterpene saponin as cancer chemotherapy drugs was hampered primarily by moderate anticancer potency and the lack the mechanism of action.  In this study, the authors synthesized a series of Albiziabioside A derivs. and evaluated the antitumor activity both in vitro and in vivo.  Compds. D13 possessed strong inhibitory activity against HCT116 cells with IC50 values of 5.19 μM.  More importantly, compd. D13 (28-O-((1-(3-acetylphenyl)-1H-1,2,3-triazol-4-yl)methyl)-3-O-[α-L-arabinopyranosyl-(1→6)-2-acetamido-2-deoxy-β-D-glucopyranosy] oleanolic ester) had a favorable selectivity and was efficacious against MDR cancer cells.  Moreover, compd. D13 could induce apoptosis and ferroptosis through the mitochondrial pathway as a p53 activator.  In addn., compd. D13 significantly suppressed tumorigenesis without inducing toxicity in normal organs in vivo.  Collectively, this study provides a clin. relevant argument for considering triterpene saponin derivs. D13 as potential cancer therapeutic candidates with enhanced activity, acceptable safety and novel mechanisms of action.  To the best of the authors' knowledge, this compd. is the first drug candidate which can induce apoptosis and ferroptosis as a p53 activator.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhhmVSy2TA3rVg90H21EOLACvtfcHk0lhCRyxbCDFQHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFOqsLfF&md5=4c40c677ce6ce7c7a4a3b797a60fb71a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.08.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.08.036%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DG.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DHou%26aufirst%3DZ.%26aulast%3DLuan%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DNovel%2520antitumor%2520compound%2520optimized%2520from%2520natural%2520saponin%2520Albiziabioside%2520A%2520induced%2520caspase-dependent%2520apoptosis%2520and%2520ferroptosis%2520as%2520a%2520p53%2520activator%2520through%2520the%2520mitochondrial%2520pathway%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D157%26spage%3D759%26epage%3D772%26doi%3D10.1016%2Fj.ejmech.2018.08.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortorella, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ververis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karagiannis, T. C.</span></span> <span> </span><span class="NLM_article-title">The Warburg effect: molecular aspects and therapeutic possibilities</span>. <i>Mol. Biol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">825</span>– <span class="NLM_lpage">834</span>, <span class="refDoi"> DOI: 10.1007/s11033-014-3764-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1007%2Fs11033-014-3764-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=25253100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1WjsrjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2015&pages=825-834&author=H.+Ngoauthor=S.+M.+Tortorellaauthor=K.+Ververisauthor=T.+C.+Karagiannis&title=The+Warburg+effect%3A+molecular+aspects+and+therapeutic+possibilities&doi=10.1007%2Fs11033-014-3764-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The Warburg effect: molecular aspects and therapeutic possibilities</span></div><div class="casAuthors">Ngo, Hanh; Tortorella, Stephanie M.; Ververis, Katherine; Karagiannis, Tom C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biology Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">825-834</span>CODEN:
                <span class="NLM_cas:coden">MLBRBU</span>;
        ISSN:<span class="NLM_cas:issn">0301-4851</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  It has been about nine decades since the proposal of Otto Warburg on the metab. of cancer cells.  Unlike normal cells which undergo glycolysis and oxidative phosphorylation in the presence of oxygen, proliferating and cancer cells exhibit an increased uptake of glucose and increased rate of glycolysis and predominantly undergo lactic acid fermn.  Whether this phenomenon is the consequence of genetic dysregulation in cancer or is the cause of cancer still remains unknown.  However, there is certainly a strong link between the genetic factors, epigenetic modulation, cancer immunosurveillance and the Warburg effect, which will be discussed in this review.  Dichloroacetate and 3-bromopyruvate are among the substances that have been studied as potential cancer therapies.  With our expanding knowledge of cellular metab., therapies targeting the Warburg effect appear very promising.  This review discusses different aspects of these emerging therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbYEdx_7JhSLVg90H21EOLACvtfcHk0lgbCnPcN-xtAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1WjsrjN&md5=73de89472472d4facee5e0bb6d0ac1cf</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs11033-014-3764-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11033-014-3764-7%26sid%3Dliteratum%253Aachs%26aulast%3DNgo%26aufirst%3DH.%26aulast%3DTortorella%26aufirst%3DS.%2BM.%26aulast%3DVerveris%26aufirst%3DK.%26aulast%3DKaragiannis%26aufirst%3DT.%2BC.%26atitle%3DThe%2520Warburg%2520effect%253A%2520molecular%2520aspects%2520and%2520therapeutic%2520possibilities%26jtitle%3DMol.%2520Biol.%2520Rep.%26date%3D2015%26volume%3D42%26spage%3D825%26epage%3D834%26doi%3D10.1007%2Fs11033-014-3764-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ribas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ruiz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Checa, J. C.</span></span> <span> </span><span class="NLM_article-title">Mitochondria, cholesterol and cancer cell metabolism</span>. <i>Clin. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1186/s40169-016-0106-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1186%2Fs40169-016-0106-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=27455839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A280%3ADC%252BC2s3jvFWnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=22-46&author=V.+Ribasauthor=C.+Garcia-Ruizauthor=J.+C.+Fernandez-Checa&title=Mitochondria%2C+cholesterol+and+cancer+cell+metabolism&doi=10.1186%2Fs40169-016-0106-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria, cholesterol and cancer cell metabolism</span></div><div class="casAuthors">Ribas Vicent; Garcia-Ruiz Carmen; Fernandez-Checa Jose C; Ribas Vicent; Garcia-Ruiz Carmen; Fernandez-Checa Jose C; Garcia-Ruiz Carmen; Fernandez-Checa Jose C</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and translational medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22</span>
        ISSN:<span class="NLM_cas:issn">2001-1326</span>.
    </div><div class="casAbstract">Given the role of mitochondria in oxygen consumption, metabolism and cell death regulation, alterations in mitochondrial function or dysregulation of cell death pathways contribute to the genesis and progression of cancer.  Cancer cells exhibit an array of metabolic transformations induced by mutations leading to gain-of-function of oncogenes and loss-of-function of tumor suppressor genes that include increased glucose consumption, reduced mitochondrial respiration, increased reactive oxygen species generation and cell death resistance, all of which ensure cancer progression.  Cholesterol metabolism is disturbed in cancer cells and supports uncontrolled cell growth.  In particular, the accumulation of cholesterol in mitochondria emerges as a molecular component that orchestrates some of these metabolic alterations in cancer cells by impairing mitochondrial function.  As a consequence, mitochondrial cholesterol loading in cancer cells may contribute, in part, to the Warburg effect stimulating aerobic glycolysis to meet the energetic demand of proliferating cells, while protecting cancer cells against mitochondrial apoptosis due to changes in mitochondrial membrane dynamics.  Further understanding the complexity in the metabolic alterations of cancer cells, mediated largely through alterations in mitochondrial function, may pave the way to identify more efficient strategies for cancer treatment involving the use of small molecules targeting mitochondria, cholesterol homeostasis/trafficking and specific metabolic pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTwY5kA-3-wozslzEEsg76ufW6udTcc2ebwZuNBfmwKi7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s3jvFWnsg%253D%253D&md5=58aa7c95a432c0714e0654620765c753</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1186%2Fs40169-016-0106-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40169-016-0106-5%26sid%3Dliteratum%253Aachs%26aulast%3DRibas%26aufirst%3DV.%26aulast%3DGarcia-Ruiz%26aufirst%3DC.%26aulast%3DFernandez-Checa%26aufirst%3DJ.%2BC.%26atitle%3DMitochondria%252C%2520cholesterol%2520and%2520cancer%2520cell%2520metabolism%26jtitle%3DClin.%2520Transl.%2520Med.%26date%3D2016%26volume%3D5%26spage%3D22%26epage%3D46%26doi%3D10.1186%2Fs40169-016-0106-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemberg, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamprecht, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skouta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaitsev, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleason, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: an iron-dependent form of nonapoptotic cell death</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">1060</span>– <span class="NLM_lpage">1072</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.03.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.cell.2012.03.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=22632970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC38XnslSntrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2012&pages=1060-1072&author=S.+J.+Dixonauthor=K.+M.+Lembergauthor=M.+R.+Lamprechtauthor=R.+Skoutaauthor=E.+M.+Zaitsevauthor=C.+E.+Gleasonauthor=D.+N.+Patelauthor=A.+J.+Bauerauthor=A.+M.+Cantleyauthor=W.+S.+Yangauthor=B.+Morrisonauthor=B.+R.+Stockwell&title=Ferroptosis%3A+an+iron-dependent+form+of+nonapoptotic+cell+death&doi=10.1016%2Fj.cell.2012.03.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death</span></div><div class="casAuthors">Dixon, Scott J.; Lemberg, Kathryn M.; Lamprecht, Michael R.; Skouta, Rachid; Zaitsev, Eleina M.; Gleason, Caroline E.; Patel, Darpan N.; Bauer, Andras J.; Cantley, Alexandra M.; Yang, Wan Seok; Morrison, Barclay; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1060-1072</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Nonapoptotic forms of cell death may facilitate the selective elimination of some tumor cells or be activated in specific pathol. states.  The oncogenic RAS-selective lethal small mol. erastin triggers a unique iron-dependent form of nonapoptotic cell death that we term ferroptosis.  Ferroptosis is dependent upon intracellular iron, but not other metals, and is morphol., biochem., and genetically distinct from apoptosis, necrosis, and autophagy.  We identify the small mol. ferrostatin-1 as a potent inhibitor of ferroptosis in cancer cells and glutamate-induced cell death in organotypic rat brain slices, suggesting similarities between these two processes.  Indeed, erastin, like glutamate, inhibits cystine uptake by the cystine/glutamate antiporter (system xc-), creating a void in the antioxidant defenses of the cell and ultimately leading to iron-dependent, oxidative death.  Thus, activation of ferroptosis results in the nonapoptotic destruction of certain cancer cells, whereas inhibition of this process may protect organisms from neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzDzMapViBQ7Vg90H21EOLACvtfcHk0ljRM5LaMi-bMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnslSntrw%253D&md5=5d3b8c55a053dfde7e758cc1701ef71b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.03.042%26sid%3Dliteratum%253Aachs%26aulast%3DDixon%26aufirst%3DS.%2BJ.%26aulast%3DLemberg%26aufirst%3DK.%2BM.%26aulast%3DLamprecht%26aufirst%3DM.%2BR.%26aulast%3DSkouta%26aufirst%3DR.%26aulast%3DZaitsev%26aufirst%3DE.%2BM.%26aulast%3DGleason%26aufirst%3DC.%2BE.%26aulast%3DPatel%26aufirst%3DD.%2BN.%26aulast%3DBauer%26aufirst%3DA.%2BJ.%26aulast%3DCantley%26aufirst%3DA.%2BM.%26aulast%3DYang%26aufirst%3DW.%2BS.%26aulast%3DMorrison%26aufirst%3DB.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DFerroptosis%253A%2520an%2520iron-dependent%2520form%2520of%2520nonapoptotic%2520cell%2520death%26jtitle%3DCell%26date%3D2012%26volume%3D149%26spage%3D1060%26epage%3D1072%26doi%3D10.1016%2Fj.cell.2012.03.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Louandre, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcq, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouhlal, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachaier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saidak, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francois, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debuysscher, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbare, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauffert, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galmiche, A.</span></span> <span> </span><span class="NLM_article-title">The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>356</i></span>,  <span class="NLM_fpage">971</span>– <span class="NLM_lpage">977</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2014.11.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.canlet.2014.11.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=25444922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGitb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=356&publication_year=2015&pages=971-977&author=C.+Louandreauthor=I.+Marcqauthor=H.+Bouhlalauthor=E.+Lachaierauthor=C.+Godinauthor=Z.+Saidakauthor=C.+Francoisauthor=D.+Chatelainauthor=V.+Debuysscherauthor=J.+C.+Barbareauthor=B.+Chauffertauthor=A.+Galmiche&title=The+retinoblastoma+%28Rb%29+protein+regulates+ferroptosis+induced+by+sorafenib+in+human+hepatocellular+carcinoma+cells&doi=10.1016%2Fj.canlet.2014.11.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells</span></div><div class="casAuthors">Louandre, Christophe; Marcq, Ingrid; Bouhlal, Hicham; Lachaier, Emma; Godin, Corinne; Saidak, Zuzana; Francois, Catherine; Chatelain, Denis; Debuysscher, Veronique; Barbare, Jean-Claude; Chauffert, Bruno; Galmiche, Antoine</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">356</span>
        (<span class="NLM_cas:issue">2_Part_B</span>),
    <span class="NLM_cas:pages">971-977</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Sorafenib is the treatment of ref. for advanced hepatocellular carcinoma (HCC), the most frequent form of primary liver tumor.  The loss of function of the retinoblastoma (Rb) protein is an important event during liver carcinogenesis, but it is unclear whether the Rb status modulates the response of HCC cells to sorafenib.  Here, we examd. this question in HCC cells with reduced levels of Rb achieved through stable RNA interference.  We show that HCC cells with reduced levels of Rb exhibit a two- to threefold increase in cell death induction upon exposure to sorafenib compared with controls.  Sorafenib treatment of Balb/c nude mice that received tumor xenografts derived from HCC cells with reduced Rb levels resulted in complete tumor regression in 50% of the animals treated, compared with tumor stabilization in mice that received control cells.  We show that, upon exposure to sorafenib, the Rb-neg. status of HCC cells promotes the occurrence of ferroptosis, a form of oxidative necrosis.  The findings highlight the role of Rb in the response of HCC cells to sorafenib and the regulation of ferroptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyULbspsXmPrVg90H21EOLACvtfcHk0ljRM5LaMi-bMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGitb3I&md5=b06b12ef692d8d73cb71a50dc9490ecf</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2014.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2014.11.014%26sid%3Dliteratum%253Aachs%26aulast%3DLouandre%26aufirst%3DC.%26aulast%3DMarcq%26aufirst%3DI.%26aulast%3DBouhlal%26aufirst%3DH.%26aulast%3DLachaier%26aufirst%3DE.%26aulast%3DGodin%26aufirst%3DC.%26aulast%3DSaidak%26aufirst%3DZ.%26aulast%3DFrancois%26aufirst%3DC.%26aulast%3DChatelain%26aufirst%3DD.%26aulast%3DDebuysscher%26aufirst%3DV.%26aulast%3DBarbare%26aufirst%3DJ.%2BC.%26aulast%3DChauffert%26aufirst%3DB.%26aulast%3DGalmiche%26aufirst%3DA.%26atitle%3DThe%2520retinoblastoma%2520%2528Rb%2529%2520protein%2520regulates%2520ferroptosis%2520induced%2520by%2520sorafenib%2520in%2520human%2520hepatocellular%2520carcinoma%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2015%26volume%3D356%26spage%3D971%26epage%3D977%26doi%3D10.1016%2Fj.canlet.2014.11.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manz, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchette, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torti, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torti, S. V.</span></span> <span> </span><span class="NLM_article-title">Iron and cancer: recent insights</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1368</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1111/nyas.13008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1111%2Fnyas.13008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=26890363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC28XotVSlurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1368&publication_year=2016&pages=149-161&author=D.+H.+Manzauthor=N.+L.+Blanchetteauthor=B.+T.+Paulauthor=F.+M.+Tortiauthor=S.+V.+Torti&title=Iron+and+cancer%3A+recent+insights&doi=10.1111%2Fnyas.13008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Iron and cancer: recent insights</span></div><div class="casAuthors">Manz, David H.; Blanchette, Nicole L.; Paul, Bibbin T.; Torti, Frank M.; Torti, Suzy V.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1368</span>
        (<span class="NLM_cas:issue">1, Cooley's Anemia</span>),
    <span class="NLM_cas:pages">149-161</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Iron is an essential dietary element.  However, the ability of iron to cycle between oxidized and reduced forms also renders it capable of contributing to free radical formation, which can have deleterious effects, including promutagenic effects that can potentiate tumor formation.  Dysregulation of iron metab. can increase cancer risk and promote tumor growth.  Cancer cells exhibit an enhanced dependence on iron relative to their normal counterparts, a phenomenon we have termed iron addiction.  Work conducted in the past few years has revealed new cellular processes and mechanisms that deepen our understanding of the link between iron and cancer.  Control of iron efflux through the combined action of ferroportin, an iron efflux pump, and its regulator hepcidin appears to play an important role in tumorigenesis.  Ferroptosis is a form of iron-dependent cell death involving the prodn. of reactive oxygen species.  Specific mechanisms involved in ferroptosis, including depletion of glutathione and inhibition of glutathione peroxidase 4, have been uncovered.  Ferritinophagy is a newly identified mechanism for degrdn. of the iron storage protein ferritin.  Perturbations of mechanisms that control transcripts encoding proteins that regulate iron have been obsd. in cancer cells, including differences in miRNA, methylation, and acetylation.  These new insights may ultimately provide new therapeutic opportunities for treating cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKgIKbYi8YobVg90H21EOLACvtfcHk0lixVuOWfWWgxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotVSlurs%253D&md5=95ebb3d87a2ec39a0a67e9538767d21b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fnyas.13008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fnyas.13008%26sid%3Dliteratum%253Aachs%26aulast%3DManz%26aufirst%3DD.%2BH.%26aulast%3DBlanchette%26aufirst%3DN.%2BL.%26aulast%3DPaul%26aufirst%3DB.%2BT.%26aulast%3DTorti%26aufirst%3DF.%2BM.%26aulast%3DTorti%26aufirst%3DS.%2BV.%26atitle%3DIron%2520and%2520cancer%253A%2520recent%2520insights%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2016%26volume%3D1368%26spage%3D149%26epage%3D161%26doi%3D10.1111%2Fnyas.13008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: process and function</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">369</span>– <span class="NLM_lpage">379</span>, <span class="refDoi"> DOI: 10.1038/cdd.2015.158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1038%2Fcdd.2015.158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=26794443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2jtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=369-379&author=Y.+Xieauthor=W.+Houauthor=X.+Songauthor=Y.+Yuauthor=J.+Huangauthor=X.+Sunauthor=R.+Kangauthor=D.+Tang&title=Ferroptosis%3A+process+and+function&doi=10.1038%2Fcdd.2015.158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis: process and function</span></div><div class="casAuthors">Xie, Y.; Hou, W.; Song, X.; Yu, Y.; Huang, J.; Sun, X.; Kang, R.; Tang, D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">369-379</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ferroptosis is a recently recognized form of regulated cell death.  It is characterized morphol. by the presence of smaller than normal mitochondria with condensed mitochondrial membrane densities, redn. or vanishing of mitochondria crista, and outer mitochondrial membrane rupture.  It can be induced by exptl. compds. (e.g., erastin, Ras-selective lethal small mol. 3, and buthionine sulfoximine) or clin. drugs (e.g., sulfasalazine, sorafenib, and artesunate) in cancer cells and certain normal cells (e.g., kidney tubule cells, neurons, fibroblasts, and T cells).  Activation of mitochondrial voltage-dependent anion channels and mitogen-activated protein kinases, upregulation of endoplasmic reticulum stress, and inhibition of cystine/glutamate antiporter is involved in the induction of ferroptosis.  This process is characterized by the accumulation of lipid peroxidn. products and lethal reactive oxygen species (ROS) derived from iron metab. and can be pharmacol. inhibited by iron chelators (e.g., deferoxamine and desferrioxamine mesylate) and lipid peroxidn. inhibitors (e.g., ferrostatin, liproxstatin, and zileuton).  Glutathione peroxidase 4, heat shock protein beta-1, and nuclear factor erythroid 2-related factor 2 function as neg. regulators of ferroptosis by limiting ROS prodn. and reducing cellular iron uptake, resp.  In contrast, NADPH oxidase and p53 (esp. acetylation-defective mutant p53) act as pos. regulators of ferroptosis by promotion of ROS prodn. and inhibition of expression of SLC7A11 (a specific light-chain subunit of the cystine/glutamate antiporter), resp.  Misregulated ferroptosis has been implicated in multiple physiol. and pathol. processes, including cancer cell death, neurotoxicity, neurodegenerative diseases, acute renal failure, drug-induced hepatotoxicity, hepatic and heart ischemia/reperfusion injury, and T-cell immunity.  In this review, we summarize the regulation mechanisms and signaling pathways of ferroptosis and discuss the role of ferroptosis in disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPYoAemdpXQrVg90H21EOLACvtfcHk0lixVuOWfWWgxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2jtbk%253D&md5=1d0b55e47c4ed56444149c7ba35efb58</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2015.158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2015.158%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%26aulast%3DHou%26aufirst%3DW.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DKang%26aufirst%3DR.%26aulast%3DTang%26aufirst%3DD.%26atitle%3DFerroptosis%253A%2520process%2520and%2520function%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2016%26volume%3D23%26spage%3D369%26epage%3D379%26doi%3D10.1038%2Fcdd.2015.158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">SriRamaratnam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsch, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skouta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viswanathan, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheah, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clemons, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamji, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clish, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girotti, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornish, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span> <span> </span><span class="NLM_article-title">Regulation of ferroptotic cancer cell death by GPX4</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">317</span>– <span class="NLM_lpage">331</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2013.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.cell.2013.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=24439385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtF2is70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2014&pages=317-331&author=W.+S.+Yangauthor=R.+SriRamaratnamauthor=M.+E.+Welschauthor=K.+Shimadaauthor=R.+Skoutaauthor=V.+S.+Viswanathanauthor=J.+H.+Cheahauthor=P.+A.+Clemonsauthor=A.+F.+Shamjiauthor=C.+B.+Clishauthor=L.+M.+Brownauthor=A.+W.+Girottiauthor=V.+W.+Cornishauthor=S.+L.+Schreiberauthor=B.+R.+Stockwell&title=Regulation+of+ferroptotic+cancer+cell+death+by+GPX4&doi=10.1016%2Fj.cell.2013.12.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Ferroptotic Cancer Cell Death by GPX4</span></div><div class="casAuthors">Yang, Wan Seok; SriRamaratnam, Rohitha; Welsch, Matthew E.; Shimada, Kenichi; Skouta, Rachid; Viswanathan, Vasanthi S.; Cheah, Jaime H.; Clemons, Paul A.; Shamji, Alykhan F.; Clish, Clary B.; Brown, Lewis M.; Girotti, Albert W.; Cornish, Virginia W.; Schreiber, Stuart L.; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">317-331</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Ferroptosis is a form of nonapoptotic cell death for which key regulators remain unknown.  We sought a common mediator for the lethality of 12 ferroptosis-inducing small mols.  We used targeted metabolomic profiling to discover that depletion of glutathione causes inactivation of glutathione peroxidases (GPXs) in response to one class of compds. and a chemoproteomics strategy to discover that GPX4 is directly inhibited by a second class of compds.  GPX4 overexpression and knockdown modulated the lethality of 12 ferroptosis inducers, but not of 11 compds. with other lethal mechanisms.  In addn., two representative ferroptosis inducers prevented tumor growth in xenograft mouse tumor models.  Sensitivity profiling in 177 cancer cell lines revealed that diffuse large B cell lymphomas and renal cell carcinomas are particularly susceptible to GPX4-regulated ferroptosis.  Thus, GPX4 is an essential regulator of ferroptotic cancer cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdxNz56kpRuLVg90H21EOLACvtfcHk0lh-WRCY173-MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtF2is70%253D&md5=f5f607e12540847d9a25d8c205ba2e3c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2013.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2013.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%2BS.%26aulast%3DSriRamaratnam%26aufirst%3DR.%26aulast%3DWelsch%26aufirst%3DM.%2BE.%26aulast%3DShimada%26aufirst%3DK.%26aulast%3DSkouta%26aufirst%3DR.%26aulast%3DViswanathan%26aufirst%3DV.%2BS.%26aulast%3DCheah%26aufirst%3DJ.%2BH.%26aulast%3DClemons%26aufirst%3DP.%2BA.%26aulast%3DShamji%26aufirst%3DA.%2BF.%26aulast%3DClish%26aufirst%3DC.%2BB.%26aulast%3DBrown%26aufirst%3DL.%2BM.%26aulast%3DGirotti%26aufirst%3DA.%2BW.%26aulast%3DCornish%26aufirst%3DV.%2BW.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DRegulation%2520of%2520ferroptotic%2520cancer%2520cell%2520death%2520by%2520GPX4%26jtitle%3DCell%26date%3D2014%26volume%3D156%26spage%3D317%26epage%3D331%26doi%3D10.1016%2Fj.cell.2013.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stockwell, B. R.</span></span> <span> </span><span class="NLM_article-title">Ferroptosis: death by lipid peroxidation</span>. <i>Trends Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">165</span>– <span class="NLM_lpage">176</span>, <span class="refDoi"> DOI: 10.1016/j.tcb.2015.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.tcb.2015.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=26653790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVCisbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=165-176&author=W.+S.+Yangauthor=B.+R.+Stockwell&title=Ferroptosis%3A+death+by+lipid+peroxidation&doi=10.1016%2Fj.tcb.2015.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Ferroptosis: Death by Lipid Peroxidation</span></div><div class="casAuthors">Yang, Wan Seok; Stockwell, Brent R.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">165-176</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Ferroptosis is a regulated form of cell death driven by loss of activity of the lipid repair enzyme glutathione peroxidase 4 (GPX4) and subsequent accumulation of lipid-based reactive oxygen species (ROS), particularly lipid hydroperoxides.  This form of iron-dependent cell death is genetically, biochem., and morphol. distinct from other cell death modalities, including apoptosis, unregulated necrosis, and necroptosis.  Ferroptosis is regulated by specific pathways and is involved in diverse biol. contexts.  Here we summarize the discovery of ferroptosis, the mechanism of ferroptosis regulation, and its increasingly appreciated relevance to both normal and pathol. physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs1AaEhcSJa7Vg90H21EOLACvtfcHk0lh-WRCY173-MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVCisbfK&md5=6b46735835ccc4add329d40713a4b6cd</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.tcb.2015.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tcb.2015.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%2BS.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DFerroptosis%253A%2520death%2520by%2520lipid%2520peroxidation%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D2016%26volume%3D26%26spage%3D165%26epage%3D176%26doi%3D10.1016%2Fj.tcb.2015.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. Z.</span></span> <span> </span><span class="NLM_article-title">Switching apoptosis to ferroptosis: metal-organic network for high-efficiency anticancer therapy</span>. <i>Nano Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">284</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1021/acs.nanolett.6b04060</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.nanolett.6b04060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFGgtL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=284-291&author=D.+W.+Zhengauthor=Q.+Leiauthor=J.+Y.+Zhuauthor=J.+X.+Fanauthor=C.+X.+Liauthor=C.+Liauthor=Z.+Xuauthor=S.+X.+Chengauthor=X.+Z.+Zhang&title=Switching+apoptosis+to+ferroptosis%3A+metal-organic+network+for+high-efficiency+anticancer+therapy&doi=10.1021%2Facs.nanolett.6b04060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Switching Apoptosis to Ferroptosis: Metal-Organic Network for High-Efficiency Anticancer Therapy</span></div><div class="casAuthors">Zheng, Di-Wei; Lei, Qi; Zhu, Jing-Yi; Fan, Jin-Xuan; Li, Chu-Xin; Li, Cao; Xu, Zushun; Cheng, Si-Xue; Zhang, Xian-Zheng</div><div class="citationInfo"><span class="NLM_cas:title">Nano Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">284-291</span>CODEN:
                <span class="NLM_cas:coden">NALEFD</span>;
        ISSN:<span class="NLM_cas:issn">1530-6984</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Discovering advanced materials for regulating cell death is of great importance in the development of anticancer therapy.  Herein, by harnessing the recently discovered oxidative stress regulation ability of p53 and the Fenton reaction inducing capability of metal-org. network (MON), MON encapsulated with p53 plasmid (MON-p53) was designed to eradicate cancer cells via ferroptosis/apoptosis hybrid pathway.  After confirming the detailed mechanism of MON-p53 in evoking ferroptosis, we further discovered that MON-p53 mediated a "bystander effect" to further sensitize cancer cells toward the MON-p53 induced ferroptosis.  A 75-day anticancer expt. indicated that MON-p53 treatment not only suppressed the tumor growth but also prolonged the life-span of tumor bearing mice.  Owing to its ability to promote intracellular oxidative stress, MON-p53 decreased the blood metastasis, lung metastasis, and liver metastasis.  As a consequence, discovering methods to induce cell ferroptosis would provide a new insight in designing anticancer materials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjk3LQK93MaLVg90H21EOLACvtfcHk0liNxT3Vl7xHrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFGgtL7J&md5=7b98dcde2542944285e9940c7bb62d57</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.nanolett.6b04060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.nanolett.6b04060%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DD.%2BW.%26aulast%3DLei%26aufirst%3DQ.%26aulast%3DZhu%26aufirst%3DJ.%2BY.%26aulast%3DFan%26aufirst%3DJ.%2BX.%26aulast%3DLi%26aufirst%3DC.%2BX.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DS.%2BX.%26aulast%3DZhang%26aufirst%3DX.%2BZ.%26atitle%3DSwitching%2520apoptosis%2520to%2520ferroptosis%253A%2520metal-organic%2520network%2520for%2520high-efficiency%2520anticancer%2520therapy%26jtitle%3DNano%2520Lett.%26date%3D2017%26volume%3D17%26spage%3D284%26epage%3D291%26doi%3D10.1021%2Facs.nanolett.6b04060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chou, T. C.</span></span> <i>Chemotherapy: synergism and antagonismin The Encyclopedia of Cancer</i>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">Academic Press</span>, <span class="NLM_year">2002</span>; pp  <span class="NLM_fpage">473</span>– <span class="NLM_lpage">484</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2FB0-12-227555-1%2F00504-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=473-484&author=T.+C.+Chou&title=Chemotherapy%3A+synergism+and+antagonismin+The+Encyclopedia+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2FB0-12-227555-1%2F00504-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB0-12-227555-1%252F00504-9%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DT.%2BC.%26btitle%3DChemotherapy%253A%2520synergism%2520and%2520antagonismin%2520The%2520Encyclopedia%2520of%2520Cancer%26pub%3DAcademic%2520Press%26date%3D2002%26spage%3D473%26epage%3D484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chanmee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ontong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konno, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itano, N.</span></span> <span> </span><span class="NLM_article-title">Tumor-associated macrophages as major players in the tumor microenvironment</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1670</span>– <span class="NLM_lpage">1690</span>, <span class="refDoi"> DOI: 10.3390/cancers6031670</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.3390%2Fcancers6031670" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=25125485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252FitFeqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1670-1690&author=T.+Chanmeeauthor=P.+Ontongauthor=K.+Konnoauthor=N.+Itano&title=Tumor-associated+macrophages+as+major+players+in+the+tumor+microenvironment&doi=10.3390%2Fcancers6031670"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-associated macrophages as major players in the tumor microenvironment</span></div><div class="casAuthors">Chanmee Theerawut; Itano Naoki; Ontong Pawared; Konno Kenjiro</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1670-90</span>
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    </div><div class="casAbstract">During tumor progression, circulating monocytes and macrophages are actively recruited into tumors where they alter the tumor microenvironment to accelerate tumor progression.  Macrophages shift their functional phenotypes in response to various microenvironmental signals generated from tumor and stromal cells.  Based on their function, macrophages are divided broadly into two categories: classical M1 and alternative M2 macrophages.  The M1 macrophage is involved in the inflammatory response, pathogen clearance, and antitumor immunity.  In contrast, the M2 macrophage influences an anti-inflammatory response, wound healing, and pro-tumorigenic properties.  Tumor-associated macrophages (TAMs) closely resemble the M2-polarized macrophages and are critical modulators of the tumor microenvironment.  Clinicopathological studies have suggested that TAM accumulation in tumors correlates with a poor clinical outcome.  Consistent with that evidence, experimental and animal studies have supported the notion that TAMs can provide a favorable microenvironment to promote tumor development and progression.  In this review article, we present an overview of mechanisms responsible for TAM recruitment and highlight the roles of TAMs in the regulation of tumor angiogenesis, invasion, metastasis, immunosuppression, and chemotherapeutic resistance.  Finally, we discuss TAM-targeting therapy as a promising novel strategy for an indirect cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3nAZ005HBjHp3bfzSLaX5fW6udTcc2eZ1i1vR1Wu-77ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252FitFeqsw%253D%253D&md5=3ca0072c54401b6cd75d193327e1c7e2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.3390%2Fcancers6031670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers6031670%26sid%3Dliteratum%253Aachs%26aulast%3DChanmee%26aufirst%3DT.%26aulast%3DOntong%26aufirst%3DP.%26aulast%3DKonno%26aufirst%3DK.%26aulast%3DItano%26aufirst%3DN.%26atitle%3DTumor-associated%2520macrophages%2520as%2520major%2520players%2520in%2520the%2520tumor%2520microenvironment%26jtitle%3DCancers%26date%3D2014%26volume%3D6%26spage%3D1670%26epage%3D1690%26doi%3D10.3390%2Fcancers6031670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gyamfi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, J. S.</span></span> <span> </span><span class="NLM_article-title">The role of tumor-associated macrophage in breast cancer biology</span>. <i>Histol. Histopathol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=28681373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlGmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&pages=133-145&author=J.+Choiauthor=J.+Gyamfiauthor=H.+Jangauthor=J.+S.+Koo&title=The+role+of+tumor-associated+macrophage+in+breast+cancer+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The role of tumor-associated macrophage in breast cancer biology</span></div><div class="casAuthors">Choi, Junjeong; Gyamfi, Jones; Jang, Haerin; Koo, Ja Seung</div><div class="citationInfo"><span class="NLM_cas:title">Histology and Histopathology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1,2,3</span>),
    <span class="NLM_cas:pages">133-145</span>CODEN:
                <span class="NLM_cas:coden">HIHIES</span>;
        ISSN:<span class="NLM_cas:issn">0213-3911</span>.
    
            (<span class="NLM_cas:orgname">University of Murcia</span>)
        </div><div class="casAbstract">A review.  Breast cancer is the most commonly diagnosed malignant tumor in women worldwide and contributes significantly as the primary cause of female cancer related mortality.  Hence, research is focused on discovering new and effective treatment targets.  The breast tumor microenvironment (TME) comprising of recruited host stromal cells and tumor cells, has recently emerged as an important player in tumor progression, with the potential for future treatment.  The TME comprises immune system elements (such as macrophages and lymphocytes), cells composing blood vessel, fibroblast, myofibroblast, mesenchymal stem cells, adipocytes and extracellular matrix (ECM).  Among these cells, tumor-assocd. macrophages (TAM) are the prominent components of TME in breast cancers.  Macrophages exhibit a high plasticity in response to various external signals and participate in innate and adoptive immune responses to control numerous factors of TME.  Depending on the microenvironmental signal present, macrophages are polarized into two distinct phenotypes, the classically activated (M1) or the alternative activated (M2) macrophages.  Tumor-assocd. macrophages (TAMs) closely resemble the M2-polarized.  Clinicopathol. studies have suggested that TAM accumulation in tumors correlates with a poor clin. outcome.  In human breast carcinomas, high TAM d. correlates with poor prognosis.  Over the years, studies into the role of TAMs in breast cancer progression have identified TAMs to be capable of inducing angiogenesis, remodelling the tumor extracellular matrix to aid invasion, modeling breast cancer cells to evade host immune system and recruiting immunosuppressive leukocytes to the tumor microenvironment.  Along with these functions, the potential role for TAMs in activation of breast cancer stem cells (CSC) has also emerged.  Thus, TAMs in breast cancer can enhance cancer cell invasion by degrading the ECM, stimulate tumor vascularization and angiogenesis and suppress the antitumor functions of cytotoxic T cells resulting in poor prognosis for patients.  These observations make TAMs an attractive target for therapeutic intervention by targeting various aspects of their function.  This review discusses the mechanisms responsible for TAM recruitment and highlights the roles of TAMs in regulating tumor angiogenesis, invasion, metastasis, immunosuppression, and chemotherapeutic resistance.  Finally, the potential for TAM-targeted therapy as a promising novel strategy is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIKh8NLowpfLVg90H21EOLACvtfcHk0liUQyN_xjHeLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlGmsLs%253D&md5=f935c2ca750285a65c3fd1d1a1e3cee1</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DGyamfi%26aufirst%3DJ.%26aulast%3DJang%26aufirst%3DH.%26aulast%3DKoo%26aufirst%3DJ.%2BS.%26atitle%3DThe%2520role%2520of%2520tumor-associated%2520macrophage%2520in%2520breast%2520cancer%2520biology%26jtitle%3DHistol.%2520Histopathol.%26date%3D2018%26volume%3D33%26spage%3D133%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaijer, S. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwager, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vries, E. G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van
der Vegt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, C. P.</span></span> <span> </span><span class="NLM_article-title">Tumor-associated macrophages in breast cancer: innocent bystander or important player?</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">178</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2018.08.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.ctrv.2018.08.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=30227299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslalsLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2018&pages=178-189&author=S.+Q.+Qiuauthor=S.+J.+H.+Waaijerauthor=M.+C.+Zwagerauthor=E.+G.+E.+de+Vriesauthor=B.+van%0Ader+Vegtauthor=C.+P.+Schroder&title=Tumor-associated+macrophages+in+breast+cancer%3A+innocent+bystander+or+important+player%3F&doi=10.1016%2Fj.ctrv.2018.08.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-associated macrophages in breast cancer: Innocent bystander or important player?</span></div><div class="casAuthors">Qiu, Si-Qi; Waaijer, Stijn J. H.; Zwager, Mieke C.; de Vries, Elisabeth G. E.; van der Vegt, Bert; Schroeder, Carolien P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">178-189</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Tumor-assocd. macrophages (TAMs) are important tumor-promoting cells in the breast tumor microenvironment.  Preclinically TAMs stimulate breast tumor progression, including tumor cell growth, invasion and metastasis.  TAMs also induce resistance to multiple types of treatment in breast cancer models.  The underlying mechanisms include: induction and maintenance of tumor-promoting phenotype in TAMs, inhibition of CD8+ T cell function, degrdn. of extracellular matrix, stimulation of angiogenesis and inhibition of phagocytosis.  Several studies reported that high TAM infiltration of breast tumors is correlated with a worse patient prognosis.  Based on these findings, macrophage-targeted treatment strategies have been developed and are currently being evaluated in clin. breast cancer trials.  These strategies include: inhibition of macrophage recruitment, repolarization of TAMs to an antitumor phenotype, and enhancement of macrophage-mediated tumor cell killing or phagocytosis.  This review summarizes the functional aspects of TAMs and the rationale and current evidence for TAMs as a therapeutic target in breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEqjY2hZRtIbVg90H21EOLACvtfcHk0liUQyN_xjHeLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslalsLvI&md5=9d0f7ad9b91a910109f9ac2e9942eee0</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2018.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2018.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DS.%2BQ.%26aulast%3DWaaijer%26aufirst%3DS.%2BJ.%2BH.%26aulast%3DZwager%26aufirst%3DM.%2BC.%26aulast%3Dde%2BVries%26aufirst%3DE.%2BG.%2BE.%26aulast%3Dvan%2Bder%2BVegt%26aufirst%3DB.%26aulast%3DSchroder%26aufirst%3DC.%2BP.%26atitle%3DTumor-associated%2520macrophages%2520in%2520breast%2520cancer%253A%2520innocent%2520bystander%2520or%2520important%2520player%253F%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2018%26volume%3D70%26spage%3D178%26epage%3D189%26doi%3D10.1016%2Fj.ctrv.2018.08.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akazawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuze, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagaoka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, Y.</span></span> <span> </span><span class="NLM_article-title">M2-like macrophage polarization in high lactic acid-producing head and neck cancer</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>108</i></span>,  <span class="NLM_fpage">1128</span>– <span class="NLM_lpage">1134</span>, <span class="refDoi"> DOI: 10.1111/cas.13244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1111%2Fcas.13244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=28370718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotVKgu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2017&pages=1128-1134&author=T.+Ohashiauthor=M.+Aokiauthor=H.+Tomitaauthor=T.+Akazawaauthor=K.+Satoauthor=B.+Kuzeauthor=K.+Mizutaauthor=A.+Haraauthor=H.+Nagaokaauthor=N.+Inoueauthor=Y.+Ito&title=M2-like+macrophage+polarization+in+high+lactic+acid-producing+head+and+neck+cancer&doi=10.1111%2Fcas.13244"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">M2-like macrophage polarization in high lactic acid-producing head and neck cancer</span></div><div class="casAuthors">Ohashi, Toshimitsu; Aoki, Mitsuhiro; Tomita, Hiroyuki; Akazawa, Takashi; Sato, Katsuya; Kuze, Bunya; Mizuta, Keisuke; Hara, Akira; Nagaoka, Hitoshi; Inoue, Norimitsu; Ito, Yatsuji</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1128-1134</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Reprogramming of glucose metab. in tumor cells is referred to as the Warburg effect and results in increased lactic acid secretion into the tumor microenvironment.  We have previously shown that lactic acid has important roles as a pro-inflammatory and immunosuppressive mediator and promotes tumor progression.  In this study, we examd. the relationship between the lactic acid concn. and expression of LDHA and GLUT1, which are related to the Warburg effect, in human head and neck squamous cell carcinoma (HNSCC).  Tumors expressing lower levels of LDHA and GLUT1 had a higher concn. of lactic acid than those with higher LDHA and GLUT1 expression.  Lactic acid also suppressed the expression of LDHA and GLUT1 in vitro.  We previously reported that lactic acid enhances expression of an M2 macrophage marker, ARG1, in murine macrophages.  Therefore, we investigated the relationship between the lactic acid concn. and polarization of M2 macrophages in HNSCC by measuring the expression of M2 macrophage markers, CSF1R and CD163, normalized using a pan-macrophage marker, CD68.  Tumors with lower levels of CD68 showed a higher concn. of lactic acid, whereas those with higher levels of CSF1R showed a significantly higher concn. of lactic acid.  A similar tendency was obsd. for CD163.  These results suggest that tumor-secreted lactic acid is linked to the redn. of macrophages in tumors and promotes induction of M2-like macrophage polarization in human HNSCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7VxCipjyQN7Vg90H21EOLACvtfcHk0liUQyN_xjHeLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotVKgu70%253D&md5=c6a911d6af52e81ff75cc6c508881ad2</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1111%2Fcas.13244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13244%26sid%3Dliteratum%253Aachs%26aulast%3DOhashi%26aufirst%3DT.%26aulast%3DAoki%26aufirst%3DM.%26aulast%3DTomita%26aufirst%3DH.%26aulast%3DAkazawa%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DKuze%26aufirst%3DB.%26aulast%3DMizuta%26aufirst%3DK.%26aulast%3DHara%26aufirst%3DA.%26aulast%3DNagaoka%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DN.%26aulast%3DIto%26aufirst%3DY.%26atitle%3DM2-like%2520macrophage%2520polarization%2520in%2520high%2520lactic%2520acid-producing%2520head%2520and%2520neck%2520cancer%26jtitle%3DCancer%2520Sci.%26date%3D2017%26volume%3D108%26spage%3D1128%26epage%3D1134%26doi%3D10.1111%2Fcas.13244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Netea-Maier, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smit, J. W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netea, M. G.</span></span> <span> </span><span class="NLM_article-title">Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>413</i></span>,  <span class="NLM_fpage">102</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2017.10.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.canlet.2017.10.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=29111350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsleksb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=413&publication_year=2018&pages=102-109&author=R.+T.+Netea-Maierauthor=J.+W.+A.+Smitauthor=M.+G.+Netea&title=Metabolic+changes+in+tumor+cells+and+tumor-associated+macrophages%3A+A+mutual+relationship&doi=10.1016%2Fj.canlet.2017.10.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship</span></div><div class="casAuthors">Netea-Maier, Romana T.; Smit, Johannes W. A.; Netea, Mihai G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">413</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">102-109</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  In order to adapt to the reduced availability of nutrients and oxygen in the tumor microenvironment and the increased requirements of energy and building blocks necessary for maintaining their high proliferation rate, malignant cells undergo metabolic changes that result in an increased prodn. of lactate, nitric oxide, reactive oxygen species, prostaglandins and other byproducts of arachidonic acid metab. that influence both the compn. of the inflammatory microenvironment and the function of the tumor-assocd. macrophages (TAMs).  In response to cues present in the TME, among which products of altered tumor cell metab., TAMs are also required to reprogram their metab., with activation of glycolysis, fatty acid synthesis and altered nitrogen cycle metab.  These changes result in functional reprogramming of TAMs which includes changes in the prodn. of cytokines and angiogenic factors, and contribute to the tumor progression and metastasis.  Understanding the metabolic changes governing the intricate relationship between the tumor cells and the TAMs represents an essential step towards developing novel therapeutic approaches targeting the metabolic reprogramming of the immune cells to potentiate their tumoricidal potential and to circumvent therapy resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUx3g18kQLZbVg90H21EOLACvtfcHk0li_hFbD-HxEag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsleksb3M&md5=09576f0d282e3f2c2ff08fc8b9e2f7bc</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2017.10.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2017.10.037%26sid%3Dliteratum%253Aachs%26aulast%3DNetea-Maier%26aufirst%3DR.%2BT.%26aulast%3DSmit%26aufirst%3DJ.%2BW.%2BA.%26aulast%3DNetea%26aufirst%3DM.%2BG.%26atitle%3DMetabolic%2520changes%2520in%2520tumor%2520cells%2520and%2520tumor-associated%2520macrophages%253A%2520A%2520mutual%2520relationship%26jtitle%3DCancer%2520Lett.%26date%3D2018%26volume%3D413%26spage%3D102%26epage%3D109%26doi%3D10.1016%2Fj.canlet.2017.10.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, P.</span></span> <span> </span><span class="NLM_article-title">Metabolic reprogramming for cancer cells and their microenvironment: beyond the Warburg effect</span>. <i>Biochim. Biophys. Acta, Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1870</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1016/j.bbcan.2018.06.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.bbcan.2018.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=29959989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Kms7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1870&publication_year=2018&pages=51-66&author=L.+Sunauthor=C.+Suoauthor=S.+T.+Liauthor=H.+Zhangauthor=P.+Gao&title=Metabolic+reprogramming+for+cancer+cells+and+their+microenvironment%3A+beyond+the+Warburg+effect&doi=10.1016%2Fj.bbcan.2018.06.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect</span></div><div class="casAuthors">Sun, Linchong; Suo, Caixia; Li, Shi-ting; Zhang, Huafeng; Gao, Ping</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1870</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-66</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">While metabolic reprogramming of cancer cells has long been considered from the standpoint of how and why cancer cells preferentially utilize glucose via aerobic glycolysis, the so-called Warburg Effect, the progress in the following areas during the past several years has substantially advanced our understanding of the rewired metabolic network in cancer cells that is intertwined with oncogenic signaling.  First, in addn. to the major nutrient substrates glucose and glutamine, cancer cells have been discovered to utilize a variety of unconventional nutrient sources for survival.  Second, the deregulated biomass synthesis is intertwined with cell cycle progression to coordinate the accelerated progression of cancer cells.  Third, the reciprocal regulation of cancer cell's metabolic alterations and the microenvironment, involving extensive host immune cells and microbiota, have come into view as crit. mechanisms to regulate cancer progression.  These and other advances are shaping the current and future paradigm of cancer metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo20YUgrxWL67Vg90H21EOLACvtfcHk0li_hFbD-HxEag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Kms7zE&md5=4a6e4d58cfb56462e1bed23e5a919222</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2018.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2018.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DSuo%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DS.%2BT.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DP.%26atitle%3DMetabolic%2520reprogramming%2520for%2520cancer%2520cells%2520and%2520their%2520microenvironment%253A%2520beyond%2520the%2520Warburg%2520effect%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2018%26volume%3D1870%26spage%3D51%26epage%3D66%26doi%3D10.1016%2Fj.bbcan.2018.06.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span> <span> </span><span class="NLM_article-title">Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK/STAT3 signaling pathway in breast cancer</span>. <i>Cell Cycle</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">438</span>, <span class="refDoi"> DOI: 10.1080/15384101.2018.1444305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1080%2F15384101.2018.1444305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=29468929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmt1anu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=428-438&author=X.+Muauthor=W.+Shiauthor=Y.+Xuauthor=C.+Xuauthor=T.+Zhaoauthor=B.+Gengauthor=J.+Yangauthor=J.+Panauthor=S.+Huauthor=C.+Zhangauthor=J.+Zhangauthor=C.+Wangauthor=J.+Shenauthor=Y.+Cheauthor=Z.+Liuauthor=Y.+Lvauthor=H.+Wenauthor=Q.+You&title=Tumor-derived+lactate+induces+M2+macrophage+polarization+via+the+activation+of+the+ERK%2FSTAT3+signaling+pathway+in+breast+cancer&doi=10.1080%2F15384101.2018.1444305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK/STAT3 signaling pathway in breast cancer</span></div><div class="casAuthors">Mu, Xianmin; Shi, Wei; Xu, Yue; Xu, Che; Zhao, Ting; Geng, Biao; Yang, Jing; Pan, Jinshun; Hu, Shi; Zhang, Chen; Zhang, Juan; Wang, Chao; Shen, Jiajia; Che, Yin; Liu, Zheng; Lv, Yuanfang; Wen, Hao; You, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">428-438</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1551-4005</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Tumor-assocd. macrophages (TAM) are prominent components of tumor microenvironment (TME) and capable of promoting cancer progression.  However, the mechanisms for the formation of M2-like TAMs remain enigmatic.  Here, we show that lactate is a pivotal oncometabolite in the TME that drives macrophage M2-polarization to promote breast cancer proliferation, migration, and angiogenesis.  In addn., we identified that the activation of ERK/STAT3, major signaling mols. in the lactate signaling pathway, deepens our mol. understanding of how lactate educates TAMs.  Moreover, suppression of ERK/STAT3 signaling diminished tumor growth and angiogenesis by abolishing lactate-induced M2 macrophage polarization.  Finally, research data of the natural compd. withanolide D provide evidence for ERK/STAT3 signaling as a potential therapeutic strategy for the prevention and treatment of breast cancer.  These findings suggest that the lactate-ERK/STAT3 signaling pathway is a driver of breast cancer progression by stimulating macrophage M2-like polarization and reveal potential new therapeutic targets for breast cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIbyqrf8oZ7bVg90H21EOLACvtfcHk0li6Jf1mu9PxBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmt1anu7s%253D&md5=eba545f83e1cccb98f745249c704611d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1080%2F15384101.2018.1444305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F15384101.2018.1444305%26sid%3Dliteratum%253Aachs%26aulast%3DMu%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DGeng%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLv%26aufirst%3DY.%26aulast%3DWen%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DQ.%26atitle%3DTumor-derived%2520lactate%2520induces%2520M2%2520macrophage%2520polarization%2520via%2520the%2520activation%2520of%2520the%2520ERK%252FSTAT3%2520signaling%2520pathway%2520in%2520breast%2520cancer%26jtitle%3DCell%2520Cycle%26date%3D2018%26volume%3D17%26spage%3D428%26epage%3D438%26doi%3D10.1080%2F15384101.2018.1444305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amantini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabissi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maines, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burattini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berardi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montironi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tortora, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cascinu, S.</span></span> <span> </span><span class="NLM_article-title">Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma</span>. <i>Cancer Immunol. Immunother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1757</span>– <span class="NLM_lpage">1768</span>, <span class="refDoi"> DOI: 10.1007/s00262-013-1487-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1007%2Fs00262-013-1487-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=24132754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CrtLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2013&pages=1757-1768&author=M.+Santoniauthor=F.+Massariauthor=C.+Amantiniauthor=M.+Nabissiauthor=F.+Mainesauthor=L.+Burattiniauthor=R.+Berardiauthor=G.+Santoniauthor=R.+Montironiauthor=G.+Tortoraauthor=S.+Cascinu&title=Emerging+role+of+tumor-associated+macrophages+as+therapeutic+targets+in+patients+with+metastatic+renal+cell+carcinoma&doi=10.1007%2Fs00262-013-1487-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma</span></div><div class="casAuthors">Santoni, Matteo; Massari, Francesco; Amantini, Consuelo; Nabissi, Massimo; Maines, Francesca; Burattini, Luciano; Berardi, Rossana; Santoni, Giorgio; Montironi, Rodolfo; Tortora, Giampaolo; Cascinu, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Immunology Immunotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1757-1768</span>CODEN:
                <span class="NLM_cas:coden">CIIMDN</span>;
        ISSN:<span class="NLM_cas:issn">0340-7004</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Tumor-assocd. macrophages (TAMs) derived from peripheral blood monocytes recruited into the renal cell carcinoma (RCC) microenvironment.  In response to inflammatory stimuli, macrophages undergo M1 (classical) or M2 (alternative) activation.  M1 cells produce high levels of inflammatory cytokines, such as tumor necrosis factor-α, interleukin (IL)-12, IL-23 and IL-6, while M2 cells produce anti-inflammatory cytokines, such as IL-10, thus contributing to RCC-related immune dysfunction.  The presence of extensive TAM infiltration in RCC microenvironment contributes to cancer progression and metastasis by stimulating angiogenesis, tumor growth, and cellular migration and invasion.  Moreover, TAMs are involved in epithelial-mesenchymal transition of RCC cancer cells and in the development of tumor resistance to targeted agents.  Interestingly, macrophage autophagy seems to play an important role in RCC.  Based on this scenario, TAMs represent a promising and effective target for cancer therapy in RCC.  Several strategies have been proposed to suppress TAM recruitment, to deplete their no., to switch M2 TAMs into antitumor M1 phenotype and to inhibit TAM-assocd. mols.  In this review, we summarize current data on the essential role of TAMs in RCC angiogenesis, invasion, impaired anti-tumor immune response and development of drug resistance, thus describing the emerging TAM-centered therapies for RCC patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolZG976wpuQbVg90H21EOLACvtfcHk0li6Jf1mu9PxBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CrtLvF&md5=1160c0890450df83400121069c437a24</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1007%2Fs00262-013-1487-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00262-013-1487-6%26sid%3Dliteratum%253Aachs%26aulast%3DSantoni%26aufirst%3DM.%26aulast%3DMassari%26aufirst%3DF.%26aulast%3DAmantini%26aufirst%3DC.%26aulast%3DNabissi%26aufirst%3DM.%26aulast%3DMaines%26aufirst%3DF.%26aulast%3DBurattini%26aufirst%3DL.%26aulast%3DBerardi%26aufirst%3DR.%26aulast%3DSantoni%26aufirst%3DG.%26aulast%3DMontironi%26aufirst%3DR.%26aulast%3DTortora%26aufirst%3DG.%26aulast%3DCascinu%26aufirst%3DS.%26atitle%3DEmerging%2520role%2520of%2520tumor-associated%2520macrophages%2520as%2520therapeutic%2520targets%2520in%2520patients%2520with%2520metastatic%2520renal%2520cell%2520carcinoma%26jtitle%3DCancer%2520Immunol.%2520Immunother.%26date%3D2013%26volume%3D62%26spage%3D1757%26epage%3D1768%26doi%3D10.1007%2Fs00262-013-1487-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sica, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larghi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancino, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubino, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totaro, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rimoldi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biswas, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allavena, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantovani, A.</span></span> <span> </span><span class="NLM_article-title">Macrophage polarization in tumour progression</span>. <i>Semin. Cancer Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.1016/j.semcancer.2008.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=10.1016%2Fj.semcancer.2008.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=18467122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVGmsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=349-355&author=A.+Sicaauthor=P.+Larghiauthor=A.+Mancinoauthor=L.+Rubinoauthor=C.+Portaauthor=M.+G.+Totaroauthor=M.+Rimoldiauthor=S.+K.+Biswasauthor=P.+Allavenaauthor=A.+Mantovani&title=Macrophage+polarization+in+tumour+progression&doi=10.1016%2Fj.semcancer.2008.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage polarization in tumour progression</span></div><div class="casAuthors">Sica, Antonio; Larghi, Paola; Mancino, Alessandra; Rubino, Luca; Porta, Chiara; Totaro, Maria Grazia; Rimoldi, Monica; Biswas, Subhra Kumar; Allavena, Paola; Mantovani, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cancer Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">349-355</span>CODEN:
                <span class="NLM_cas:coden">SECBE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-579X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Macrophages are a fundamental part of the innate defense mechanisms, which can promote specific immunity by inducing T cell recruitment and activation.  Despite this, their presence within the tumor microenvironment has been assocd. with enhanced tumor progression and shown to promote cancer cell growth and spread, angiogenesis and immunosuppression.  This paradoxical role of macrophages in cancer finds an explanation in their functional plasticity, that may result in the polarized expression of either pro- or anti-tumoral functions.  Key players in the setting of their phenotype are the microenvironmental signals to which macrophages are exposed, which selectively tune their functions within a functional spectrum encompassing the M1 and M2 extremes.  Here, we discuss recent findings suggesting that targeting tumor-assocd. macrophages (TAMs) polarization may represent a novel therapeutic strategy against cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphZcYy9ySqx7Vg90H21EOLACvtfcHk0lhdO32oS5Dn0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVGmsLo%253D&md5=a786b03442ac65bb774e8b87ea84e0b1</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.semcancer.2008.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcancer.2008.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DSica%26aufirst%3DA.%26aulast%3DLarghi%26aufirst%3DP.%26aulast%3DMancino%26aufirst%3DA.%26aulast%3DRubino%26aufirst%3DL.%26aulast%3DPorta%26aufirst%3DC.%26aulast%3DTotaro%26aufirst%3DM.%2BG.%26aulast%3DRimoldi%26aufirst%3DM.%26aulast%3DBiswas%26aufirst%3DS.%2BK.%26aulast%3DAllavena%26aufirst%3DP.%26aulast%3DMantovani%26aufirst%3DA.%26atitle%3DMacrophage%2520polarization%2520in%2520tumour%2520progression%26jtitle%3DSemin.%2520Cancer%2520Biol.%26date%3D2008%26volume%3D18%26spage%3D349%26epage%3D355%26doi%3D10.1016%2Fj.semcancer.2008.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i27"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00644">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_32873"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00644">10.1021/acs.jmedchem.9b00644</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00644/suppl_file/jm9b00644_si_001.csv">CSV</a>)</p></li><li><p class="inline">Experimental procedures and spectroscopic data for compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00644/suppl_file/jm9b00644_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00644/suppl_file/jm9b00644_si_001.csv">jm9b00644_si_001.csv (0.7 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00644/suppl_file/jm9b00644_si_002.pdf">jm9b00644_si_002.pdf (692.92 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00644&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00644%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-19%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00644" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                10MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679abfd87b523c40","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
